BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qin N, Yang F, Li A, Prifti E, Chen Y, Shao L, Guo J, Le Chatelier E, Yao J, Wu L, Zhou J, Ni S, Liu L, Pons N, Batto JM, Kennedy SP, Leonard P, Yuan C, Ding W, Chen Y, Hu X, Zheng B, Qian G, Xu W, Ehrlich SD, Zheng S, Li L. Alterations of the human gut microbiome in liver cirrhosis. Nature. 2014;513:59-64. [PMID: 25079328 DOI: 10.1038/nature13568] [Cited by in Crossref: 980] [Cited by in F6Publishing: 893] [Article Influence: 122.5] [Reference Citation Analysis]
Number Citing Articles
1 Doycheva I, Leise MD, Watt KD. The Intestinal Microbiome and the Liver Transplant Recipient: What We Know and What We Need to Know. Transplantation. 2016;100:61-68. [PMID: 26647107 DOI: 10.1097/tp.0000000000001008] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
2 Hatton G, Shawcross DL. Is treating the gut microbiome the key to achieving better outcomes in cirrhosis? Expert Review of Gastroenterology & Hepatology 2018;13:1-2. [DOI: 10.1080/17474124.2019.1543587] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
3 Zhu J, Liao M, Yao Z, Liang W, Li Q, Liu J, Yang H, Ji Y, Wei W, Tan A, Liang S, Chen Y, Lin H, Zhu X, Huang S, Tian J, Tang R, Wang Q, Mo Z. Breast cancer in postmenopausal women is associated with an altered gut metagenome. Microbiome 2018;6:136. [PMID: 30081953 DOI: 10.1186/s40168-018-0515-3] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 14.5] [Reference Citation Analysis]
4 Wang JM, Yang MX, Wu QF, Chen J, Deng SF, Chen L, Wei DN, Liang FR. Improvement of intestinal flora: accompany with the antihypertensive effect of electroacupuncture on stage 1 hypertension. Chin Med 2021;16:7. [PMID: 33413552 DOI: 10.1186/s13020-020-00417-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Wu S, Sun C, Li Y, Wang T, Jia L, Lai S, Yang Y, Luo P, Dai D, Yang YQ, Luo Q, Gao NL, Ning K, He LJ, Zhao XM, Chen WH. GMrepo: a database of curated and consistently annotated human gut metagenomes. Nucleic Acids Res 2020;48:D545-53. [PMID: 31504765 DOI: 10.1093/nar/gkz764] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
6 Xue F, Wang Y, Zhao Y, Nan X, Hua D, Sun F, Yang L, Jiang L, Xiong B. Ruminal Methanogenic Responses to the Thiamine Supplementation in High-Concentrate Diets. Animals (Basel) 2020;10:E935. [PMID: 32481707 DOI: 10.3390/ani10060935] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Morgan MY. Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides. Metab Brain Dis 2016;31:1361-4. [PMID: 27638474 DOI: 10.1007/s11011-016-9910-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
8 [DOI: 10.1101/180406] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
9 Jian X, Zhu Y, Ouyang J, Wang Y, Lei Q, Xia J, Guan Y, Zhang J, Guo J, He Y, Wang J, Li J, Lin J, Su M, Li G, Wu M, Qiu L, Xiang J, Xie L, Jia W, Zhou W. Alterations of gut microbiome accelerate multiple myeloma progression by increasing the relative abundances of nitrogen-recycling bacteria. Microbiome 2020;8:74. [PMID: 32466801 DOI: 10.1186/s40168-020-00854-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
10 Lou J, Jiang Y, Rao B, Li A, Ding S, Yan H, Zhou H, Liu Z, Shi Q, Cui G, Yu Z, Ren Z. Fecal Microbiomes Distinguish Patients With Autoimmune Hepatitis From Healthy Individuals. Front Cell Infect Microbiol 2020;10:342. [PMID: 32850468 DOI: 10.3389/fcimb.2020.00342] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Ghapanchi J, Bazargani A, Khorshidi H, Erfani M, Rezazadeh F, Azad A, Derafshi R, Kalantari AH. Isolation and Identification of Non- Commensal Pathogenic Bacteria in the Saliva of Patients Candidate for Liver Transplant: A Cross Sectional Study in Shiraz, South of Iran. J Dent (Shiraz) 2020;21:81-6. [PMID: 32582821 DOI: 10.30476/DENTJODS.2019.77854.] [Reference Citation Analysis]
12 Hsu CL, Duan Y, Fouts DE, Schnabl B. Intestinal virome and therapeutic potential of bacteriophages in liver disease. J Hepatol 2021:S0168-8278(21)01997-8. [PMID: 34437908 DOI: 10.1016/j.jhep.2021.08.003] [Reference Citation Analysis]
13 Kinumaki A, Sekizuka T, Hamada H, Kato K, Yamashita A, Kuroda M. Characterization of the gut microbiota of Kawasaki disease patients by metagenomic analysis. Front Microbiol 2015;6:824. [PMID: 26322033 DOI: 10.3389/fmicb.2015.00824] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
14 Zhou Y, Xu H, Huang H, Li Y, Chen H, He J, Du Y, Chen Y, Zhou Y, Nie Y. Are There Potential Applications of Fecal Microbiota Transplantation beyond Intestinal Disorders? Biomed Res Int. 2019;2019:3469754. [PMID: 31467881 DOI: 10.1155/2019/3469754] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
15 Li T, Li H, Gatesoupe FJ, She R, Lin Q, Yan X, Li J, Li X. Bacterial Signatures of "Red-Operculum" Disease in the Gut of Crucian Carp (Carassius auratus). Microb Ecol 2017;74:510-21. [PMID: 28364130 DOI: 10.1007/s00248-017-0967-1] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 9.2] [Reference Citation Analysis]
16 Zhou YH, Gallins P. A Review and Tutorial of Machine Learning Methods for Microbiome Host Trait Prediction.Front Genet. 2019;10:579. [PMID: 31293616 DOI: 10.3389/fgene.2019.00579] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 16.7] [Reference Citation Analysis]
17 Heidrich V, Bruno JS, Knebel FH, de Molla VC, Miranda-Silva W, Asprino PF, Tucunduva L, Rocha V, Novis Y, Arrais-Rodrigues C, Fregnani ER, Camargo AA. Dental Biofilm Microbiota Dysbiosis Is Associated With the Risk of Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation. Front Immunol 2021;12:692225. [PMID: 34220852 DOI: 10.3389/fimmu.2021.692225] [Reference Citation Analysis]
18 Ruppé E, Greub G, Schrenzel J. Messages from the first International Conference on Clinical Metagenomics (ICCMg). Microbes Infect 2017;19:223-8. [PMID: 28161601 DOI: 10.1016/j.micinf.2017.01.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
19 Shankar V, Reo NV, Paliy O. Simultaneous fecal microbial and metabolite profiling enables accurate classification of pediatric irritable bowel syndrome. Microbiome. 2015;3:73. [PMID: 26653757 DOI: 10.1186/s40168-015-0139-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
20 Bhat M, Arendt BM, Bhat V, Renner EL, Humar A, Allard JP. Implication of the intestinal microbiome in complications of cirrhosis. World J Hepatol 2016; 8(27): 1128-1136 [PMID: 27721918 DOI: 10.4254/wjh.v8.i27.1128] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
21 Brüssow H. Human microbiota: 'the philosophers have only interpreted the world in various ways. The point, however, is to change it'. Microb Biotechnol 2015;8:11-2. [PMID: 25627840 DOI: 10.1111/1751-7915.12259] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
22 Ehrlich SD. The human gut microbiome impacts health and disease. C R Biol 2016;339:319-23. [PMID: 27236827 DOI: 10.1016/j.crvi.2016.04.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
23 Iebba V, Guerrieri F, Di Gregorio V, Levrero M, Gagliardi A, Santangelo F, Sobolev AP, Circi S, Giannelli V, Mannina L, Schippa S, Merli M. Combining amplicon sequencing and metabolomics in cirrhotic patients highlights distinctive microbiota features involved in bacterial translocation, systemic inflammation and hepatic encephalopathy. Sci Rep 2018;8:8210. [PMID: 29844325 DOI: 10.1038/s41598-018-26509-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 7.5] [Reference Citation Analysis]
24 Shi Z, Lei H, Chen G, Yuan P, Cao Z, Ser HL, Zhu X, Wu F, Liu C, Dong M, Song Y, Guo Y, Chen C, Hu K, Zhu Y, Zeng XA, Zhou J, Lu Y, Patterson AD, Zhang L. Impaired Intestinal Akkermansia muciniphila and Aryl Hydrocarbon Receptor Ligands Contribute to Nonalcoholic Fatty Liver Disease in Mice. mSystems 2021;6:e00985-20. [PMID: 33622853 DOI: 10.1128/mSystems.00985-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Louvet A, Mathurin P. Alcoholic liver disease: mechanisms of injury and targeted treatment. Nat Rev Gastroenterol Hepatol. 2015;12:231-242. [PMID: 25782093 DOI: 10.1038/nrgastro.2015.35] [Cited by in Crossref: 371] [Cited by in F6Publishing: 343] [Article Influence: 53.0] [Reference Citation Analysis]
26 Ni J, Fu C, Huang R, Li Z, Li S, Cao P, Zhong K, Ge M, Gao Y. Metabolic syndrome cannot mask the changes of faecal microbiota compositions caused by primary hepatocellular carcinoma. Lett Appl Microbiol 2021;73:73-80. [PMID: 33768575 DOI: 10.1111/lam.13477] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Sun L, Ma L, Zhang H, Cao Y, Wang C, Hou N, Huang N, von Deneen KM, Zhao C, Shi Y, Pan Y, Wang M, Ji G, Nie Y. Fto Deficiency Reduces Anxiety- and Depression-Like Behaviors in Mice via Alterations in Gut Microbiota. Theranostics 2019;9:721-33. [PMID: 30809304 DOI: 10.7150/thno.31562] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 9.3] [Reference Citation Analysis]
28 Gao M, Wang H, Luo H, Sun Y, Wang L, Ding S, Ren H, Gang J, Rao B, Liu S, Wang X, Gao X, Li M, Zou Y, Liu C, Yuan C, Sun J, Cui G, Ren Z. Characterization of the Human Oropharyngeal Microbiomes in SARS-CoV-2 Infection and Recovery Patients. Adv Sci (Weinh) 2021;8:e2102785. [PMID: 34423593 DOI: 10.1002/advs.202102785] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Qu J, Zhao Y, Yin J. Identification and Analysis of Human Microbe-Disease Associations by Matrix Decomposition and Label Propagation. Front Microbiol 2019;10:291. [PMID: 30863376 DOI: 10.3389/fmicb.2019.00291] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
30 Sheng S, Chen J, Zhang Y, Qin Q, Li W, Yan S, Wang Y, Li T, Gao X, Tang L, Li A, Ding S. Structural and Functional Alterations of Gut Microbiota in Males With Hyperuricemia and High Levels of Liver Enzymes. Front Med (Lausanne) 2021;8:779994. [PMID: 34869502 DOI: 10.3389/fmed.2021.779994] [Reference Citation Analysis]
31 Rao BC, Lou JM, Wang WJ, Li A, Cui GY, Yu ZJ, Ren ZG. Human microbiome is a diagnostic biomarker in hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2020;19:109-15. [PMID: 32037278 DOI: 10.1016/j.hbpd.2020.01.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
32 Fukui H. Gut Microbiome-based Therapeutics in Liver Cirrhosis: Basic Consideration for the Next Step. J Clin Transl Hepatol 2017;5:249-60. [PMID: 28936406 DOI: 10.14218/JCTH.2017.00008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
33 Nagao Y, Tanigawa T. Red complex periodontal pathogens are risk factors for liver cirrhosis. Biomed Rep 2019;11:199-206. [PMID: 31632667 DOI: 10.3892/br.2019.1245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Tu Q, Li J, Shi Z, Chen Y, Lin L, Li J, Wang H, Yan J, Zhou Q, Li X, Li L, Zhou J, He Z. HuMiChip2 for strain level identification and functional profiling of human microbiomes. Appl Microbiol Biotechnol 2017;101:423-35. [PMID: 27734124 DOI: 10.1007/s00253-016-7910-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
35 Truong DT, Tett A, Pasolli E, Huttenhower C, Segata N. Microbial strain-level population structure and genetic diversity from metagenomes. Genome Res 2017;27:626-38. [PMID: 28167665 DOI: 10.1101/gr.216242.116] [Cited by in Crossref: 296] [Cited by in F6Publishing: 234] [Article Influence: 59.2] [Reference Citation Analysis]
36 Vaikunthanathan T, Safinia N, Lombardi G, Lechler RI. Microbiota, immunity and the liver. Immunol Lett. 2016;171:36-49. [PMID: 26835593 DOI: 10.1016/j.imlet.2016.01.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
37 Vonaesch P, Morien E, Andrianonimiadana L, Sanke H, Mbecko JR, Huus KE, Naharimanananirina T, Gondje BP, Nigatoloum SN, Vondo SS, Kaleb Kandou JE, Randremanana R, Rakotondrainipiana M, Mazel F, Djorie SG, Gody JC, Finlay BB, Rubbo PA, Wegener Parfrey L, Collard JM, Sansonetti PJ; Afribiota Investigators. Stunted childhood growth is associated with decompartmentalization of the gastrointestinal tract and overgrowth of oropharyngeal taxa. Proc Natl Acad Sci U S A 2018;115:E8489-98. [PMID: 30126990 DOI: 10.1073/pnas.1806573115] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 13.8] [Reference Citation Analysis]
38 Prifti E, Chevaleyre Y, Hanczar B, Belda E, Danchin A, Clément K, Zucker JD. Interpretable and accurate prediction models for metagenomics data. Gigascience 2020;9:giaa010. [PMID: 32150601 DOI: 10.1093/gigascience/giaa010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
39 Park SY, Hwang BO, Lim M, Ok SH, Lee SK, Chun KS, Park KK, Hu Y, Chung WY, Song NY. Oral-Gut Microbiome Axis in Gastrointestinal Disease and Cancer. Cancers (Basel) 2021;13:2124. [PMID: 33924899 DOI: 10.3390/cancers13092124] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Ma JE, Xiong XW, Xu JG, Gong JS, Li J, Xu Q, Li YF, Yang YB, Zhou M, Zhu XN, Tan YW, Sheng WT, Wang ZF, Tu XT, Zeng CY, Zhang XQ, Rao YS. Metagenomic Analysis Identifies Sex-Related Cecal Microbial Gene Functions and Bacterial Taxa in the Quail. Front Vet Sci 2021;8:693755. [PMID: 34660751 DOI: 10.3389/fvets.2021.693755] [Reference Citation Analysis]
41 Elchaninov AV, Fatkhudinov TK, Vishnyakova PA, Lokhonina AV, Sukhikh GT. Phenotypical and Functional Polymorphism of Liver Resident Macrophages. Cells 2019;8:E1032. [PMID: 31491903 DOI: 10.3390/cells8091032] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
42 Li Y, Yi J, Zeng Q, Liu Y, Yang B, Liu B, Li Y, Mehmood K, Hussain R, Tang Z, Zhang H, Li Y. Zearalenone exposure mediated hepatotoxicity via mitochondrial apoptotic and autophagy pathways: Associated with gut microbiome and metabolites. Toxicology 2021;462:152957. [PMID: 34537261 DOI: 10.1016/j.tox.2021.152957] [Reference Citation Analysis]
43 Wang X, Xie G, Zhao A, Zheng X, Huang F, Wang Y, Yao C, Jia W, Liu P. Serum Bile Acids Are Associated with Pathological Progression of Hepatitis B-Induced Cirrhosis. J Proteome Res 2016;15:1126-34. [PMID: 25964117 DOI: 10.1021/acs.jproteome.5b00217] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 6.5] [Reference Citation Analysis]
44 Song W, Sun LY, Zhu ZJ. Effects of Previous Kasai Surgery on Gut Microbiota and Bile Acid in Biliary Atresia With End-Stage Liver Disease. Front Med (Lausanne) 2021;8:704328. [PMID: 34646837 DOI: 10.3389/fmed.2021.704328] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Yang X, Lu D, Zhuo J, Lin Z, Yang M, Xu X. The Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases. Int J Biol Sci 2020;16:2357-66. [PMID: 32760203 DOI: 10.7150/ijbs.46405] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
46 Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol 2021;19:55-71. [PMID: 32887946 DOI: 10.1038/s41579-020-0433-9] [Cited by in Crossref: 125] [Cited by in F6Publishing: 117] [Article Influence: 62.5] [Reference Citation Analysis]
47 Guan G, Wang H, Chen S, Liu G, Xiong X, Tan B, Duraipandiyan V, Al-Dhabi NA, Fang J. Dietary Chitosan Supplementation Increases Microbial Diversity and Attenuates the Severity of Citrobacter rodentium Infection in Mice. Mediators Inflamm 2016;2016:9236196. [PMID: 27761062 DOI: 10.1155/2016/9236196] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
48 Ghosh TS, Rampelli S, Jeffery IB, Santoro A, Neto M, Capri M, Giampieri E, Jennings A, Candela M, Turroni S, Zoetendal EG, Hermes GDA, Elodie C, Meunier N, Brugere CM, Pujos-Guillot E, Berendsen AM, De Groot LCPGM, Feskins EJM, Kaluza J, Pietruszka B, Bielak MJ, Comte B, Maijo-Ferre M, Nicoletti C, De Vos WM, Fairweather-Tait S, Cassidy A, Brigidi P, Franceschi C, O'Toole PW. Mediterranean diet intervention alters the gut microbiome in older people reducing frailty and improving health status: the NU-AGE 1-year dietary intervention across five European countries. Gut 2020;69:1218-28. [PMID: 32066625 DOI: 10.1136/gutjnl-2019-319654] [Cited by in Crossref: 135] [Cited by in F6Publishing: 129] [Article Influence: 67.5] [Reference Citation Analysis]
49 Zhu Q, Hou Q, Huang S, Ou Q, Huo D, Vázquez-Baeza Y, Cen C, Cantu V, Estaki M, Chang H, Belda-Ferre P, Kim HC, Chen K, Knight R, Zhang J. Compositional and genetic alterations in Graves' disease gut microbiome reveal specific diagnostic biomarkers. ISME J 2021. [PMID: 34079079 DOI: 10.1038/s41396-021-01016-7] [Reference Citation Analysis]
50 Chen Y, Liu P, Liu R, Hu S, He Z, Dong G, Feng C, An S, Ying X. Comprehensive Strain-Level Analysis of the Gut Microbe Faecalibacterium prausnitzii in Patients with Liver Cirrhosis. mSystems 2021;6:e0077521. [PMID: 34342541 DOI: 10.1128/mSystems.00775-21] [Reference Citation Analysis]
51 Caussy C, Tripathi A, Humphrey G, Bassirian S, Singh S, Faulkner C, Bettencourt R, Rizo E, Richards L, Xu ZZ, Downes MR, Evans RM, Brenner DA, Sirlin CB, Knight R, Loomba R. A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease. Nat Commun 2019;10:1406. [PMID: 30926798 DOI: 10.1038/s41467-019-09455-9] [Cited by in Crossref: 84] [Cited by in F6Publishing: 84] [Article Influence: 28.0] [Reference Citation Analysis]
52 Mohammed H, Varoni EM, Cochis A, Cordaro M, Gallenzi P, Patini R, Staderini E, Lajolo C, Rimondini L, Rocchetti V. Oral Dysbiosis in Pancreatic Cancer and Liver Cirrhosis: A Review of the Literature. Biomedicines 2018;6:E115. [PMID: 30544974 DOI: 10.3390/biomedicines6040115] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 7.8] [Reference Citation Analysis]
53 Lu H, Chen L, Pan X, Yao Y, Zhang H, Zhu X, Lou X, Zhu C, Wang J, Li L, Wu Z. Lactitol Supplementation Modulates Intestinal Microbiome in Liver Cirrhotic Patients. Front Med (Lausanne) 2021;8:762930. [PMID: 34722597 DOI: 10.3389/fmed.2021.762930] [Reference Citation Analysis]
54 Yu D, Yang Y, Long J, Xu W, Cai Q, Wu J, Cai H, Zheng W, Shu XO. Long-term Diet Quality and Gut Microbiome Functionality: A Prospective, Shotgun Metagenomic Study among Urban Chinese Adults. Curr Dev Nutr 2021;5:nzab026. [PMID: 33937616 DOI: 10.1093/cdn/nzab026] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Yao M, Xie J, Du H, Mcclements DJ, Xiao H, Li L. Progress in microencapsulation of probiotics: A review. Comprehensive Reviews in Food Science and Food Safety 2020;19:857-74. [DOI: 10.1111/1541-4337.12532] [Cited by in Crossref: 47] [Cited by in F6Publishing: 22] [Article Influence: 23.5] [Reference Citation Analysis]
56 Kamer AR, Pushalkar S, Gulivindala D, Butler T, Li Y, Annam KRC, Glodzik L, Ballman KV, Corby PM, Blennow K, Zetterberg H, Saxena D, de Leon MJ. Periodontal dysbiosis associates with reduced CSF Aβ42 in cognitively normal elderly. Alzheimers Dement (Amst) 2021;13:e12172. [PMID: 33869725 DOI: 10.1002/dad2.12172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Kawaguchi T, Suzuki F, Imamura M, Murashima N, Yanase M, Mine T, Fujisawa M, Sato I, Yoshiji H, Okita K, Suzuki K. Rifaximin-altered gut microbiota components associated with liver/neuropsychological functions in patients with hepatic encephalopathy: An exploratory data analysis of phase II/III clinical trials. Hepatol Res 2019;49:404-18. [PMID: 30589492 DOI: 10.1111/hepr.13300] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
58 Chen YX, Lai LN, Zhang HY, Bi YH, Meng L, Li XJ, Tian XX, Wang LM, Fan YM, Zhao ZF, Han DW, Ji C. Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis. World J Gastroenterol 2016; 22(10): 2949-2959 [PMID: 26973391 DOI: 10.3748/wjg.v22.i10.2949] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
59 Yoshioka K, Kakihana K, Doki N, Ohashi K. Gut microbiota and acute graft-versus-host disease. Pharmacol Res 2017;122:90-5. [PMID: 28576475 DOI: 10.1016/j.phrs.2017.05.028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
60 Wang H, Yan Y, Yi X, Duan Y, Wang J, Li S, Luo L, Huang T, Inglis B, Li X, Ji W, Tan T, Si W. Histopathological Features and Composition of Gut Microbiota in Rhesus Monkey of Alcoholic Liver Disease.Front Microbiol. 2019;10:165. [PMID: 30800107 DOI: 10.3389/fmicb.2019.00165] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
61 Guo H, Ma C, Zheng W, Luo Y, Li C, Li X, Ma X, Feng C, Zhang T, Han Y, Luo Z, Zhan Y, Li R, Wang L, Jiang J. Dual‐Stimuli‐Responsive Gut Microbiota‐Targeting Berberine‐CS/PT‐NPs Improved Metabolic Status in Obese Hamsters. Adv Funct Mater 2019;29:1808197. [DOI: 10.1002/adfm.201808197] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
62 Huang R, Li T, Ni J, Bai X, Gao Y, Li Y, Zhang P, Gong Y. Different Sex-Based Responses of Gut Microbiota During the Development of Hepatocellular Carcinoma in Liver-Specific Tsc1-Knockout Mice. Front Microbiol 2018;9:1008. [PMID: 29867896 DOI: 10.3389/fmicb.2018.01008] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
63 Li CC, Liu C, Fu M, Hu KQ, Aizawa K, Takahashi S, Hiroyuki S, Cheng J, von Lintig J, Wang XD. Tomato Powder Inhibits Hepatic Steatosis and Inflammation Potentially Through Restoring SIRT1 Activity and Adiponectin Function Independent of Carotenoid Cleavage Enzymes in Mice. Mol Nutr Food Res 2018;62:e1700738. [PMID: 29266812 DOI: 10.1002/mnfr.201700738] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 8.3] [Reference Citation Analysis]
64 Wu H, Zeng B, Li B, Ren B, Zhao J, Li M, Peng X, Feng M, Li J, Wei H, Cheng L, Zhou X. Research on oral microbiota of monozygotic twins with discordant caries experience - in vitro and in vivo study. Sci Rep 2018;8:7267. [PMID: 29740156 DOI: 10.1038/s41598-018-25636-w] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
65 Lasker S, Rahman MM, Parvez F, Zamila M, Miah P, Nahar K, Kabir F, Sharmin SB, Subhan N, Ahsan GU, Alam MA. High-fat diet-induced metabolic syndrome and oxidative stress in obese rats are ameliorated by yogurt supplementation. Sci Rep 2019;9:20026. [PMID: 31882854 DOI: 10.1038/s41598-019-56538-0] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 14.3] [Reference Citation Analysis]
66 Brown SM, Chen H, Hao Y, Laungani BP, Ali TA, Dong C, Lijeron C, Kim B, Wultsch C, Pei Z, Krampis K. MGS-Fast: Metagenomic shotgun data fast annotation using microbial gene catalogs. Gigascience 2019;8:giz020. [PMID: 30942867 DOI: 10.1093/gigascience/giz020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
67 Chen B, Huang H, Pan CQ. The role of gut microbiota in hepatitis B disease progression and treatment. J Viral Hepat 2021. [PMID: 34415656 DOI: 10.1111/jvh.13595] [Reference Citation Analysis]
68 Bajaj JS. Gut Microbiota as Biosensors in Patients With Cirrhosis. Cell Mol Gastroenterol Hepatol 2019;8:231-3. [PMID: 31132339 DOI: 10.1016/j.jcmgh.2019.04.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
69 Cannon MD, Martin P, Carrion AF. Bacterial Infection in Patients with Cirrhosis: Don't Get Bugged to Death. Dig Dis Sci 2020;65:31-7. [PMID: 31768880 DOI: 10.1007/s10620-019-05943-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
70 Mima K, Nakagawa S, Sawayama H, Ishimoto T, Imai K, Iwatsuki M, Hashimoto D, Baba Y, Yamashita YI, Yoshida N, Chikamoto A, Baba H. The microbiome and hepatobiliary-pancreatic cancers.Cancer Lett. 2017;402:9-15. [PMID: 28527946 DOI: 10.1016/j.canlet.2017.05.001] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 11.4] [Reference Citation Analysis]
71 Yeoh YK, Chen Z, Wong MCS, Hui M, Yu J, Ng SC, Sung JJY, Chan FKL, Chan PKS. Southern Chinese populations harbour non-nucleatum Fusobacteria possessing homologues of the colorectal cancer-associated FadA virulence factor. Gut 2020;69:1998-2007. [PMID: 32051205 DOI: 10.1136/gutjnl-2019-319635] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
72 Rath S, Rud T, Karch A, Pieper DH, Vital M. Pathogenic functions of host microbiota. Microbiome 2018;6:174. [PMID: 30266099 DOI: 10.1186/s40168-018-0542-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
73 Bai X, Ren J, Fan Y, Sun F. KIMI: Knockoff Inference for Motif Identification from molecular sequences with controlled false discovery rate. Bioinformatics 2021;37:759-66. [PMID: 33119059 DOI: 10.1093/bioinformatics/btaa912] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
74 Shen L, Liu L, Ji HF. Regulative effects of curcumin spice administration on gut microbiota and its pharmacological implications. Food Nutr Res 2017;61:1361780. [PMID: 28814952 DOI: 10.1080/16546628.2017.1361780] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 11.8] [Reference Citation Analysis]
75 Wang Z, Lou H, Wang Y, Shamir R, Jiang R, Chen T. GePMI: A statistical model for personal intestinal microbiome identification. NPJ Biofilms Microbiomes 2018;4:20. [PMID: 30210803 DOI: 10.1038/s41522-018-0065-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
76 Weir V, Reddy KR. Nonpharmacologic Management of Hepatic Encephalopathy. Clinics in Liver Disease 2020;24:243-61. [DOI: 10.1016/j.cld.2020.01.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
77 Wu X, Huang S, Huang J, Peng P, Liu Y, Han B, Sun D. Identification of the Potential Role of the Rumen Microbiome in Milk Protein and Fat Synthesis in Dairy Cows Using Metagenomic Sequencing. Animals (Basel) 2021;11:1247. [PMID: 33926012 DOI: 10.3390/ani11051247] [Reference Citation Analysis]
78 Wang Y, Wang S, Wu C, Chen X, Duan Z, Xu Q, Jiang W, Xu L, Wang T, Su L, Wang Y, Chen Y, Zhang J, Huang Y, Tong S, Zhou C, Deng S, Qin N. Oral Microbiome Alterations Associated with Early Childhood Caries Highlight the Importance of Carbohydrate Metabolic Activities. mSystems 2019;4:e00450-19. [PMID: 31690590 DOI: 10.1128/mSystems.00450-19] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
79 Yassour M, Vatanen T, Siljander H, Hämäläinen AM, Härkönen T, Ryhänen SJ, Franzosa EA, Vlamakis H, Huttenhower C, Gevers D, Lander ES, Knip M, Xavier RJ; DIABIMMUNE Study Group. Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability. Sci Transl Med 2016;8:343ra81. [PMID: 27306663 DOI: 10.1126/scitranslmed.aad0917] [Cited by in Crossref: 414] [Cited by in F6Publishing: 367] [Article Influence: 82.8] [Reference Citation Analysis]
80 Zheng N, Li SH, Dong B, Sun W, Li HR, Zhang YL, Li P, Fang ZW, Chen CM, Han XY, Li B, Zhang SY, Xu M, Zhang GX, Xin Y, Ma YF, Wan XY, Yan QL. Comparison of the gut microbiota of short-term and long-term medical workers and non-medical controls: a cross-sectional analysis. Clin Microbiol Infect 2021;27:1285-92. [PMID: 33160036 DOI: 10.1016/j.cmi.2020.10.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
81 Doré J, Multon MC, Béhier JM, Affagard H, Andremont A, Barthélémy P, Batista R, Bonneville M, Bonny C, Boyaval G, Chamaillard M, Chevalier MP, Cordaillat-Simmons M, Cournarie F, Diaz I, Guillaume E, Guyard C, Jouvin-Marche E, Martin FP, Petiteau D; les participants à la table ronde 2 des Ateliers de Giens XXXII. Microbiote intestinal : qu’en attendre au plan physiologique et thérapeutique ? Therapie 2017;72:1-19. [PMID: 28214070 DOI: 10.1016/j.therap.2017.01.001] [Reference Citation Analysis]
82 Hajishengallis G, Chavakis T. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat Rev Immunol 2021;21:426-40. [PMID: 33510490 DOI: 10.1038/s41577-020-00488-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 18.0] [Reference Citation Analysis]
83 Khan A, Ding Z, Ishaq M, Bacha AS, Khan I, Hanif A, Li W, Guo X. Understanding the Effects of Gut Microbiota Dysbiosis on Nonalcoholic Fatty Liver Disease and the Possible Probiotics Role: Recent Updates. Int J Biol Sci 2021;17:818-33. [PMID: 33767591 DOI: 10.7150/ijbs.56214] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
84 Teng F, Yang F, Huang S, Bo C, Xu ZZ, Amir A, Knight R, Ling J, Xu J. Prediction of Early Childhood Caries via Spatial-Temporal Variations of Oral Microbiota. Cell Host Microbe 2015;18:296-306. [PMID: 26355216 DOI: 10.1016/j.chom.2015.08.005] [Cited by in Crossref: 109] [Cited by in F6Publishing: 97] [Article Influence: 18.2] [Reference Citation Analysis]
85 Alili R, Belda E, Le P, Wirth T, Zucker JD, Prifti E, Clément K. Exploring Semi-Quantitative Metagenomic Studies Using Oxford Nanopore Sequencing: A Computational and Experimental Protocol. Genes (Basel) 2021;12:1496. [PMID: 34680891 DOI: 10.3390/genes12101496] [Reference Citation Analysis]
86 Hamid H, Zhang JY, Li WX, Liu C, Li ML, Zhao LH, Ji C, Ma QG. Interactions between the cecal microbiota and non-alcoholic steatohepatitis using laying hens as the model. Poult Sci 2019;98:2509-21. [PMID: 30690636 DOI: 10.3382/ps/pey596] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
87 Xiong F, Wu S, Qin L, Shi M, Li W, Zou H, Li M, Wang G. Transcriptome analysis of grass carp provides insights into disease-related genes and novel regulation pattern of bile acid feedback in response to lithocholic acid. Aquaculture 2019;500:613-21. [DOI: 10.1016/j.aquaculture.2018.10.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
88 Lu M, Xuan S, Wang Z. Oral microbiota: A new view of body health. Food Science and Human Wellness 2019;8:8-15. [DOI: 10.1016/j.fshw.2018.12.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
89 Macnaughtan J, Figorilli F, García-López E, Lu H, Jones H, Sawhney R, Suzuki K, Fairclough S, Marsden J, Moratella A, Cox IJ, Thomas L, Davies N, Williams R, Mookerjee R, Wright G, Jalan R. A Double-Blind, Randomized Placebo-Controlled Trial of Probiotic Lactobacillus casei Shirota in Stable Cirrhotic Patients.Nutrients. 2020;12. [PMID: 32498372 DOI: 10.3390/nu12061651] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
90 Yu L, Zhao XK, Cheng ML, Yang GZ, Wang B, Liu HJ, Hu YX, Zhu LL, Zhang S, Xiao ZW, Liu YM, Zhang BF, Mu M. Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury. Sci Rep 2017;7:1359. [PMID: 28465509 DOI: 10.1038/s41598-017-01271-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
91 Yu X, Jin Y, Zhou W, Xiao T, Wu Z, Su J, Gao H, Shen P, Zheng B, Luo Q, Li L, Xiao Y. Rifaximin Modulates the Gut Microbiota to Prevent Hepatic Encephalopathy in Liver Cirrhosis Without Impacting the Resistome. Front Cell Infect Microbiol 2022;11:761192. [DOI: 10.3389/fcimb.2021.761192] [Reference Citation Analysis]
92 Hoyles L, Fernández-Real JM, Federici M, Serino M, Abbott J, Charpentier J, Heymes C, Luque JL, Anthony E, Barton RH, Chilloux J, Myridakis A, Martinez-Gili L, Moreno-Navarrete JM, Benhamed F, Azalbert V, Blasco-Baque V, Puig J, Xifra G, Ricart W, Tomlinson C, Woodbridge M, Cardellini M, Davato F, Cardolini I, Porzio O, Gentileschi P, Lopez F, Foufelle F, Butcher SA, Holmes E, Nicholson JK, Postic C, Burcelin R, Dumas ME. Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women. Nat Med 2018;24:1070-80. [PMID: 29942096 DOI: 10.1038/s41591-018-0061-3] [Cited by in Crossref: 214] [Cited by in F6Publishing: 197] [Article Influence: 53.5] [Reference Citation Analysis]
93 Okumura T, Horiba K, Kamei H, Takeuchi S, Suzuki T, Torii Y, Kawada JI, Takahashi Y, Ogura Y, Ogi T, Ito Y. Temporal dynamics of the plasma microbiome in recipients at early post-liver transplantation: a retrospective study. BMC Microbiol 2021;21:104. [PMID: 33823791 DOI: 10.1186/s12866-021-02154-w] [Reference Citation Analysis]
94 Grąt M, Wronka KM, Krasnodębski M, Masior Ł, Lewandowski Z, Kosińska I, Grąt K, Stypułkowski J, Rejowski S, Wasilewicz M, Gałęcka M, Szachta P, Krawczyk M. Profile of Gut Microbiota Associated With the Presence of Hepatocellular Cancer in Patients With Liver Cirrhosis. Transplant Proc 2016;48:1687-91. [PMID: 27496472 DOI: 10.1016/j.transproceed.2016.01.077] [Cited by in Crossref: 86] [Cited by in F6Publishing: 76] [Article Influence: 17.2] [Reference Citation Analysis]
95 Kim SE, Park JW, Kim HS, Jang MK, Suk KT, Kim DJ. The Role of Gut Dysbiosis in Acute-on-Chronic Liver Failure. Int J Mol Sci 2021;22:11680. [PMID: 34769109 DOI: 10.3390/ijms222111680] [Reference Citation Analysis]
96 Kemp KM, Colson J, Lorenz RG, Maynard CL, Pollock JS. Early life stress in mice alters gut microbiota independent of maternal microbiota inheritance. Am J Physiol Regul Integr Comp Physiol 2021;320:R663-74. [PMID: 33655759 DOI: 10.1152/ajpregu.00072.2020] [Reference Citation Analysis]
97 Zhou Y, Gao X, Small DM, Chen H. Extreme spicy food cravers displayed increased brain activity in response to pictures of foods containing chili peppers: an fMRI study. Appetite 2019;142:104379. [DOI: 10.1016/j.appet.2019.104379] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
98 Zeng T, Ye Y, Mu C, Wang K, Li R, Wang C. Gut Microbiota and Metabolic Phenotype of Portunus Trituberculatus. Chinese Journal of Analytical Chemistry 2016;44:1867-73. [DOI: 10.1016/s1872-2040(16)60978-7] [Cited by in Crossref: 7] [Article Influence: 1.2] [Reference Citation Analysis]
99 Heintz-Buschart A, May P, Laczny CC, Lebrun LA, Bellora C, Krishna A, Wampach L, Schneider JG, Hogan A, de Beaufort C, Wilmes P. Integrated multi-omics of the human gut microbiome in a case study of familial type 1 diabetes. Nat Microbiol 2016;2:16180. [PMID: 27723761 DOI: 10.1038/nmicrobiol.2016.180] [Cited by in Crossref: 119] [Cited by in F6Publishing: 112] [Article Influence: 19.8] [Reference Citation Analysis]
100 Bernardi M, Moreau R, Angeli P, Schnabl B, Arroyo V. Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis. Journal of Hepatology 2015;63:1272-84. [DOI: 10.1016/j.jhep.2015.07.004] [Cited by in Crossref: 272] [Cited by in F6Publishing: 231] [Article Influence: 38.9] [Reference Citation Analysis]
101 Shen J, McFarland AG, Young VB, Hayden MK, Hartmann EM. Toward Accurate and Robust Environmental Surveillance Using Metagenomics. Front Genet 2021;12:600111. [PMID: 33747038 DOI: 10.3389/fgene.2021.600111] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 Nobs SP, Tuganbaev T, Elinav E. Microbiome diurnal rhythmicity and its impact on host physiology and disease risk. EMBO Rep 2019;20:e47129. [PMID: 30877136 DOI: 10.15252/embr.201847129] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 10.3] [Reference Citation Analysis]
103 Hundertmark J, Krenkel O, Tacke F. Adapted Immune Responses of Myeloid-Derived Cells in Fatty Liver Disease. Front Immunol 2018;9:2418. [PMID: 30405618 DOI: 10.3389/fimmu.2018.02418] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
104 Wu Z, Jin T, Weng J. A thorough analysis of diabetes research in China from 1995 to 2015: current scenario and future scope. Sci China Life Sci 2019;62:46-62. [DOI: 10.1007/s11427-018-9377-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
105 Zhang W, Sun R, Xu L, Liang J, Wu T, Zhou J. Effects of micro-/nano-hydroxyapatite and phytoremediation on fungal community structure in copper contaminated soil. Ecotoxicology and Environmental Safety 2019;174:100-9. [DOI: 10.1016/j.ecoenv.2019.02.048] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
106 Sarangi AN, Goel A, Singh A, Sasi A, Aggarwal R. Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration. BMC Gastroenterol 2017;17:125. [PMID: 29179682 DOI: 10.1186/s12876-017-0683-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
107 Wakita Y, Shimomura Y, Kitada Y, Yamamoto H, Ohashi Y, Matsumoto M. Taxonomic classification for microbiome analysis, which correlates well with the metabolite milieu of the gut. BMC Microbiol 2018;18:188. [PMID: 30445918 DOI: 10.1186/s12866-018-1311-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
108 Guan H, Pu Y, Liu C, Lou T, Tan S, Kong M, Sun Z, Mei Z, Qi Q, Quan Z, Zhao G, Zheng Y. Comparison of Fecal Collection Methods on Variation in Gut Metagenomics and Untargeted Metabolomics. mSphere 2021;6:e0063621. [PMID: 34523982 DOI: 10.1128/mSphere.00636-21] [Reference Citation Analysis]
109 Fukui H. Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far? Diseases. 2019;7. [PMID: 31726747 DOI: 10.3390/diseases7040058] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 10.3] [Reference Citation Analysis]
110 Yin R, Liu S, Jiang X, Zhang X, Wei F, Hu J. The Qingchangligan Formula Alleviates Acute Liver Failure by Regulating Galactose Metabolism and Gut Microbiota. Front Cell Infect Microbiol 2022;11:771483. [DOI: 10.3389/fcimb.2021.771483] [Reference Citation Analysis]
111 Sauerbruch T, Hennenberg M, Trebicka J, Beuers U. Bile Acids, Liver Cirrhosis, and Extrahepatic Vascular Dysfunction. Front Physiol 2021;12:718783. [PMID: 34393832 DOI: 10.3389/fphys.2021.718783] [Reference Citation Analysis]
112 Feng J, Li B, Jiang X, Yang Y, Wells GF, Zhang T, Li X. Antibiotic resistome in a large-scale healthy human gut microbiota deciphered by metagenomic and network analyses: Antibiotic resistome. Environ Microbiol 2018;20:355-68. [DOI: 10.1111/1462-2920.14009] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 13.0] [Reference Citation Analysis]
113 Ridlon JM, Kang DJ, Hylemon PB, Bajaj JS. Gut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut. Dig Dis 2015;33:338-45. [PMID: 26045267 DOI: 10.1159/000371678] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 7.3] [Reference Citation Analysis]
114 Fleury V, Zekeridou A, Lazarevic V, Gaïa N, Giannopoulou C, Genton L, Cancela J, Girard M, Goldstein R, Bally JF, Mombelli A, Schrenzel J, Burkhard PR. Oral Dysbiosis and Inflammation in Parkinson's Disease. J Parkinsons Dis 2021;11:619-31. [PMID: 33646178 DOI: 10.3233/JPD-202459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 Derovs A, Laivacuma S, Krumina A. Targeting Microbiota: What Do We Know about It at Present? Medicina (Kaunas) 2019;55:E459. [PMID: 31405111 DOI: 10.3390/medicina55080459] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
116 Cohen LJ, Kang HS, Chu J, Huang YH, Gordon EA, Reddy BV, Ternei MA, Craig JW, Brady SF. Functional metagenomic discovery of bacterial effectors in the human microbiome and isolation of commendamide, a GPCR G2A/132 agonist. Proc Natl Acad Sci U S A 2015;112:E4825-34. [PMID: 26283367 DOI: 10.1073/pnas.1508737112] [Cited by in Crossref: 92] [Cited by in F6Publishing: 78] [Article Influence: 13.1] [Reference Citation Analysis]
117 Fu M, Zhang X, Liang Y, Lin S, Qian W, Fan S. Alterations in Vaginal Microbiota and Associated Metabolome in Women with Recurrent Implantation Failure. mBio 2020;11:e03242-19. [PMID: 32487762 DOI: 10.1128/mBio.03242-19] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
118 Zhu Q, Li B, He T, Li G, Jiang X. Robust biomarker discovery for microbiome-wide association studies. Methods 2020;173:44-51. [PMID: 31238097 DOI: 10.1016/j.ymeth.2019.06.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
119 Fernández-Murga ML, Petrov PD, Conde I, Castell JV, Goméz-Lechón MJ, Jover R. Advances in drug-induced cholestasis: Clinical perspectives, potential mechanisms and in vitro systems. Food Chem Toxicol 2018;120:196-212. [PMID: 29990576 DOI: 10.1016/j.fct.2018.07.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
120 Bajaj JS, Sikaroodi M, Shamsaddini A, Henseler Z, Santiago-Rodriguez T, Acharya C, Fagan A, Hylemon PB, Fuchs M, Gavis E, Ward T, Knights D, Gillevet PM. Interaction of bacterial metagenome and virome in patients with cirrhosis and hepatic encephalopathy. Gut 2021;70:1162-73. [PMID: 32998876 DOI: 10.1136/gutjnl-2020-322470] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
121 Meng C, Wang W, Hao Z, Liu H. Investigation on the influence of isolated environment on human psychological and physiological health. Science of The Total Environment 2020;716:136972. [DOI: 10.1016/j.scitotenv.2020.136972] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
122 Jiménez-Hernández N, Serrano-Villar S, Domingo A, Pons X, Artacho A, Estrada V, Moya A, Gosalbes MJ. Modulation of Saliva Microbiota through Prebiotic Intervention in HIV-Infected Individuals. Nutrients 2019;11:E1346. [PMID: 31208015 DOI: 10.3390/nu11061346] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
123 Moghadamrad S, Hassan M, McCoy KD, Kirundi J, Kellmann P, De Gottardi A. Attenuated fibrosis in specific pathogen-free microbiota in experimental cholestasis- and toxin-induced liver injury. FASEB J 2019;33:12464-76. [PMID: 31431085 DOI: 10.1096/fj.201901113R] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
124 Harmsen HJ, de Goffau MC. The Human Gut Microbiota. Adv Exp Med Biol. 2016;902:95-108. [PMID: 27161353 DOI: 10.1007/978-3-319-31248-4_7] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 6.7] [Reference Citation Analysis]
125 Nishikawa H, Enomoto H, Nishiguchi S, Iijima H. Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis. Int J Mol Sci. 2020;21:5254. [PMID: 32722100 DOI: 10.3390/ijms21155254] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
126 Ren Z, Jiang J, Xie H, Li A, Lu H, Xu S, Zhou L, Zhang H, Cui G, Chen X, Liu Y, Wu L, Qin N, Sun R, Wang W, Li L, Zheng S. Gut microbial profile analysis by MiSeq sequencing of pancreatic carcinoma patients in China. Oncotarget. 2017;8:95176-95191. [PMID: 29221120 DOI: 10.18632/oncotarget.18820] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 11.4] [Reference Citation Analysis]
127 Bajaj JS, Matin P, White MB, Fagan A, Deeb JG, Acharya C, Dalmet SS, Sikaroodi M, Gillevet PM, Sahingur SE. Periodontal therapy favorably modulates the oral-gut-hepatic axis in cirrhosis. Am J Physiol Gastrointest Liver Physiol 2018;315:G824-37. [PMID: 30118351 DOI: 10.1152/ajpgi.00230.2018] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
128 Zheng R, Wang G, Pang Z, Ran N, Gu Y, Guan X, Yuan Y, Zuo X, Pan H, Zheng J, Wang F. Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma. Cancer Med 2020;9:4232-50. [PMID: 32281295 DOI: 10.1002/cam4.3045] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
129 Curry KD, Nute MG, Treangen TJ. It takes guts to learn: machine learning techniques for disease detection from the gut microbiome. Emerg Top Life Sci 2021;5:815-27. [PMID: 34779841 DOI: 10.1042/ETLS20210213] [Reference Citation Analysis]
130 Shao L, Liao J, Qian J, Chen W, Fan X. MetaGeneBank: a standardized database to study deep sequenced metagenomic data from human fecal specimen. BMC Microbiol 2021;21:263. [PMID: 34592929 DOI: 10.1186/s12866-021-02321-z] [Reference Citation Analysis]
131 Mizuno S, Ono K, Mikami Y, Naganuma M, Fukuda T, Minami K, Masaoka T, Terada S, Yoshida T, Saigusa K, Hirahara N, Miyata H, Suda W, Hattori M, Kanai T. 5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitis. Intest Res 2020;18:69-78. [PMID: 32013315 DOI: 10.5217/ir.2019.00084] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
132 Song Z, Cai Y, Lao X, Wang X, Lin X, Cui Y, Kalavagunta PK, Liao J, Jin L, Shang J, Li J. Taxonomic profiling and populational patterns of bacterial bile salt hydrolase (BSH) genes based on worldwide human gut microbiome. Microbiome 2019;7:9. [PMID: 30674356 DOI: 10.1186/s40168-019-0628-3] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 22.0] [Reference Citation Analysis]
133 Jin Y, Wu Y, Zeng Z, Jin C, Wu S, Wang Y, Fu Z. From the Cover: Exposure to Oral Antibiotics Induces Gut Microbiota Dysbiosis Associated with Lipid Metabolism Dysfunction and Low-Grade Inflammation in Mice. Toxicol Sci 2016;154:140-52. [DOI: 10.1093/toxsci/kfw150] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 8.2] [Reference Citation Analysis]
134 Luo G, Li B, Yang C, Wang Y, Bian X, Li W, Liu F, Huo G. Major Traditional Probiotics: Comparative Genomic Analyses and Roles in Gut Microbiome of Eight Cohorts. Front Microbiol 2019;10:712. [PMID: 31024492 DOI: 10.3389/fmicb.2019.00712] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
135 Wang Z, Wang Q, Wang X, Zhu L, Chen J, Zhang B, Chen Y, Yuan Z. Gut microbial dysbiosis is associated with development and progression of radiation enteritis during pelvic radiotherapy. J Cell Mol Med 2019;23:3747-56. [PMID: 30908851 DOI: 10.1111/jcmm.14289] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 9.3] [Reference Citation Analysis]
136 Wan S, Nie Y, Zhang Y, Huang C, Zhu X. Gut Microbial Dysbiosis Is Associated With Profibrotic Factors in Liver Fibrosis Mice. Front Cell Infect Microbiol 2020;10:18. [PMID: 32083022 DOI: 10.3389/fcimb.2020.00018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
137 Giuffrè M, Campigotto M, Campisciano G, Comar M, Crocè LS. A story of liver and gut microbes: how does the intestinal flora affect liver disease? A review of the literature. Am J Physiol Gastrointest Liver Physiol 2020;318:G889-906. [PMID: 32146836 DOI: 10.1152/ajpgi.00161.2019] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 13.5] [Reference Citation Analysis]
138 Wu H, Cai L, Li D, Wang X, Zhao S, Zou F, Zhou K. Metagenomics Biomarkers Selected for Prediction of Three Different Diseases in Chinese Population. Biomed Res Int 2018;2018:2936257. [PMID: 29568746 DOI: 10.1155/2018/2936257] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
139 Duong N, Bajaj JS. The impact of the gut microbiome on liver transplantation. Curr Opin Organ Transplant 2021;26:587-94. [PMID: 34636770 DOI: 10.1097/MOT.0000000000000930] [Reference Citation Analysis]
140 Gómez-Hurtado I, Such J, Francés R. Microbiome and bacterial translocation in cirrhosis. Gastroenterol Hepatol 2016;39:687-96. [PMID: 26775042 DOI: 10.1016/j.gastrohep.2015.10.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
141 Bromberg JS, Fricke WF, Brinkman CC, Simon T, Mongodin EF. Microbiota-implications for immunity and transplantation. Nat Rev Nephrol. 2015;11:342-353. [PMID: 25963591 DOI: 10.1038/nrneph.2015.70] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
142 Wang C, Yan D, Huang J, Li Y. Impacts of changes in intestinal flora on the metabolism of Sprague-Dawley rats. Bioengineered 2021;12:10603-11. [PMID: 34852718 DOI: 10.1080/21655979.2021.2000242] [Reference Citation Analysis]
143 Lira-Junior R, Boström EA. Oral-gut connection: one step closer to an integrated view of the gastrointestinal tract? Mucosal Immunol 2018;11:316-8. [PMID: 29297500 DOI: 10.1038/mi.2017.116] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
144 Yamamoto K, Ishigami M, Honda T, Takeyama T, Ito T, Ishizu Y, Kuzuya T, Hayashi K, Goto H, Hirooka Y. Influence of proton pump inhibitors on microbiota in chronic liver disease patients. Hepatol Int 2019;13:234-44. [DOI: 10.1007/s12072-019-09932-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
145 [DOI: 10.1101/225581] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
146 Hrncir T, Hrncirova L, Kverka M, Hromadka R, Machova V, Trckova E, Kostovcikova K, Kralickova P, Krejsek J, Tlaskalova-Hogenova H. Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions. Microorganisms 2021;9:957. [PMID: 33946843 DOI: 10.3390/microorganisms9050957] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
147 Buttó LF, Haller D. Functional relevance of microbiome signatures: The correlation era requires tools for consolidation. Journal of Allergy and Clinical Immunology 2017;139:1092-8. [DOI: 10.1016/j.jaci.2017.02.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
148 Meissner EG. The Gut-Liver Axis in Hepatitis C Virus Infection: A Path Towards Altering the Natural History of Fibrosis Progression? Clin Infect Dis 2018;67:878-80. [PMID: 29718134 DOI: 10.1093/cid/ciy208] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
149 Blum HE. The human microbiome. Adv Med Sci 2017;62:414-20. [PMID: 28711782 DOI: 10.1016/j.advms.2017.04.005] [Cited by in Crossref: 87] [Cited by in F6Publishing: 64] [Article Influence: 17.4] [Reference Citation Analysis]
150 Yamamoto K, Honda T, Ito T, Ishizu Y, Kuzuya T, Nakamura M, Miyahara R, Kawashima H, Ishigami M, Fujishiro M. The relationship between oral-origin bacteria in the fecal microbiome and albumin-bilirubin grade in patients with hepatitis C. J Gastroenterol Hepatol 2021;36:790-9. [PMID: 32744764 DOI: 10.1111/jgh.15206] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
151 Sampaio-maia B, Simões-silva L, Pestana M, Araujo R, Soares-silva I. The Role of the Gut Microbiome on Chronic Kidney Disease. Elsevier; 2016. pp. 65-94. [DOI: 10.1016/bs.aambs.2016.06.002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 5.7] [Reference Citation Analysis]
152 Qin W, Song P, Lin G, Huang Y, Wang L, Zhou X, Li S, Zhang T. Gut Microbiota Plasticity Influences the Adaptability of Wild and Domestic Animals in Co-inhabited Areas. Front Microbiol 2020;11:125. [PMID: 32117147 DOI: 10.3389/fmicb.2020.00125] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
153 Lutz P, Nattermann J. Misery acquaints a man with dangerous bedfellows: But how to get rid of them? Liver Int 2017;37:1446-8. [PMID: 28940955 DOI: 10.1111/liv.13472] [Reference Citation Analysis]
154 Sharma SP, Suk KT, Kim DJ. Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases. World J Gastroenterol 2021; 27(37): 6161-6179 [PMID: 34712025 DOI: 10.3748/wjg.v27.i37.6161] [Reference Citation Analysis]
155 Piñero F, Vazquez M, Baré P, Rohr C, Mendizabal M, Sciara M, Alonso C, Fay F, Silva M. A different gut microbiome linked to inflammation found in cirrhotic patients with and without hepatocellular carcinoma. Ann Hepatol 2019;18:480-7. [PMID: 31023615 DOI: 10.1016/j.aohep.2018.10.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
156 Gao R, Kong C, Li H, Huang L, Qu X, Qin N, Qin H. Dysbiosis signature of mycobiota in colon polyp and colorectal cancer. Eur J Clin Microbiol Infect Dis 2017;36:2457-68. [DOI: 10.1007/s10096-017-3085-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
157 Huh YJ, Seo JY, Nam J, Yang J, McDowell A, Kim YK, Lee JH. Bariatric/Metabolic Surgery Induces Noticeable Changes of Microbiota and Their Secreting Extracellular Vesicle Composition in the Gut. Obes Surg 2019;29:2470-84. [PMID: 31129882 DOI: 10.1007/s11695-019-03852-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
158 Bres E, Koppe L. Is there still a place for prebiotics in chronic kidney disease? Nephrol Dial Transplant 2019;34:1812-6. [PMID: 31280294 DOI: 10.1093/ndt/gfz124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
159 Song R, Yao J, Shi Q, Wei R. Nanocomposite of Half-Fin Anchovy Hydrolysates/Zinc Oxide Nanoparticles Exhibits Actual Non-Toxicity and Regulates Intestinal Microbiota, Short-Chain Fatty Acids Production and Oxidative Status in Mice. Mar Drugs 2018;16:E23. [PMID: 29324644 DOI: 10.3390/md16010023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
160 Jin Y, Zeng Z, Wu Y, Zhang S, Fu Z. Oral Exposure of Mice to Carbendazim Induces Hepatic Lipid Metabolism Disorder and Gut Microbiota Dysbiosis. Toxicol Sci 2015;147:116-26. [DOI: 10.1093/toxsci/kfv115] [Cited by in Crossref: 77] [Cited by in F6Publishing: 70] [Article Influence: 11.0] [Reference Citation Analysis]
161 Monteleone AM, Troisi J, Serena G, Fasano A, Dalle Grave R, Cascino G, Marciello F, Calugi S, Scala G, Corrivetti G, Monteleone P. The Gut Microbiome and Metabolomics Profiles of Restricting and Binge-Purging Type Anorexia Nervosa. Nutrients 2021;13:507. [PMID: 33557302 DOI: 10.3390/nu13020507] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
162 Xue F, Nan X, Sun F, Pan X, Guo Y, Jiang L, Xiong B. Metagenome sequencing to analyze the impacts of thiamine supplementation on ruminal fungi in dairy cows fed high-concentrate diets. AMB Express 2018;8:159. [PMID: 30284053 DOI: 10.1186/s13568-018-0680-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
163 Oh TG, Kim SM, Atkins AR, Yu RT, Downes M, Evans RM, Loomba R. Proton pump inhibitor use status does not modify the microbiome signature for cirrhosis. Cell Metab 2021;33:457. [PMID: 33657386 DOI: 10.1016/j.cmet.2021.02.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
164 Doré J, Multon M, Béhier J, Affagard H, Andremont A, Barthélémy P, Batitsa R, Bonneville M, Bonny C, Boyaval G, Chamaillard M, Chevalier M, Cordaillat-simmons M, Cournarie F, Diaz I, Guillaume E, Guyard C, Jouvin-marche E, Martin F, Petiteau D. The human gut microbiome as source of innovation for health: Which physiological and therapeutic outcomes could we expect? Therapies 2017;72:21-38. [DOI: 10.1016/j.therap.2016.12.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
165 Helenius-Hietala J, Suominen AL, Ruokonen H, Knuuttila M, Puukka P, Jula A, Meurman JH, Åberg F. Periodontitis is associated with incident chronic liver disease-A population-based cohort study. Liver Int 2019;39:583-91. [PMID: 30300961 DOI: 10.1111/liv.13985] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
166 Ragusa M, Santagati M, Mirabella F, Lauretta G, Cirnigliaro M, Brex D, Barbagallo C, Domini CN, Gulisano M, Barone R, Trovato L, Oliveri S, Mongelli G, Spitale A, Barbagallo D, Di Pietro C, Stefani S, Rizzo R, Purrello M. Potential Associations Among Alteration of Salivary miRNAs, Saliva Microbiome Structure, and Cognitive Impairments in Autistic Children. Int J Mol Sci 2020;21:E6203. [PMID: 32867322 DOI: 10.3390/ijms21176203] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
167 Liu S, Zhao W, Liu X, Cheng L. Metagenomic analysis of the gut microbiome in atherosclerosis patients identify cross-cohort microbial signatures and potential therapeutic target. FASEB J. 2020;34:14166-14181. [PMID: 32939880 DOI: 10.1096/fj.202000622r] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
168 Dubinkina VB, Tyakht AV, Odintsova VY, Yarygin KS, Kovarsky BA, Pavlenko AV, Ischenko DS, Popenko AS, Alexeev DG, Taraskina AY, Nasyrova RF, Krupitsky EM, Shalikiani NV, Bakulin IG, Shcherbakov PL, Skorodumova LO, Larin AK, Kostryukova ES, Abdulkhakov RA, Abdulkhakov SR, Malanin SY, Ismagilova RK, Grigoryeva TV, Ilina EN, Govorun VM. Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease. Microbiome. 2017;5:141. [PMID: 29041989 DOI: 10.1186/s40168-017-0359-2] [Cited by in Crossref: 124] [Cited by in F6Publishing: 109] [Article Influence: 24.8] [Reference Citation Analysis]
169 Tilg H, Grander C, Moschen AR. How does the microbiome affect liver disease? Clin Liver Dis (Hoboken) 2016;8:123-6. [PMID: 31041079 DOI: 10.1002/cld.586] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
170 Yang B, Petrick JL, Thistle JE, Pinto LA, Kemp TJ, Tran HQ, Gewirtz AT, Waterboer T, Fedirko V, Jenab M, Graubard BI, Weinstein SJ, Albanes D, McGlynn KA. Bacterial Translocation and Risk of Liver Cancer in a Finnish Cohort. Cancer Epidemiol Biomarkers Prev 2019;28:807-13. [PMID: 30602499 DOI: 10.1158/1055-9965.EPI-18-0240] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
171 Ferrere G, Wrzosek L, Cailleux F, Turpin W, Puchois V, Spatz M, Ciocan D, Rainteau D, Humbert L, Hugot C, Gaudin F, Noordine M, Robert V, Berrebi D, Thomas M, Naveau S, Perlemuter G, Cassard A. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice. Journal of Hepatology 2017;66:806-15. [DOI: 10.1016/j.jhep.2016.11.008] [Cited by in Crossref: 127] [Cited by in F6Publishing: 119] [Article Influence: 25.4] [Reference Citation Analysis]
172 Macnaughtan J, Jalan R. Clinical and Pathophysiological Consequences of Alterations in the Microbiome in Cirrhosis. American Journal of Gastroenterology 2015;110:1399-410. [DOI: 10.1038/ajg.2015.313] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
173 Li J, Tuo B. Current and Emerging Approaches for Hepatic Fibrosis Treatment. Gastroenterol Res Pract 2021;2021:6612892. [PMID: 34326871 DOI: 10.1155/2021/6612892] [Reference Citation Analysis]
174 Wang WL, Xu SY, Ren ZG, Tao L, Jiang JW, Zheng SS. Application of metagenomics in the human gut microbiome. World J Gastroenterol 2015; 21(3): 803-814 [PMID: 25624713 DOI: 10.3748/wjg.v21.i3.803] [Cited by in CrossRef: 174] [Cited by in F6Publishing: 127] [Article Influence: 24.9] [Reference Citation Analysis]
175 Wang X, Li MM, Niu Y, Zhang X, Yin JB, Zhao CJ, Wang RT. Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma. Dis Markers 2019;2019:5945721. [PMID: 31485278 DOI: 10.1155/2019/5945721] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
176 Olsen I, Yamazaki K. Can oral bacteria affect the microbiome of the gut? J Oral Microbiol 2019;11:1586422. [PMID: 30911359 DOI: 10.1080/20002297.2019.1586422] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 24.3] [Reference Citation Analysis]
177 Wang X, Ye T, Chen WJ, Lv Y, Hao Z, Chen J, Zhao JY, Wang HP, Cai YK. Structural shift of gut microbiota during chemo-preventive effects of epigallocatechin gallate on colorectal carcinogenesis in mice. World J Gastroenterol 2017; 23(46): 8128-8139 [PMID: 29290650 DOI: 10.3748/wjg.v23.i46.8128] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
178 Xing Z, Zhang Y, Li M, Guo C, Mi S. RBUD: A New Functional Potential Analysis Approach for Whole Microbial Genome Shotgun Sequencing. Microorganisms 2020;8:E1563. [PMID: 33050530 DOI: 10.3390/microorganisms8101563] [Reference Citation Analysis]
179 Tan Z, Yang T, Wang Y, Xing K, Zhang F, Zhao X, Ao H, Chen S, Liu J, Wang C. Metagenomic Analysis of Cecal Microbiome Identified Microbiota and Functional Capacities Associated with Feed Efficiency in Landrace Finishing Pigs. Front Microbiol 2017;8:1546. [PMID: 28848539 DOI: 10.3389/fmicb.2017.01546] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 7.6] [Reference Citation Analysis]
180 Yu Q, Wu L, Ji J, Feng J, Dai W, Li J, Wu J, Guo C. Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma. J Hepatocell Carcinoma 2020;7:271-88. [PMID: 33150145 DOI: 10.2147/JHC.S277870] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
181 Kriss M, Hazleton KZ, Nusbacher NM, Martin CG, Lozupone CA. Low diversity gut microbiota dysbiosis: drivers, functional implications and recovery. Curr Opin Microbiol. 2018;44:34-40. [PMID: 30036705 DOI: 10.1016/j.mib.2018.07.003] [Cited by in Crossref: 105] [Cited by in F6Publishing: 96] [Article Influence: 26.3] [Reference Citation Analysis]
182 Ju C, Tacke F. Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies. Cell Mol Immunol. 2016;13:316-327. [PMID: 26908374 DOI: 10.1038/cmi.2015.104] [Cited by in Crossref: 254] [Cited by in F6Publishing: 243] [Article Influence: 42.3] [Reference Citation Analysis]
183 Kanhar S, Sahoo AK, Mahapatra AK. The ameliorative effect of Homalium nepalense on carbon tetrachloride-induced hepatocellular injury in rats. Biomed Pharmacother 2018;103:903-14. [PMID: 29710507 DOI: 10.1016/j.biopha.2018.04.048] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
184 Piano S, Brocca A, Mareso S, Angeli P. Infections complicating cirrhosis. Liver Int. 2018;38 Suppl 1:126-133. [PMID: 29427501 DOI: 10.1111/liv.13645] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 18.7] [Reference Citation Analysis]
185 Hill-Burns EM, Debelius JW, Morton JT, Wissemann WT, Lewis MR, Wallen ZD, Peddada SD, Factor SA, Molho E, Zabetian CP, Knight R, Payami H. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome. Mov Disord. 2017;32:739-749. [PMID: 28195358 DOI: 10.1002/mds.26942] [Cited by in Crossref: 313] [Cited by in F6Publishing: 281] [Article Influence: 62.6] [Reference Citation Analysis]
186 Bruneau A, Hundertmark J, Guillot A, Tacke F. Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases. Front Med (Lausanne) 2021;8:725390. [PMID: 34650994 DOI: 10.3389/fmed.2021.725390] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
187 Schwenger KJ, Clermont-Dejean N, Allard JP. The role of the gut microbiome in chronic liver disease: the clinical evidence revised. JHEP Rep 2019;1:214-26. [PMID: 32039372 DOI: 10.1016/j.jhepr.2019.04.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 9.7] [Reference Citation Analysis]
188 Anand G, Zarrinpar A, Loomba R. Targeting Dysbiosis for the Treatment of Liver Disease. Semin Liver Dis. 2016;36:37-47. [PMID: 26870931 DOI: 10.1055/s-0035-1571276] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
189 Jie Z, Xia H, Zhong SL, Feng Q, Li S, Liang S, Zhong H, Liu Z, Gao Y, Zhao H, Zhang D, Su Z, Fang Z, Lan Z, Li J, Xiao L, Li J, Li R, Li X, Li F, Ren H, Huang Y, Peng Y, Li G, Wen B, Dong B, Chen JY, Geng QS, Zhang ZW, Yang H, Wang J, Wang J, Zhang X, Madsen L, Brix S, Ning G, Xu X, Liu X, Hou Y, Jia H, He K, Kristiansen K. The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun. 2017;8:845. [PMID: 29018189 DOI: 10.1038/s41467-017-00900-1] [Cited by in Crossref: 424] [Cited by in F6Publishing: 400] [Article Influence: 84.8] [Reference Citation Analysis]
190 Gao W, Wang Y, Bi J, Chen X, Li N, Wang Y, Tang H, Mao J. Impaired CCR9/CCL25 signalling induced by inefficient dendritic cells contributes to intestinal immune imbalance in nonalcoholic steatohepatitis. Biochem Biophys Res Commun 2021;534:34-40. [PMID: 33310185 DOI: 10.1016/j.bbrc.2020.12.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
191 Jiang L, Stärkel P, Fan JG, Fouts DE, Bacher P, Schnabl B. The gut mycobiome: a novel player in chronic liver diseases. J Gastroenterol 2021;56:1-11. [PMID: 33151407 DOI: 10.1007/s00535-020-01740-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
192 Ren Z, Chen X, Hong L, Zhao X, Cui G, Li A, Liu Y, Zhou L, Sun R, Shen S, Li J, Lou J, Zhou H, Wang J, Xu G, Yu Z, Song Y, Chen X. Nanoparticle Conjugation of Ginsenoside Rg3 Inhibits Hepatocellular Carcinoma Development and Metastasis. Small 2020;16:e1905233. [PMID: 31814271 DOI: 10.1002/smll.201905233] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
193 Derrien M, Alvarez AS, de Vos WM. The Gut Microbiota in the First Decade of Life. Trends Microbiol 2019;27:997-1010. [PMID: 31474424 DOI: 10.1016/j.tim.2019.08.001] [Cited by in Crossref: 93] [Cited by in F6Publishing: 85] [Article Influence: 31.0] [Reference Citation Analysis]
194 Zhang J, Sun Z, Jiang S, Bai X, Ma C, Peng Q, Chen K, Chang H, Fang T, Zhang H. Probiotic Bifidobacterium lactis V9 Regulates the Secretion of Sex Hormones in Polycystic Ovary Syndrome Patients through the Gut-Brain Axis. mSystems 2019;4:e00017-19. [PMID: 31020040 DOI: 10.1128/mSystems.00017-19] [Cited by in Crossref: 44] [Cited by in F6Publishing: 26] [Article Influence: 14.7] [Reference Citation Analysis]
195 Kim YK, Song J. Therapeutic Applications of Resveratrol in Hepatic Encephalopathy through Its Regulation of the Microbiota, Brain Edema, and Inflammation. J Clin Med 2021;10:3819. [PMID: 34501267 DOI: 10.3390/jcm10173819] [Reference Citation Analysis]
196 Kim H, Worsley O, Yang E, Purbojati RW, Liang AL, Tan W, Moses DID, Hartono S, Fan V, Lim TKH, Schuster SC, Foo RS, Chow PKH, Pettersson S. Persistent changes in liver methylation and microbiome composition following reversal of diet-induced non-alcoholic-fatty liver disease. Cell Mol Life Sci 2019;76:4341-54. [PMID: 31119300 DOI: 10.1007/s00018-019-03114-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
197 Murtaza N, Ó Cuív P, Morrison M. Diet and the Microbiome. Gastroenterol Clin North Am 2017;46:49-60. [PMID: 28164852 DOI: 10.1016/j.gtc.2016.09.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
198 Huan H, Ren T, Xu L, Hu H, Liu C. Compositional distinction of gut microbiota between Han Chinese and Tibetan populations with liver cirrhosis. PeerJ 2021;9:e12142. [PMID: 34616612 DOI: 10.7717/peerj.12142] [Reference Citation Analysis]
199 Bozward AG, Warricker F, Oo YH, Khakoo SI. Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade. Front Immunol 2021;12:643310. [PMID: 33995362 DOI: 10.3389/fimmu.2021.643310] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
200 Ren Z, Li A, Jiang J, Zhou L, Yu Z, Lu H, Xie H, Chen X, Shao L, Zhang R, Xu S, Zhang H, Cui G, Sun R, Wen H, Lerut JP, Kan Q, Li L, Zheng S. Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma. Gut. 2019;68:1014-1023. [PMID: 30045880 DOI: 10.1136/gutjnl-2017-315084] [Cited by in Crossref: 156] [Cited by in F6Publishing: 154] [Article Influence: 39.0] [Reference Citation Analysis]
201 Chen M, Liao Z, Lu B, Wang M, Lin L, Zhang S, Li Y, Liu D, Liao Q, Xie Z. Huang-Lian-Jie-Du-Decoction Ameliorates Hyperglycemia and Insulin Resistant in Association With Gut Microbiota Modulation. Front Microbiol 2018;9:2380. [PMID: 30349514 DOI: 10.3389/fmicb.2018.02380] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 9.8] [Reference Citation Analysis]
202 Blesl A, Jüngst C, Lammert F, Fauler G, Rainer F, Leber B, Feldbacher N, Stromberger S, Wildburger R, Spindelböck W, Fickert P, Horvath A, Stadlbauer V. Secondary Sclerosing Cholangitis in Critically Ill Patients Alters the Gut-Liver Axis: A Case Control Study. Nutrients 2020;12:E2728. [PMID: 32906634 DOI: 10.3390/nu12092728] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
203 Jiang S, Xiao G, Koh AY, Kim J, Li Q, Zhan X. A Bayesian zero-inflated negative binomial regression model for the integrative analysis of microbiome data. Biostatistics 2021;22:522-40. [PMID: 31844880 DOI: 10.1093/biostatistics/kxz050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
204 Bajaj JS, Shamsaddini A, Acharya C, Fagan A, Sikaroodi M, Gavis E, McGeorge S, Khoruts A, Fuchs M, Sterling RK, Lee H, Gillevet PM. Multiple bacterial virulence factors focused on adherence and biofilm formation associate with outcomes in cirrhosis. Gut Microbes 2021;13:1993584. [PMID: 34743650 DOI: 10.1080/19490976.2021.1993584] [Reference Citation Analysis]
205 Alazawi W, Bernabe E, Tai D, Janicki T, Kemos P, Samsuddin S, Syn WK, Gillam D, Turner W. Periodontitis is associated with significant hepatic fibrosis in patients with non-alcoholic fatty liver disease. PLoS One 2017;12:e0185902. [PMID: 29220367 DOI: 10.1371/journal.pone.0185902] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]
206 Zheng Y, Yue C, Zhang H, Chen H, Liu Y, Li J. Deoxycholic Acid and Lithocholic Acid Alleviate Liver Injury and Inflammation in Mice with Klebsiella pneumoniae-Induced Liver Abscess and Bacteremia. J Inflamm Res 2021;14:777-89. [PMID: 33727851 DOI: 10.2147/JIR.S298495] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
207 Heidrich B, Vital M, Plumeier I, Döscher N, Kahl S, Kirschner J, Ziegert S, Solbach P, Lenzen H, Potthoff A, Manns MP, Wedemeyer H, Pieper DH. Intestinal microbiota in patients with chronic hepatitis C with and without cirrhosis compared with healthy controls.Liver Int. 2018;38:50-58. [PMID: 28561276 DOI: 10.1111/liv.13485] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 7.6] [Reference Citation Analysis]
208 Bjerring PN, Morgan MY, Vilstrup H, Nielsen SM, Christensen R, Gluud LL; Cochrane Hepato-Biliary Group. Medical interventions for prevention and treatment of hepatic encephalopathy in adults with cirrhosis: a network meta-analysis. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd013241] [Reference Citation Analysis]
209 Keshavarzian A, Engen P, Bonvegna S, Cilia R. The gut microbiome in Parkinson's disease: A culprit or a bystander? Prog Brain Res 2020;252:357-450. [PMID: 32247371 DOI: 10.1016/bs.pbr.2020.01.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
210 Tong X, Su F, Xu X, Xu H, Yang T, Xu Q, Dai H, Huang K, Zou L, Zhang W, Pei S, Xiao F, Li Y, Wang C. Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients. Front Cell Infect Microbiol 2019;9:149. [PMID: 31165050 DOI: 10.3389/fcimb.2019.00149] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
211 Bieghs V, Trautwein C. Innate immune signaling and gut-liver interactions in non-alcoholic fatty liver disease. Hepatobiliary Surg Nutr. 2014;3:377-385. [PMID: 25568861 DOI: 10.3978/j.issn.2304-3881.2014.12.04] [Cited by in F6Publishing: 22] [Reference Citation Analysis]
212 Zhao S, Lieberman TD, Poyet M, Kauffman KM, Gibbons SM, Groussin M, Xavier RJ, Alm EJ. Adaptive Evolution within Gut Microbiomes of Healthy People. Cell Host Microbe 2019;25:656-667.e8. [PMID: 31028005 DOI: 10.1016/j.chom.2019.03.007] [Cited by in Crossref: 118] [Cited by in F6Publishing: 90] [Article Influence: 39.3] [Reference Citation Analysis]
213 Watt KD. The evolving role of the microbiome in liver failure and liver transplantation. Liver Transpl 2016;22:58-61. [PMID: 27588961 DOI: 10.1002/lt.24623] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
214 Hrncir T, Hrncirova L, Kverka M, Tlaskalova-Hogenova H. The role of gut microbiota in intestinal and liver diseases. Lab Anim 2019;53:271-80. [PMID: 30580671 DOI: 10.1177/0023677218818605] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
215 Ahlawat S, Asha, Sharma KK. Gut-organ axis: a microbial outreach and networking. Lett Appl Microbiol 2021;72:636-68. [PMID: 32472555 DOI: 10.1111/lam.13333] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
216 Gao NL, Zhang C, Zhang Z, Hu S, Lercher MJ, Zhao XM, Bork P, Liu Z, Chen WH. MVP: a microbe-phage interaction database. Nucleic Acids Res 2018;46:D700-7. [PMID: 29177508 DOI: 10.1093/nar/gkx1124] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 10.3] [Reference Citation Analysis]
217 Xu J, Wang R, You S, Zhang L, Zheng P, Ji G, Liu B. Traditional Chinese medicine Lingguizhugan decoction treating non-alcoholic fatty liver disease with spleen-yang deficiency pattern: Study protocol for a multicenter randomized controlled trial. Trials 2020;21:512. [PMID: 32522273 DOI: 10.1186/s13063-020-04362-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
218 Lv LX, Fang DQ, Shi D, Chen DY, Yan R, Zhu YX, Chen YF, Shao L, Guo FF, Wu WR, Li A, Shi HY, Jiang XW, Jiang HY, Xiao YH, Zheng SS, Li LJ. Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis. Environ Microbiol. 2016;18:2272-2286. [PMID: 27243236 DOI: 10.1111/1462-2920.13401] [Cited by in Crossref: 96] [Cited by in F6Publishing: 96] [Article Influence: 19.2] [Reference Citation Analysis]
219 Wu L, Xie X, Li Y, Liang T, Zhong H, Ma J, Yang L, Yang J, Li L, Xi Y, Li H, Zhang J, Chen X, Ding Y, Wu Q. Metagenomics-Based Analysis of the Age-Related Cumulative Effect of Antibiotic Resistance Genes in Gut Microbiota. Antibiotics (Basel) 2021;10:1006. [PMID: 34439056 DOI: 10.3390/antibiotics10081006] [Reference Citation Analysis]
220 Ling Z, Liu X, Cheng Y, Jiang X, Jiang H, Wang Y, Li L. Decreased Diversity of the Oral Microbiota of Patients with Hepatitis B Virus-Induced Chronic Liver Disease: A Pilot Project. Sci Rep. 2015;5:17098. [PMID: 26606973 DOI: 10.1038/srep17098] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 6.6] [Reference Citation Analysis]
221 Beghini F, Pasolli E, Truong TD, Putignani L, Cacciò SM, Segata N. Large-scale comparative metagenomics of Blastocystis, a common member of the human gut microbiome. ISME J 2017;11:2848-63. [PMID: 28837129 DOI: 10.1038/ismej.2017.139] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 11.4] [Reference Citation Analysis]
222 Shao L, Ling Z, Chen D, Liu Y, Yang F, Li L. Disorganized Gut Microbiome Contributed to Liver Cirrhosis Progression: A Meta-Omics-Based Study. Front Microbiol 2018;9:3166. [PMID: 30631318 DOI: 10.3389/fmicb.2018.03166] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
223 Li T, Long M, Ji C, Shen Z, Gatesoupe FJ, Zhang X, Zhang Q, Zhang L, Zhao Y, Liu X, Li A. Alterations of the gut microbiome of largemouth bronze gudgeon (Coreius guichenoti) suffering from furunculosis. Sci Rep 2016;6:30606. [PMID: 27465687 DOI: 10.1038/srep30606] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 7.5] [Reference Citation Analysis]
224 Nicoletti A, Ponziani FR, Biolato M, Valenza V, Marrone G, Sganga G, Gasbarrini A, Miele L, Grieco A. Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation. World J Gastroenterol 2019; 25(33): 4814-4834 [PMID: 31543676 DOI: 10.3748/wjg.v25.i33.4814] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 26] [Article Influence: 10.3] [Reference Citation Analysis]
225 Liu Y, Jin Y, Li J, Zhao L, Li Z, Xu J, Zhao F, Feng J, Chen H, Fang C, Shilpakar R, Wei Y. Small Bowel Transit and Altered Gut Microbiota in Patients With Liver Cirrhosis. Front Physiol 2018;9:470. [PMID: 29780327 DOI: 10.3389/fphys.2018.00470] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
226 Li W, Wu X, Hu X, Wang T, Liang S, Duan Y, Jin F, Qin B. Structural changes of gut microbiota in Parkinson’s disease and its correlation with clinical features. Sci China Life Sci 2017;60:1223-33. [DOI: 10.1007/s11427-016-9001-4] [Cited by in Crossref: 126] [Cited by in F6Publishing: 125] [Article Influence: 25.2] [Reference Citation Analysis]
227 Zhang Z, Peng Q, Huo D, Jiang S, Ma C, Chang H, Chen K, Li C, Pan Y, Zhang J. Melatonin Regulates the Neurotransmitter Secretion Disorder Induced by Caffeine Through the Microbiota-Gut-Brain Axis in Zebrafish (Danio rerio). Front Cell Dev Biol 2021;9:678190. [PMID: 34095150 DOI: 10.3389/fcell.2021.678190] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
228 Gluud LL, Vilstrup H, Morgan MY. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Database Syst Rev. 2016;CD003044. [PMID: 27153247 DOI: 10.1002/14651858.cd003044.pub4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
229 Meng X, Li S, Li Y, Gan RY, Li HB. Gut Microbiota's Relationship with Liver Disease and Role in Hepatoprotection by Dietary Natural Products and Probiotics. Nutrients. 2018;10:1457. [PMID: 30297615 DOI: 10.3390/nu10101457] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 10.8] [Reference Citation Analysis]
230 Chen Y, Ji F, Guo J, Shi D, Fang D, Li L. Dysbiosis of small intestinal microbiota in liver cirrhosis and its association with etiology. Sci Rep. 2016;6:34055. [PMID: 27687977 DOI: 10.1038/srep34055] [Cited by in Crossref: 86] [Cited by in F6Publishing: 82] [Article Influence: 14.3] [Reference Citation Analysis]
231 Witherden EA, Shoaie S, Hall RA, Moyes DL. The Human Mucosal Mycobiome and Fungal Community Interactions. J Fungi (Basel) 2017;3:E56. [PMID: 29371572 DOI: 10.3390/jof3040056] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
232 Li Q, Chen H, Zhang M, Wu T, Liu R. Altered short chain fatty acid profiles induced by dietary fiber intervention regulate AMPK levels and intestinal homeostasis. Food Funct 2019;10:7174-87. [DOI: 10.1039/c9fo01465a] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 4.7] [Reference Citation Analysis]
233 Solé C, Guilly S, Da Silva K, Llopis M, Le-Chatelier E, Huelin P, Carol M, Moreira R, Fabrellas N, De Prada G, Napoleone L, Graupera I, Pose E, Juanola A, Borruel N, Berland M, Toapanta D, Casellas F, Guarner F, Doré J, Solà E, Ehrlich SD, Ginès P. Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and Prognosis. Gastroenterology 2021;160:206-218.e13. [PMID: 32941879 DOI: 10.1053/j.gastro.2020.08.054] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
234 Wiest R. The Gut Microbiome and Cirrhosis: Basic Aspects. In: de Franchis R, editor. Portal Hypertension VI. Cham: Springer International Publishing; 2016. pp. 139-68. [DOI: 10.1007/978-3-319-23018-4_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
235 Dhungel E, Mreyoud Y, Gwak HJ, Rajeh A, Rho M, Ahn TH. MegaR: an interactive R package for rapid sample classification and phenotype prediction using metagenome profiles and machine learning. BMC Bioinformatics 2021;22:25. [PMID: 33461494 DOI: 10.1186/s12859-020-03933-4] [Reference Citation Analysis]
236 Zhao F, An R, Wang L, Shan J, Wang X. Specific Gut Microbiome and Serum Metabolome Changes in Lung Cancer Patients. Front Cell Infect Microbiol 2021;11:725284. [PMID: 34527604 DOI: 10.3389/fcimb.2021.725284] [Reference Citation Analysis]
237 Fulcher JA. Is the Oral Microbiome Important in HIV-Associated Inflammation? mSphere 2020;5:e00034-20. [PMID: 32024706 DOI: 10.1128/mSphere.00034-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
238 Nakamura K, Sakuragi N, Takakuwa A, Ayabe T. Paneth cell α-defensins and enteric microbiota in health and disease. Biosci Microbiota Food Health 2016;35:57-67. [PMID: 27200259 DOI: 10.12938/bmfh.2015-019] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 6.9] [Reference Citation Analysis]
239 Wang W, Wang J, Li J, Yan P, Jin Y, Zhang R, Yue W, Guo Q, Geng J. Cholecystectomy Damages Aging-Associated Intestinal Microbiota Construction. Front Microbiol. 2018;9:1402. [PMID: 29988510 DOI: 10.3389/fmicb.2018.01402] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
240 Huan H, Hu H, Chen XH, Gao WN, Li LL, Li J, Deng K, Liu C. Diversity of intestinal microflora in tibetan patients with liver cirrhosis based on high-throughput sequencing. Shijie Huaren Xiaohua Zazhi 2019; 27(18): 1142-1148 [DOI: 10.11569/wcjd.v27.i18.1142] [Reference Citation Analysis]
241 Zhou R, Fan X, Schnabl B. Role of the intestinal microbiome in liver fibrosis development and new treatment strategies. Transl Res 2019;209:22-38. [PMID: 30853445 DOI: 10.1016/j.trsl.2019.02.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
242 Bajaj JS. Alcohol, liver disease and the gut microbiota. Nat Rev Gastroenterol Hepatol 2019;16:235-46. [DOI: 10.1038/s41575-018-0099-1] [Cited by in Crossref: 122] [Cited by in F6Publishing: 120] [Article Influence: 40.7] [Reference Citation Analysis]
243 Bai R, Bai M, Zhao Z, Chen N, Yang Y, Tang Z. Alternation of supragingival microbiome in patients with cirrhosis of different Child-Pugh scores. Oral Dis 2020. [PMID: 33274586 DOI: 10.1111/odi.13743] [Reference Citation Analysis]
244 Sato K, Takahashi N, Kato T, Matsuda Y, Yokoji M, Yamada M, Nakajima T, Kondo N, Endo N, Yamamoto R, Noiri Y, Ohno H, Yamazaki K. Aggravation of collagen-induced arthritis by orally administered Porphyromonas gingivalis through modulation of the gut microbiota and gut immune system. Sci Rep 2017;7:6955. [PMID: 28761156 DOI: 10.1038/s41598-017-07196-7] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 15.0] [Reference Citation Analysis]
245 Hou D, Huang Z, Zeng S, Liu J, Wei D, Deng X, Weng S, Yan Q, He J. Intestinal bacterial signatures of white feces syndrome in shrimp. Appl Microbiol Biotechnol 2018;102:3701-9. [PMID: 29516144 DOI: 10.1007/s00253-018-8855-2] [Cited by in Crossref: 50] [Cited by in F6Publishing: 35] [Article Influence: 12.5] [Reference Citation Analysis]
246 Rattan P, Minacapelli CD, Rustgi V. The Microbiome and Hepatocellular Carcinoma. Liver Transpl. 2020;26:1316-1327. [PMID: 32564483 DOI: 10.1002/lt.25828] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
247 Xing Z, Li H, Li M, Gao R, Guo C, Mi S. Disequilibrium in chicken gut microflora with avian colibacillosis is related to microenvironment damaged by antibiotics. Sci Total Environ 2021;762:143058. [PMID: 33127154 DOI: 10.1016/j.scitotenv.2020.143058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
248 Lau LHS, Wong SH. Microbiota, Obesity and NAFLD. Adv Exp Med Biol. 2018;1061:111-125. [PMID: 29956210 DOI: 10.1007/978-981-10-8684-7_9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
249 Neong SF, Adebayo D, Wong F. An update on the pathogenesis and clinical management of cirrhosis with refractory ascites. Expert Rev Gastroenterol Hepatol 2019;13:293-305. [PMID: 30791777 DOI: 10.1080/17474124.2018.1555469] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
250 Berry D, Kuzyk O, Rauch I, Heider S, Schwab C, Hainzl E, Decker T, Müller M, Strobl B, Schleper C, Urich T, Wagner M, Kenner L, Loy A. Intestinal Microbiota Signatures Associated with Inflammation History in Mice Experiencing Recurring Colitis. Front Microbiol 2015;6:1408. [PMID: 26697002 DOI: 10.3389/fmicb.2015.01408] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 8.1] [Reference Citation Analysis]
251 Xia M, Pei F, Mu C, Ye Y, Wang C. Disruption of bacterial balance in the gut of Portunus trituberculatus induced by Vibrio alginolyticus infection. J Ocean Limnol 2018;36:1891-8. [DOI: 10.1007/s00343-018-7121-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
252 Han W, Wang M, Ye Y. A concurrent subtractive assembly approach for identification of disease associated sub-metagenomes. Res Comput Mol Biol 2017;2017:18-33. [PMID: 29177251 DOI: 10.1007/978-3-319-56970-3_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
253 Zhou J, Tripathi M, Sinha RA, Singh BK, Yen PM. Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease. Hepatoma Res 2021;7:11. [PMID: 33490737 DOI: 10.20517/2394-5079.2020.134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
254 Gebrebrhan H, Kambaran C, Sivro A, Adhiambo W, Siele N, Becker MG, Li J, Choi S, Mwatelah RS, Reyes NV, Akolo M, Njogu P, Cholette F, Ho J, Kim J, Peterson SW, Martin I, Sandstrom P, Mehta SD, Lorway RR, Ball TB, Kimani J, Mclaren PJ, Ji H, McKinnon LR. Rectal microbiota diversity in Kenyan MSM is inversely associated with frequency of receptive anal sex, independent of HIV status. AIDS 2021;35:1091-101. [PMID: 33534201 DOI: 10.1097/QAD.0000000000002829] [Reference Citation Analysis]
255 Lu H, Yao Y, Yang J, Zhang H, Li L. Microbiome-miRNA interactions in the progress from undifferentiated arthritis to rheumatoid arthritis: evidence, hypotheses, and opportunities. Rheumatol Int 2021;41:1567-75. [PMID: 33856544 DOI: 10.1007/s00296-021-04798-3] [Reference Citation Analysis]
256 Baffy G. Potential mechanisms linking gut microbiota and portal hypertension. Liver Int. 2019;39:598-609. [PMID: 30312513 DOI: 10.1111/liv.13986] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
257 Zeng X, Tang XJ, Sheng X, Ni W, Xin HG, Chen WZ, Jiang CF, Lin Y, Shi J, Shi B, Chen YX, Yuan ZL, Xie WF. Does low-dose rifaximin ameliorate endotoxemia in patients with liver cirrhosis: a prospective study. J Dig Dis 2015;16:665-74. [PMID: 26474237 DOI: 10.1111/1751-2980.12294] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
258 Lv L, Jiang H, Yan R, Xu D, Wang K, Wang Q, Chen X, Li L. The Salivary Microbiota, Cytokines, and Metabolome in Patients with Ankylosing Spondylitis Are Altered and More Proinflammatory than Those in Healthy Controls. mSystems 2021;6:e0117320. [PMID: 34156295 DOI: 10.1128/mSystems.01173-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
259 Wang JH, Lu J, Zhang YX, Wu J, Luo Y, Liu H. Metagenomic analysis of antibiotic resistance genes in coastal industrial mariculture systems. Bioresour Technol 2018;253:235-43. [PMID: 29353751 DOI: 10.1016/j.biortech.2018.01.035] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 12.5] [Reference Citation Analysis]
260 Friedman ES, Li Y, Shen TD, Jiang J, Chau L, Adorini L, Babakhani F, Edwards J, Shapiro D, Zhao C, Carr RM, Bittinger K, Li H, Wu GD. FXR-Dependent Modulation of the Human Small Intestinal Microbiome by the Bile Acid Derivative Obeticholic Acid. Gastroenterology. 2018;155:1741-1752.e5. [PMID: 30144429 DOI: 10.1053/j.gastro.2018.08.022] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 10.0] [Reference Citation Analysis]
261 Montella L, Sarno F, Ambrosino A, Facchini S, D'Antò M, Laterza MM, Fasano M, Quarata E, Ranucci RAN, Altucci L, Berretta M, Facchini G. The Role of Immunotherapy in a Tolerogenic Environment: Current and Future Perspectives for Hepatocellular Carcinoma. Cells 2021;10:1909. [PMID: 34440678 DOI: 10.3390/cells10081909] [Reference Citation Analysis]
262 Tilg H, Cani PD, Mayer EA. Gut microbiome and liver diseases. Gut. 2016;65:2035-2044. [PMID: 27802157 DOI: 10.1136/gutjnl-2016-312729] [Cited by in Crossref: 202] [Cited by in F6Publishing: 186] [Article Influence: 33.7] [Reference Citation Analysis]
263 Bai L, Zhou P, Li D, Ju X. Changes in the gastrointestinal microbiota of children with acute lymphoblastic leukaemia and its association with antibiotics in the short term. J Med Microbiol 2017;66:1297-307. [PMID: 28855025 DOI: 10.1099/jmm.0.000568] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
264 He J, Xu S, Zhang B, Xiao C, Chen Z, Si F, Fu J, Lin X, Zheng G, Yu G, Chen J. Gut microbiota and metabolite alterations associated with reduced bone mineral density or bone metabolic indexes in postmenopausal osteoporosis. Aging (Albany NY) 2020;12:8583-604. [PMID: 32392181 DOI: 10.18632/aging.103168] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
265 Nishimura N, Kaji K, Kitagawa K, Sawada Y, Furukawa M, Ozutsumi T, Fujinaga Y, Tsuji Y, Takaya H, Kawaratani H, Moriya K, Namisaki T, Akahane T, Fukui H, Yoshiji H. Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis. Int J Mol Sci 2021;22:6921. [PMID: 34203178 DOI: 10.3390/ijms22136921] [Reference Citation Analysis]
266 Gorham J, Gleeson M. Cirrhosis and dysbiosis: New insights from next-generation sequencing. Hepatology. 2016;63:336-338. [PMID: 26313376 DOI: 10.1002/hep.28133] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
267 Tan L, Zhang C, Liu F, Chen P, Wei X, Li H, Yi G, Xu Y, Zheng X. Three-compartment septic tanks as sustainable on-site treatment facilities? Watch out for the potential dissemination of human-associated pathogens and antibiotic resistance. J Environ Manage 2021;300:113709. [PMID: 34547574 DOI: 10.1016/j.jenvman.2021.113709] [Reference Citation Analysis]
268 Zhang Y, Zhao M, Jiang X, Qiao Q, Liu T, Zhao C, Wang M. Comprehensive Analysis of Fecal Microbiome and Metabolomics in Hepatic Fibrosis Rats Reveal Hepatoprotective Effects of Yinchen Wuling Powder From the Host-Microbial Metabolic Axis. Front Pharmacol 2021;12:713197. [PMID: 34385924 DOI: 10.3389/fphar.2021.713197] [Reference Citation Analysis]
269 Elsalem L, Jum'ah AA, Alfaqih MA, Aloudat O. The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives. Clin Exp Gastroenterol 2020;13:151-85. [PMID: 32440192 DOI: 10.2147/CEG.S243337] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
270 Maccioni L, Gao B, Leclercq S, Pirlot B, Horsmans Y, De Timary P, Leclercq I, Fouts D, Schnabl B, Stärkel P. Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans. Gut Microbes 2020;12:1782157. [PMID: 32588725 DOI: 10.1080/19490976.2020.1782157] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
271 Parker R, Im G, Jones F, Hernández OP, Nahas J, Kumar A, Wheatley D, Sinha A, Gonzalez-Reimers E, Sanchez-Pérez M, Ghezzi A, David MD, Corbett C, McCune A, Aithal GP, Holt A, Stewart S. Clinical and microbiological features of infection in alcoholic hepatitis: an international cohort study. J Gastroenterol 2017;52:1192-200. [PMID: 28389732 DOI: 10.1007/s00535-017-1336-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
272 Xie Y, Ding F, Di W, Lv Y, Xia F, Sheng Y, Yu J, Ding G. Impact of a high‑fat diet on intestinal stem cells and epithelial barrier function in middle‑aged female mice. Mol Med Rep 2020;21:1133-44. [PMID: 32016468 DOI: 10.3892/mmr.2020.10932] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
273 Barrios C, Beaumont M, Pallister T, Villar J, Goodrich JK, Clark A, Pascual J, Ley RE, Spector TD, Bell JT, Menni C. Gut-Microbiota-Metabolite Axis in Early Renal Function Decline.PLoS One. 2015;10:e0134311. [PMID: 26241311 DOI: 10.1371/journal.pone.0134311] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 10.3] [Reference Citation Analysis]
274 Khor B, Snow M, Herrman E, Ray N, Mansukhani K, Patel KA, Said-Al-Naief N, Maier T, Machida CA. Interconnections Between the Oral and Gut Microbiomes: Reversal of Microbial Dysbiosis and the Balance Between Systemic Health and Disease. Microorganisms 2021;9:496. [PMID: 33652903 DOI: 10.3390/microorganisms9030496] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
275 Katayama K. Zinc and protein metabolism in chronic liver diseases. Nutr Res. 2020;74:1-9. [PMID: 31891865 DOI: 10.1016/j.nutres.2019.11.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
276 Kishikawa T, Maeda Y, Nii T, Motooka D, Matsumoto Y, Matsushita M, Matsuoka H, Yoshimura M, Kawada S, Teshigawara S, Oguro E, Okita Y, Kawamoto K, Higa S, Hirano T, Narazaki M, Ogata A, Saeki Y, Nakamura S, Inohara H, Kumanogoh A, Takeda K, Okada Y. Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population. Ann Rheum Dis. 2020;79:103-111. [PMID: 31699813 DOI: 10.1136/annrheumdis-2019-215743] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 13.7] [Reference Citation Analysis]
277 Cao L, Zhang T, Zhu J, Li A, Zheng K, Zhang N, Su B, Xia W, Wu H, Li N, He Q. Polymorphism of TLR5 rs5744174 is associated with disease progression in Chinese patients with chronic HBV infection. APMIS 2017;125:708-16. [PMID: 28543911 DOI: 10.1111/apm.12707] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
278 Wang J, Wang Y, Zhang X, Liu J, Zhang Q, Zhao Y, Peng J, Feng Q, Dai J, Sun S. Gut Microbial Dysbiosis Is Associated with Altered Hepatic Functions and Serum Metabolites in Chronic Hepatitis B Patients. Front Microbiol. 2017;8:2222. [PMID: 29180991 DOI: 10.3389/fmicb.2017.02222] [Cited by in Crossref: 67] [Cited by in F6Publishing: 70] [Article Influence: 13.4] [Reference Citation Analysis]
279 Lu M, Wang Z. Microbiota and Aging. Adv Exp Med Biol 2018;1086:141-56. [PMID: 30232757 DOI: 10.1007/978-981-13-1117-8_9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
280 Imai J, Kitamoto S, Kamada N. The pathogenic oral-gut-liver axis: new understandings and clinical implications. Expert Rev Clin Immunol 2021;17:727-36. [PMID: 34057877 DOI: 10.1080/1744666X.2021.1935877] [Reference Citation Analysis]
281 Volant S, Lechat P, Woringer P, Motreff L, Campagne P, Malabat C, Kennedy S, Ghozlane A. SHAMAN: a user-friendly website for metataxonomic analysis from raw reads to statistical analysis. BMC Bioinformatics 2020;21:345. [PMID: 32778056 DOI: 10.1186/s12859-020-03666-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
282 Luo M, Liu Y, Wu P, Luo DX, Sun Q, Zheng H, Hu R, Pandol SJ, Li QF, Han YP, Zeng Y. Alternation of Gut Microbiota in Patients with Pulmonary Tuberculosis. Front Physiol 2017;8:822. [PMID: 29204120 DOI: 10.3389/fphys.2017.00822] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 8.2] [Reference Citation Analysis]
283 Sun YL, Li WQ, Ding PX, Wang ZW, Wei CH, Ma XX, Zhang RF, Wu Y, Zhou L, Liang RP, Zhang YP, Zhao YP, Zhu RT, Li J. Specific alterations in gut microbiota are associated with prognosis of Budd-Chiari syndrome. Oncotarget 2018;9:3303-20. [PMID: 29423048 DOI: 10.18632/oncotarget.23234] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
284 Nuzum ND, Loughman A, Szymlek-Gay EA, Hendy A, Teo WP, Macpherson H. Gut microbiota differences between healthy older adults and individuals with Parkinson's disease: A systematic review. Neurosci Biobehav Rev 2020;112:227-41. [PMID: 32032654 DOI: 10.1016/j.neubiorev.2020.02.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
285 Lemoinne S, Sabino J, Sokol H. Gut microbiota in PSC : From association to possible causality. Commentary to "Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis" by Nakamoto et al., Nature Microbiology, January 2019. Clin Res Hepatol Gastroenterol 2020;44:123-5. [PMID: 31262571 DOI: 10.1016/j.clinre.2019.06.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
286 Yang H, Guo R, Li S, Liang F, Tian C, Zhao X, Long Y, Liu F, Jiang M, Zhang Y, Ma J, Peng M, Zhang S, Ye W, Gan Q, Zeng F, Mao S, Liang Q, Ma X, Han M, Gao F, Yang R, Zhang C, Xiao L, Qin J, Li S, Zhu C. Systematic analysis of gut microbiota in pregnant women and its correlations with individual heterogeneity. NPJ Biofilms Microbiomes 2020;6:32. [PMID: 32917878 DOI: 10.1038/s41522-020-00142-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
287 Tacke F, Weiskirchen R. An update on the recent advances in antifibrotic therapy. Expert Rev Gastroenterol Hepatol. 2018;12:1143-1152. [PMID: 30261763 DOI: 10.1080/17474124.2018.1530110] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 7.8] [Reference Citation Analysis]
288 Li Y, Wang H, Li X, Li H, Zhang Q, Zhou H, He Y, Li P, Fu C, Zhang X, Qiu Y, Li J. Disordered intestinal microbes are associated with the activity of Systemic Lupus Erythematosus. Clinical Science 2019;133:821-38. [DOI: 10.1042/cs20180841] [Cited by in Crossref: 38] [Cited by in F6Publishing: 16] [Article Influence: 12.7] [Reference Citation Analysis]
289 Wang M, Cao J, Amakye WK, Gong C, Li Q, Ren J. Mid infrared light treatment attenuates cognitive decline and alters the gut microbiota community in APP/PS1 mouse model. Biochem Biophys Res Commun 2020;523:60-5. [PMID: 31831179 DOI: 10.1016/j.bbrc.2019.12.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
290 Qu L, Ma X, Fan D. Ginsenoside Rk3 Suppresses Hepatocellular Carcinoma Development through Targeting the Gut-Liver Axis. J Agric Food Chem 2021;69:10121-37. [PMID: 34415764 DOI: 10.1021/acs.jafc.1c03279] [Reference Citation Analysis]
291 Li D, Xi W, Zhang Z, Ren L, Deng C, Chen J, Sun C, Zhang N, Xu J. Oral microbial community analysis of the patients in the progression of liver cancer. Microb Pathog 2020;149:104479. [PMID: 32920149 DOI: 10.1016/j.micpath.2020.104479] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
292 Wang Y, Liu F, Zhang G, Su Y, Sun X, Chen Q, Wang C, Fu H, He Y, Zhu X, Liu X, Lv M, Zhao X, Zhao X, Li Y, Wang Q, Huang X, Zhang X. Gut microbiome alterations and its link to corticosteroid resistance in immune thrombocytopenia. Sci China Life Sci 2021;64:766-83. [PMID: 32857289 DOI: 10.1007/s11427-020-1788-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
293 Hov JR, Kummen M. Intestinal microbiota in primary sclerosing cholangitis. Current Opinion in Gastroenterology 2017;33:85-92. [DOI: 10.1097/mog.0000000000000334] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
294 Bajer L, Kverka M, Kostovcik M, Macinga P, Dvorak J, Stehlikova Z, Brezina J, Wohl P, Spicak J, Drastich P. Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis. World J Gastroenterol 2017; 23(25): 4548-4558 [PMID: 28740343 DOI: 10.3748/wjg.v23.i25.4548] [Cited by in CrossRef: 139] [Cited by in F6Publishing: 108] [Article Influence: 27.8] [Reference Citation Analysis]
295 Chen HM, Liu XW, Sun RJ, Fang JY. A survey on the developmental intestinal microbiota research in China: The history, funding, and frontiers of gut bacteria. J Dig Dis 2015;16:421-30. [PMID: 26215325 DOI: 10.1111/1751-2980.12274] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
296 Rao B, Ren T, Wang X, Wang H, Zou Y, Sun Y, Liu S, Ren Z, Yu Z. Dysbiosis in the Human Microbiome of Cholangiocarcinoma. Front Physiol 2021;12:715536. [PMID: 34867436 DOI: 10.3389/fphys.2021.715536] [Reference Citation Analysis]
297 Hong X, Chen J, Liu L, Wu H, Tan H, Xie G, Xu Q, Zou H, Yu W, Wang L, Qin N. Metagenomic sequencing reveals the relationship between microbiota composition and quality of Chinese Rice Wine. Sci Rep 2016;6:26621. [PMID: 27241862 DOI: 10.1038/srep26621] [Cited by in Crossref: 73] [Cited by in F6Publishing: 57] [Article Influence: 12.2] [Reference Citation Analysis]
298 Qian Y, Yang X, Xu S, Huang P, Li B, Du J, He Y, Su B, Xu L, Wang L, Huang R, Chen S, Xiao Q. Gut metagenomics-derived genes as potential biomarkers of Parkinson’s disease. Brain 2020;143:2474-89. [DOI: 10.1093/brain/awaa201] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
299 Chen Y, Sun H, Sun M, Shi C, Sun H, Shi X, Ji B, Cui J. Finding Colon Cancer- and Colorectal Cancer-Related Microbes Based on Microbe-Disease Association Prediction. Front Microbiol 2021;12:650056. [PMID: 33796094 DOI: 10.3389/fmicb.2021.650056] [Reference Citation Analysis]
300 Liu Q, Li B, Li Y, Wei Y, Huang B, Liang J, You Z, Li Y, Qian Q, Wang R, Zhang J, Chen R, Lyu Z, Chen Y, Shi M, Xiao X, Wang Q, Miao Q, Fang JY, Gershwin ME, Lian M, Ma X, Tang R. Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis. Gut 2021:gutjnl-2020-323565. [PMID: 34035120 DOI: 10.1136/gutjnl-2020-323565] [Reference Citation Analysis]
301 Païssé S, Valle C, Servant F, Courtney M, Burcelin R, Amar J, Lelouvier B. Comprehensive description of blood microbiome from healthy donors assessed by 16S targeted metagenomic sequencing. Transfusion 2016;56:1138-47. [PMID: 26865079 DOI: 10.1111/trf.13477] [Cited by in Crossref: 172] [Cited by in F6Publishing: 160] [Article Influence: 28.7] [Reference Citation Analysis]
302 [DOI: 10.1145/3233547.3233585] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
303 [DOI: 10.1101/816090] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
304 Jung Y, Tagele SB, Son H, Ibal JC, Kerfahi D, Yun H, Lee B, Park CY, Kim ES, Kim SJ, Shin JH. Modulation of Gut Microbiota in Korean Navy Trainees following a Healthy Lifestyle Change. Microorganisms 2020;8:E1265. [PMID: 32825401 DOI: 10.3390/microorganisms8091265] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
305 Nouvenne A, Ticinesi A, Tana C, Prati B, Catania P, Miraglia C, De' Angelis GL, Di Mario F, Meschi T. Digestive disorders and Intestinal microbiota. Acta Biomed. 2018;89:47-51. [PMID: 30561395 DOI: 10.23750/abm.v89i9-s.7912] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
306 Han ZL, Chen M, Fu XD, Yang M, Hrmova M, Zhao YH, Mou HJ. Potassium Alginate Oligosaccharides Alter Gut Microbiota, and Have Potential to Prevent the Development of Hypertension and Heart Failure in Spontaneously Hypertensive Rats. Int J Mol Sci 2021;22:9823. [PMID: 34575987 DOI: 10.3390/ijms22189823] [Reference Citation Analysis]
307 Shen TD, Pyrsopoulos N, Rustgi VK. Microbiota and the liver: Microbiota and the Liver. Liver Transpl 2018;24:539-50. [DOI: 10.1002/lt.25008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
308 Li Z, Ni M, Yu H, Wang L, Zhou X, Chen T, Liu G, Gao Y. Gut Microbiota and Liver Fibrosis: One Potential Biomarker for Predicting Liver Fibrosis. Biomed Res Int 2020;2020:3905130. [PMID: 32685479 DOI: 10.1155/2020/3905130] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
309 Burz SD, Monnoye M, Philippe C, Farin W, Ratziu V, Strozzi F, Paillarse JM, Chêne L, Blottière HM, Gérard P. Fecal Microbiota Transplant from Human to Mice Gives Insights into the Role of the Gut Microbiota in Non-Alcoholic Fatty Liver Disease (NAFLD). Microorganisms 2021;9:199. [PMID: 33477939 DOI: 10.3390/microorganisms9010199] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
310 Shen J, Shan J, Zhu X, Yang P, Zhang D, Liang B, Li M, Zang X, Dai Z. Sex specific effects of capsaicin on longevity regulation. Experimental Gerontology 2020;130:110788. [DOI: 10.1016/j.exger.2019.110788] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
311 Affeldt S, Sokolovska N, Prifti E, Zucker JD. Spectral consensus strategy for accurate reconstruction of large biological networks. BMC Bioinformatics 2016;17:493. [PMID: 28105915 DOI: 10.1186/s12859-016-1308-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
312 Woodhouse CA, Patel VC, Goldenberg S, Sanchez-Fueyo A, China L, O'Brien A, Flach C, Douiri A, Shawcross D. PROFIT, a PROspective, randomised placebo controlled feasibility trial of Faecal mIcrobiota Transplantation in cirrhosis: study protocol for a single-blinded trial. BMJ Open 2019;9:e023518. [PMID: 30772848 DOI: 10.1136/bmjopen-2018-023518] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
313 Shen YC, Lee PC, Kuo YL, Wu WK, Chen CC, Lei CH, Yeh CP, Hsu C, Hsu CH, Lin ZZ, Shao YY, Lu LC, Liu TH, Chen CH, Wu MS, Huang YH, Cheng AL. An Exploratory Study for the Association of Gut Microbiome with Efficacy of Immune Checkpoint Inhibitor in Patients with Hepatocellular Carcinoma. J Hepatocell Carcinoma 2021;8:809-22. [PMID: 34336726 DOI: 10.2147/JHC.S315696] [Reference Citation Analysis]
314 Cao R, Ren Q, Luo J, Tian Z, Liu W, Zhao B, Li J, Diao P, Tan Y, Qiu X, Zhang G, Wang Q, Guan G, Luo J, Yin H, Liu G. Analysis of Microorganism Diversity in Haemaphysalis longicornis From Shaanxi, China, Based on Metagenomic Sequencing. Front Genet 2021;12:723773. [PMID: 34567077 DOI: 10.3389/fgene.2021.723773] [Reference Citation Analysis]
315 Wang Z, He Y, Wang C, Ao H, Tan Z, Xing K. Variations in Microbial Diversity and Metabolite Profiles of Female Landrace Finishing Pigs With Distinct Feed Efficiency. Front Vet Sci 2021;8:702931. [PMID: 34307537 DOI: 10.3389/fvets.2021.702931] [Reference Citation Analysis]
316 Chaffanel F, Charron-Bourgoin F, Libante V, Leblond-Bourget N, Payot S. Resistance Genes and Genetic Elements Associated with Antibiotic Resistance in Clinical and Commensal Isolates of Streptococcus salivarius. Appl Environ Microbiol 2015;81:4155-63. [PMID: 25862227 DOI: 10.1128/AEM.00415-15] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
317 Barbuti RC, Schiavon LL, Oliveira CP, Alvares-DA-Silva MR, Sassaki LY, Passos MDCF, Farias AQ, Barros LL, Barreto BP, Albuquerque GBML, Alves AM, Navarro-Rodriguez T, Bittencourt PL. GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN GASTROINTESTINAL AND LIVER DISEASES: PROCEEDINGS OF A JOINT MEETING OF THE BRAZILIAN SOCIETY OF HEPATOLOGY (SBH), BRAZILIAN NUCLEUS FOR THE STUDY OF HELICOBACTER PYLORI AND MICROBIOTA (NBEHPM), AND BRAZILIAN FEDERATION OF GASTROENTEROLOGY (FBG). Arq Gastroenterol 2020;57:381-98. [PMID: 33331485 DOI: 10.1590/S0004-2803.202000000-72] [Reference Citation Analysis]
318 Cui HX, Zhang LS, Luo Y, Yuan K, Huang ZY, Guo Y. A Purified Anthraquinone-Glycoside Preparation From Rhubarb Ameliorates Type 2 Diabetes Mellitus by Modulating the Gut Microbiota and Reducing Inflammation. Front Microbiol 2019;10:1423. [PMID: 31293553 DOI: 10.3389/fmicb.2019.01423] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
319 Schrittwieser S, Pelaz B, Parak WJ, Lentijo-Mozo S, Soulantica K, Dieckhoff J, Ludwig F, Guenther A, Tschöpe A, Schotter J. Homogeneous Biosensing Based on Magnetic Particle Labels. Sensors (Basel) 2016;16:E828. [PMID: 27275824 DOI: 10.3390/s16060828] [Cited by in Crossref: 60] [Cited by in F6Publishing: 41] [Article Influence: 10.0] [Reference Citation Analysis]
320 Xu X, Wu A, Zhang X, Su M, Jiang T, Yuan ZM. MetaDP: a comprehensive web server for disease prediction of 16S rRNA metagenomic datasets. Biophys Rep 2016;2:106-15. [PMID: 28317014 DOI: 10.1007/s41048-016-0033-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
321 Wang Y, Pan CQ, Xing H. Advances in Gut Microbiota of Viral Hepatitis Cirrhosis. Biomed Res Int 2019;2019:9726786. [PMID: 31886272 DOI: 10.1155/2019/9726786] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
322 Wang Y, Chen Q, Deng C, Zheng Y, Sun F. KmerGO: A Tool to Identify Group-Specific Sequences With k-mers. Front Microbiol 2020;11:2067. [PMID: 32983048 DOI: 10.3389/fmicb.2020.02067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
323 Nadim MK, Durand F, Kellum JA, Levitsky J, O’leary JG, Karvellas CJ, Bajaj JS, Davenport A, Jalan R, Angeli P, Caldwell SH, Fernández J, Francoz C, Garcia-tsao G, Ginès P, Ison MG, Kramer DJ, Mehta RL, Moreau R, Mulligan D, Olson JC, Pomfret EA, Senzolo M, Steadman RH, Subramanian RM, Vincent J, Genyk YS. Management of the critically ill patient with cirrhosis: A multidisciplinary perspective. Journal of Hepatology 2016;64:717-35. [DOI: 10.1016/j.jhep.2015.10.019] [Cited by in Crossref: 150] [Cited by in F6Publishing: 111] [Article Influence: 25.0] [Reference Citation Analysis]
324 Zuo K, Li J, Li K, Hu C, Gao Y, Chen M, Hu R, Liu Y, Chi H, Wang H, Qin Y, Liu X, Li S, Cai J, Zhong J, Yang X. Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation. Gigascience 2019;8:giz058. [PMID: 31149718 DOI: 10.1093/gigascience/giz058] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 15.0] [Reference Citation Analysis]
325 Ghosh TS, Das M, Jeffery IB, O'Toole PW. Adjusting for age improves identification of gut microbiome alterations in multiple diseases. Elife 2020;9:e50240. [PMID: 32159510 DOI: 10.7554/eLife.50240] [Cited by in Crossref: 30] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
326 Bi C, Xiao G, Liu C, Yan J, Chen J, Si W, Zhang J, Liu Z. Molecular Immune Mechanism of Intestinal Microbiota and Their Metabolites in the Occurrence and Development of Liver Cancer. Front Cell Dev Biol 2021;9:702414. [PMID: 34957088 DOI: 10.3389/fcell.2021.702414] [Reference Citation Analysis]
327 Wu H, Ma Y, Peng X, Qiu W, Kong L, Ren B, Li M, Cheng G, Zhou X, Cheng L. Antibiotic-induced dysbiosis of the rat oral and gut microbiota and resistance to Salmonella. Arch Oral Biol 2020;114:104730. [PMID: 32371145 DOI: 10.1016/j.archoralbio.2020.104730] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
328 Temraz S, Nassar F, Kreidieh F, Mukherji D, Shamseddine A, Nasr R. Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome. Int J Mol Sci 2021;22:7800. [PMID: 34360566 DOI: 10.3390/ijms22157800] [Reference Citation Analysis]
329 Woodhouse CA, Patel VC, Singanayagam A, Shawcross DL. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease. Aliment Pharmacol Ther. 2018;47:192-202. [PMID: 29083037 DOI: 10.1111/apt.14397] [Cited by in Crossref: 78] [Cited by in F6Publishing: 70] [Article Influence: 15.6] [Reference Citation Analysis]
330 Campion D, Giovo I, Ponzo P, Saracco GM, Balzola F, Alessandria C. Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis. World J Hepatol 2019; 11(6): 489-512 [PMID: 31293718 DOI: 10.4254/wjh.v11.i6.489] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
331 Litwinowicz K, Choroszy M, Waszczuk E. Changes in the composition of the human intestinal microbiome in alcohol use disorder: a systematic review. The American Journal of Drug and Alcohol Abuse 2020;46:4-12. [DOI: 10.1080/00952990.2019.1669629] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
332 Bajaj JS, Khoruts A. Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis. Journal of Hepatology 2020;72:1003-27. [DOI: 10.1016/j.jhep.2020.01.017] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 17.0] [Reference Citation Analysis]
333 Patel V, Lee S, McPhail M, Da Silva K, Guilly S, Zamalloa A, Witherden E, Støy S, Manakkat Vijay GK, Pons N, Galleron N, Huang X, Gencer S, Coen M, Tranah TH, Wendon JA, Bruce K, Le Chatelier E, Ehrlich SD, Edwards LA, Shoaie S, Shawcross DL. Rifaximin reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial. J Hepatol 2021:S0168-8278(21)02040-7. [PMID: 34571050 DOI: 10.1016/j.jhep.2021.09.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
334 Ren Z, Fan Y, Li A, Shen Q, Wu J, Ren L, Lu H, Ding S, Ren H, Liu C, Liu W, Gao D, Wu Z, Guo S, Wu G, Liu Z, Yu Z, Li L. Alterations of the Human Gut Microbiome in Chronic Kidney Disease. Adv Sci (Weinh) 2020;7:2001936. [PMID: 33101877 DOI: 10.1002/advs.202001936] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
335 Woodhouse C, Singanayagam A, Patel VC. Modulating the gut-liver axis and the pivotal role of the faecal microbiome in cirrhosis. Clin Med (Lond) 2020;20:493-500. [PMID: 32934044 DOI: 10.7861/clinmed.2020-0676] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
336 Wang C, Li Q, Ren J. Microbiota-Immune Interaction in the Pathogenesis of Gut-Derived Infection. Front Immunol. 2019;10:1873. [PMID: 31456801 DOI: 10.3389/fimmu.2019.01873] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
337 Huang YC, Tan XR. Association of gut microbiota with cardiovascular diseases: Present and future. Shijie Huaren Xiaohua Zazhi 2017; 25(1): 31-42 [DOI: 10.11569/wcjd.v25.i1.31] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
338 Bosch S, Lemmen JP, Menezes R, van der Hulst R, Kuijvenhoven J, Stokkers PC, de Meij TG, de Boer NK. The influence of lifestyle factors on fecal volatile organic compound composition as measured by an electronic nose. J Breath Res 2019;13:046001. [PMID: 31170704 DOI: 10.1088/1752-7163/ab2775] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
339 Zhao N, Li M, Luo J, Wang S, Liu S, Wang S, Lyu W, Chen L, Su W, Ding H, He H. Impacts of canine distemper virus infection on the giant panda population from the perspective of gut microbiota. Sci Rep 2017;7:39954. [PMID: 28051146 DOI: 10.1038/srep39954] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
340 Dong S, Jiao J, Jia S, Li G, Zhang W, Yang K, Wang Z, Liu C, Li D, Wang X. 16S rDNA Full-Length Assembly Sequencing Technology Analysis of Intestinal Microbiome in Polycystic Ovary Syndrome. Front Cell Infect Microbiol 2021;11:634981. [PMID: 34041041 DOI: 10.3389/fcimb.2021.634981] [Reference Citation Analysis]
341 Liu Z, Li N, Fang H, Chen X, Guo Y, Gong S, Niu M, Zhou H, Jiang Y, Chang P, Chen P. Enteric dysbiosis is associated with sepsis in patients. FASEB J 2019;33:12299-310. [PMID: 31465241 DOI: 10.1096/fj.201900398RR] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
342 Li P, Cai X, Xiao N, Ma X, Zeng L, Zhang LH, Xie L, Du B. Sacha inchi (Plukenetia volubilis L.) shell extract alleviates hypertension in association with the regulation of gut microbiota. Food Funct 2020;11:8051-67. [PMID: 32852030 DOI: 10.1039/d0fo01770a] [Reference Citation Analysis]
343 Shi Z, Chen G, Cao Z, Wu F, Lei H, Chen C, Song Y, Liu C, Li J, Zhou J, Lu Y, Zhang L. Gut Microbiota and Its Metabolite Deoxycholic Acid Contribute to Sucralose Consumption-Induced Nonalcoholic Fatty Liver Disease. J Agric Food Chem 2021;69:3982-91. [PMID: 33755449 DOI: 10.1021/acs.jafc.0c07467] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
344 Yuan Y, Wang X, Xu X, Liu Y, Li C, Yang M, Yang Y, Ma Z. Evaluation of a Dual-Acting Antibacterial Agent, TNP-2092, on Gut Microbiota and Potential Application in the Treatment of Gastrointestinal and Liver Disorders. ACS Infect Dis 2020;6:820-31. [DOI: 10.1021/acsinfecdis.9b00374] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
345 Nakatsu G, Zhou H, Wu WKK, Wong SH, Coker OO, Dai Z, Li X, Szeto C, Sugimura N, Lam TY, Yu AC, Wang X, Chen Z, Wong MC, Ng SC, Chan MTV, Chan PKS, Chan FKL, Sung JJ, Yu J. Alterations in Enteric Virome Are Associated With Colorectal Cancer and Survival Outcomes. Gastroenterology 2018;155:529-541.e5. [DOI: 10.1053/j.gastro.2018.04.018] [Cited by in Crossref: 91] [Cited by in F6Publishing: 85] [Article Influence: 22.8] [Reference Citation Analysis]
346 Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev. 2017;121:27-42. [PMID: 28506744 DOI: 10.1016/j.addr.2017.05.007] [Cited by in Crossref: 359] [Cited by in F6Publishing: 356] [Article Influence: 71.8] [Reference Citation Analysis]
347 Wen C, Zheng Z, Shao T, Liu L, Xie Z, Le Chatelier E, He Z, Zhong W, Fan Y, Zhang L, Li H, Wu C, Hu C, Xu Q, Zhou J, Cai S, Wang D, Huang Y, Breban M, Qin N, Ehrlich SD. Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis. Genome Biol 2017;18:142. [PMID: 28750650 DOI: 10.1186/s13059-017-1271-6] [Cited by in Crossref: 115] [Cited by in F6Publishing: 106] [Article Influence: 23.0] [Reference Citation Analysis]
348 Land M, Hauser L, Jun SR, Nookaew I, Leuze MR, Ahn TH, Karpinets T, Lund O, Kora G, Wassenaar T, Poudel S, Ussery DW. Insights from 20 years of bacterial genome sequencing. Funct Integr Genomics 2015;15:141-61. [PMID: 25722247 DOI: 10.1007/s10142-015-0433-4] [Cited by in Crossref: 373] [Cited by in F6Publishing: 267] [Article Influence: 53.3] [Reference Citation Analysis]
349 Cavalcanti Neto MP, Aquino JDS, Romão da Silva LDF, de Oliveira Silva R, Guimarães KSDL, de Oliveira Y, de Souza EL, Magnani M, Vidal H, de Brito Alves JL. Gut microbiota and probiotics intervention: A potential therapeutic target for management of cardiometabolic disorders and chronic kidney disease? Pharmacological Research 2018;130:152-63. [DOI: 10.1016/j.phrs.2018.01.020] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 8.8] [Reference Citation Analysis]
350 Ko CY, Liu QQ, Su HZ, Zhang HP, Fan JM, Yang JH, Hu AK, Liu YQ, Chou D, Zeng YM. Gut microbiota in obstructive sleep apnea-hypopnea syndrome: disease-related dysbiosis and metabolic comorbidities. Clin Sci (Lond) 2019;133:905-17. [PMID: 30957778 DOI: 10.1042/CS20180891] [Cited by in Crossref: 26] [Cited by in F6Publishing: 11] [Article Influence: 8.7] [Reference Citation Analysis]
351 Kajihara M, Koido S, Kanai T, Ito Z, Matsumoto Y, Takakura K, Saruta M, Kato K, Odamaki T, Xiao JZ, Sato N, Ohkusa T. Characterisation of blood microbiota in patients with liver cirrhosis. Eur J Gastroenterol Hepatol. 2019;31:1577-1583. [PMID: 31441799 DOI: 10.1097/meg.0000000000001494] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
352 Bajaj JS, Betrapally NS, Gillevet PM. Decompensated cirrhosis and microbiome interpretation. Nature 2015;525:E1-2. [PMID: 26381988 DOI: 10.1038/nature14851] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 8.4] [Reference Citation Analysis]
353 Jensen A, Ladegaard Grønkjær L, Holmstrup P, Vilstrup H, Kilian M. Unique subgingival microbiota associated with periodontitis in cirrhosis patients. Sci Rep 2018;8:10718. [PMID: 30013030 DOI: 10.1038/s41598-018-28905-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
354 Chiu L, Bazin T, Truchetet ME, Schaeverbeke T, Delhaes L, Pradeu T. Protective Microbiota: From Localized to Long-Reaching Co-Immunity. Front Immunol 2017;8:1678. [PMID: 29270167 DOI: 10.3389/fimmu.2017.01678] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 11.0] [Reference Citation Analysis]
355 Almeida M, Pop M, Le Chatelier E, Prifti E, Pons N, Ghozlane A, Ehrlich SD. Capturing the most wanted taxa through cross-sample correlations. ISME J 2016;10:2459-67. [PMID: 26943627 DOI: 10.1038/ismej.2016.35] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
356 Ren YD, Ye ZS, Yang LZ, Jin LX, Wei WJ, Deng YY, Chen XX, Xiao CX, Yu XF, Xu HZ. Fecal microbiota transplantation induces hepatitis B virus e-antigen (HBeAg) clearance in patients with positive HBeAg after long-term antiviral therapy. Hepatology. 2017;65:1765-1768. [PMID: 28027582 DOI: 10.1002/hep.29008] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 12.8] [Reference Citation Analysis]
357 Bajaj JS, Liu EJ, Kheradman R, Fagan A, Heuman DM, White M, Gavis EA, Hylemon P, Sikaroodi M, Gillevet PM. Fungal dysbiosis in cirrhosis. Gut 2018;67:1146-54. [DOI: 10.1136/gutjnl-2016-313170] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 10.4] [Reference Citation Analysis]
358 Lee MH. Harness the functions of gut microbiome in tumorigenesis for cancer treatment. Cancer Commun (Lond) 2021. [PMID: 34355542 DOI: 10.1002/cac2.12200] [Reference Citation Analysis]
359 Elsemman IE, Mardinoglu A, Shoaie S, Soliman TH, Nielsen J. Systems biology analysis of hepatitis C virus infection reveals the role of copy number increases in regions of chromosome 1q in hepatocellular carcinoma metabolism. Mol Biosyst. 2016;12:1496-1506. [PMID: 27040643 DOI: 10.1039/c5mb00827a] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
360 Shamsaddini A, Gillevet PM, Acharya C, Fagan A, Gavis E, Sikaroodi M, McGeorge S, Khoruts A, Albhaisi S, Fuchs M, Sterling RK, Bajaj JS. Impact of Antibiotic Resistance Genes in Gut Microbiome of Patients With Cirrhosis. Gastroenterology 2021;161:508-521.e7. [PMID: 33857456 DOI: 10.1053/j.gastro.2021.04.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
361 Liu B, Zeng Q, Chen H, Liao J, Bai Y, Han Q, Qiao N, Wang S, Mehmood K, Hussain R, Ahmed BZ, Tang Z, Zhang H, Li Y. The hepatotoxicity of altrazine exposure in mice involves the intestinal microbiota. Chemosphere 2021;272:129572. [PMID: 33485040 DOI: 10.1016/j.chemosphere.2021.129572] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
362 Aly AM, Adel A, El-Gendy AO, Essam TM, Aziz RK. Gut microbiome alterations in patients with stage 4 hepatitis C. Gut Pathog 2016;8:42. [PMID: 27625705 DOI: 10.1186/s13099-016-0124-2] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 9.5] [Reference Citation Analysis]
363 Yun Y, Chang Y, Kim HN, Ryu S, Kwon MJ, Cho YK, Kim HL, Cheong HS, Joo EJ. Alterations of the Gut Microbiome in Chronic Hepatitis B Virus Infection Associated with Alanine Aminotransferase Level.J Clin Med. 2019;8:173. [PMID: 30717396 DOI: 10.3390/jcm8020173] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
364 Chen SZ, Ling Y, Yu LX, Song YT, Chen XF, Cao QQ, Yu H, Chen C, Tang JJ, Fan ZC, Miao YS, Dong YP, Tao JY, Monga SPS, Wen W, Wang HY. 4-phenylbutyric acid promotes hepatocellular carcinoma via initiating cancer stem cells through activation of PPAR-α. Clin Transl Med 2021;11:e379. [PMID: 33931972 DOI: 10.1002/ctm2.379] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
365 Fukui H. Leaky Gut and Gut-Liver Axis in Liver Cirrhosis: Clinical Studies Update. Gut Liver 2021;15:666-76. [PMID: 33071239 DOI: 10.5009/gnl20032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
366 Xia X, Chen J, Xia J, Wang B, Liu H, Yang L, Wang Y, Ling Z. Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis. J Int Med Res 2018;46:3596-604. [PMID: 29806520 DOI: 10.1177/0300060518776064] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
367 Weng MT, Chiu YT, Wei PY, Chiang CW, Fang HL, Wei SC. Microbiota and gastrointestinal cancer. J Formos Med Assoc 2019;118 Suppl 1:S32-41. [PMID: 30655033 DOI: 10.1016/j.jfma.2019.01.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
368 Aron-wisnewsky J, Vigliotti C, Witjes J, Le P, Holleboom AG, Verheij J, Nieuwdorp M, Clément K. Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders. Nat Rev Gastroenterol Hepatol 2020;17:279-97. [DOI: 10.1038/s41575-020-0269-9] [Cited by in Crossref: 103] [Cited by in F6Publishing: 103] [Article Influence: 51.5] [Reference Citation Analysis]
369 Hong SJ, Feuerstadt P, Brandt LJ. MELD is the only predictor of short-term mortality in cirrhotic patients with C. difficile infection. Digestive and Liver Disease 2019;51:275-80. [DOI: 10.1016/j.dld.2018.07.032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
370 Alagna L, Palomba E, Mangioni D, Bozzi G, Lombardi A, Ungaro R, Castelli V, Prati D, Vecchi M, Muscatello A, Bandera A, Gori A. Multidrug-Resistant Gram-Negative Bacteria Decolonization in Immunocompromised Patients: A Focus on Fecal Microbiota Transplantation. Int J Mol Sci 2020;21:E5619. [PMID: 32764526 DOI: 10.3390/ijms21165619] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
371 King CH, Desai H, Sylvetsky AC, LoTempio J, Ayanyan S, Carrie J, Crandall KA, Fochtman BC, Gasparyan L, Gulzar N, Howell P, Issa N, Krampis K, Mishra L, Morizono H, Pisegna JR, Rao S, Ren Y, Simonyan V, Smith K, VedBrat S, Yao MD, Mazumder R. Baseline human gut microbiota profile in healthy people and standard reporting template. PLoS One 2019;14:e0206484. [PMID: 31509535 DOI: 10.1371/journal.pone.0206484] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 10.3] [Reference Citation Analysis]
372 Luo XY, Wu KM, He XX. Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets. J Exp Clin Cancer Res 2021;40:172. [PMID: 34006331 DOI: 10.1186/s13046-021-01968-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
373 Aron-Wisnewsky J, Warmbrunn MV, Nieuwdorp M, Clément K. Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity? Gastroenterology 2020;158:1881-98. [PMID: 32044317 DOI: 10.1053/j.gastro.2020.01.049] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 12.5] [Reference Citation Analysis]
374 Lee NY, Suk KT. The Role of the Gut Microbiome in Liver Cirrhosis Treatment. Int J Mol Sci 2020;22:E199. [PMID: 33379148 DOI: 10.3390/ijms22010199] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
375 Tisza MJ, Buck CB. A catalog of tens of thousands of viruses from human metagenomes reveals hidden associations with chronic diseases. Proc Natl Acad Sci U S A 2021;118:e2023202118. [PMID: 34083435 DOI: 10.1073/pnas.2023202118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
376 Ye Z, Zhang N, Wu C, Zhang X, Wang Q, Huang X, Du L, Cao Q, Tang J, Zhou C, Hou S, He Y, Xu Q, Xiong X, Kijlstra A, Qin N, Yang P. A metagenomic study of the gut microbiome in Behcet's disease. Microbiome 2018;6:135. [PMID: 30077182 DOI: 10.1186/s40168-018-0520-6] [Cited by in Crossref: 78] [Cited by in F6Publishing: 77] [Article Influence: 19.5] [Reference Citation Analysis]
377 Wu P, Zhang R, Luo M, Zhang T, Pan L, Xu S, Pan L, Ren F, Ji C, Hu R, Noureddin M, Pandol SJ, Han YP. Liver Injury Impaired 25-Hydroxylation of Vitamin D Suppresses Intestinal Paneth Cell defensins, leading to Gut Dysbiosis and Liver Fibrogenesis. Am J Physiol Gastrointest Liver Physiol 2020. [PMID: 33084400 DOI: 10.1152/ajpgi.00021.2020] [Reference Citation Analysis]
378 Simões-silva L, Araujo R, Pestana M, Soares-silva I, Sampaio-maia B. The microbiome in chronic kidney disease patients undergoing hemodialysis and peritoneal dialysis. Pharmacological Research 2018;130:143-51. [DOI: 10.1016/j.phrs.2018.02.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
379 Han D, Gao P, Li R, Tan P, Xie J, Zhang R, Li J. Multicenter assessment of microbial community profiling using 16S rRNA gene sequencing and shotgun metagenomic sequencing. J Adv Res 2020;26:111-21. [PMID: 33133687 DOI: 10.1016/j.jare.2020.07.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
380 Bloom PP, Luévano JM Jr, Miller KJ, Chung RT. Deep stool microbiome analysis in cirrhosis reveals an association between short-chain fatty acids and hepatic encephalopathy. Ann Hepatol 2021;25:100333. [PMID: 33621653 DOI: 10.1016/j.aohep.2021.100333] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
381 Kim JW, Lee JS, Kim JH, Jeong JW, Lee DH, Nam S. Comparison of Microbiota Variation in Korean Healthy Adolescents with Adults Suggests Notable Maturity Differences. OMICS 2018;22:770-8. [PMID: 30481125 DOI: 10.1089/omi.2018.0146] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
382 Ma C, Guo H, Chang H, Huang S, Jiang S, Huo D, Zhang J, Zhu X. The effects of exopolysaccharides and exopolysaccharide-producing Lactobacillus on the intestinal microbiome of zebrafish (Danio rerio). BMC Microbiol 2020;20:300. [PMID: 33023493 DOI: 10.1186/s12866-020-01990-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
383 Berland M, Cadiou J, Levenez F, Galleron N, Quinquis B, Thirion F, Gauthier F, Le Chatelier E, Plaza Oñate F, Schwintner C, Rabot S, Lepage P, Ehrlich D, Doré J, Juste C. High engraftment capacity of frozen ready-to-use human fecal microbiota transplants assessed in germ-free mice. Sci Rep 2021;11:4365. [PMID: 33623056 DOI: 10.1038/s41598-021-83638-7] [Reference Citation Analysis]
384 Giraud J, Saleh M. Host-Microbiota Interactions in Liver Inflammation and Cancer. Cancers (Basel) 2021;13:4342. [PMID: 34503151 DOI: 10.3390/cancers13174342] [Reference Citation Analysis]
385 Zheng W, Zhao Z, Lv F, Wang R, Gong Q, Zhai B, Wang Z, Zhao Z, Li Z. Metagenomic exploration of the interactions between N and P cycling and SOM turnover in an apple orchard with a cover crop fertilized for 9 years. Biol Fertil Soils 2019;55:365-81. [DOI: 10.1007/s00374-019-01356-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 5.7] [Reference Citation Analysis]
386 Stadlbauer V, Komarova I, Klymiuk I, Durdevic M, Reisinger A, Blesl A, Rainer F, Horvath A. Disease severity and proton pump inhibitor use impact strongest on faecal microbiome composition in liver cirrhosis. Liver Int 2020;40:866-77. [PMID: 31943691 DOI: 10.1111/liv.14382] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
387 Meroni M, Longo M, Dongiovanni P. The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies. Nutrients. 2019;11. [PMID: 31689910 DOI: 10.3390/nu11112642] [Cited by in Crossref: 19] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
388 Wang Y, Gao X, Zhang X, Xiao Y, Huang J, Yu D, Li X, Hu H, Ge T, Li D, Zhang T. Gut Microbiota Dysbiosis Is Associated with Altered Bile Acid Metabolism in Infantile Cholestasis. mSystems 2019;4:e00463-19. [PMID: 31848302 DOI: 10.1128/mSystems.00463-19] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
389 Adebayo D, Neong SF, Wong F. Ascites and Hepatorenal Syndrome. Clin Liver Dis 2019;23:659-82. [PMID: 31563217 DOI: 10.1016/j.cld.2019.06.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
390 Pasolli E, Truong DT, Malik F, Waldron L, Segata N. Machine Learning Meta-analysis of Large Metagenomic Datasets: Tools and Biological Insights. PLoS Comput Biol. 2016;12:e1004977. [PMID: 27400279 DOI: 10.1371/journal.pcbi.1004977] [Cited by in Crossref: 215] [Cited by in F6Publishing: 156] [Article Influence: 35.8] [Reference Citation Analysis]
391 Úbeda M, Lario M, Muñoz L, Borrero MJ, Rodríguez-Serrano M, Sánchez-Díaz AM, Del Campo R, Lledó L, Pastor Ó, García-Bermejo L, Díaz D, Álvarez-Mon M, Albillos A. Obeticholic acid reduces bacterial translocation and inhibits intestinal inflammation in cirrhotic rats. J Hepatol 2016;64:1049-57. [PMID: 26723896 DOI: 10.1016/j.jhep.2015.12.010] [Cited by in Crossref: 80] [Cited by in F6Publishing: 75] [Article Influence: 11.4] [Reference Citation Analysis]
392 Arroyo V, Moreau R, Kamath PS, Jalan R, Ginès P, Nevens F, Fernández J, To U, García-Tsao G, Schnabl B. Acute-on-chronic liver failure in cirrhosis. Nat Rev Dis Primers 2016;2:16041. [PMID: 27277335 DOI: 10.1038/nrdp.2016.41] [Cited by in Crossref: 159] [Cited by in F6Publishing: 144] [Article Influence: 26.5] [Reference Citation Analysis]
393 Cui X, Ye L, Li J, Jin L, Wang W, Li S, Bao M, Wu S, Li L, Geng B, Zhou X, Zhang J, Cai J. Metagenomic and metabolomic analyses unveil dysbiosis of gut microbiota in chronic heart failure patients. Sci Rep 2018;8:635. [PMID: 29330424 DOI: 10.1038/s41598-017-18756-2] [Cited by in Crossref: 99] [Cited by in F6Publishing: 89] [Article Influence: 24.8] [Reference Citation Analysis]
394 Arroyo V, Angeli P, Moreau R, Jalan R, Clària J, Trebicka J, Fernández J, Gustot T, Caraceni P, Bernardi M; investigators from the EASL-CLIF Consortium, Grifols Chair and European Foundation for the Study of Chronic Liver Failure (EF-Clif). The systemic inflammation hypothesis: Towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis. J Hepatol 2021;74:670-85. [PMID: 33301825 DOI: 10.1016/j.jhep.2020.11.048] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
395 Carding SR, Davis N, Hoyles L. Review article: the human intestinal virome in health and disease. Aliment Pharmacol Ther. 2017;46:800-815. [PMID: 28869283 DOI: 10.1111/apt.14280] [Cited by in Crossref: 102] [Cited by in F6Publishing: 88] [Article Influence: 20.4] [Reference Citation Analysis]
396 Zheng H, Steele MI, Leonard SP, Motta EVS, Moran NA. Honey bees as models for gut microbiota research. Lab Anim (NY) 2018;47:317-25. [PMID: 30353179 DOI: 10.1038/s41684-018-0173-x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 42] [Article Influence: 14.8] [Reference Citation Analysis]
397 Jiang JW, Ren ZG, Lu HF, Zhang H, Li A, Cui GY, Jia JJ, Xie HY, Chen XH, He Y, Jiang L, Li LJ. Optimal immunosuppressor induces stable gut microbiota after liver transplantation. World J Gastroenterol 2018; 24(34): 3871-3883 [PMID: 30228781 DOI: 10.3748/wjg.v24.i34.3871] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
398 Li DK, Chung RT. Use of proton pump inhibitors in chronic liver diseases. Clin Liver Dis (Hoboken) 2017;10:148-51. [PMID: 30992776 DOI: 10.1002/cld.678] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
399 Bolinger H, Tran D, Harary K, Paoli GC, Guron G, Namazi H, Khaksar R. Utilizing the Microbiota and Machine Learning Algorithms to Assess Risk of Salmonella Contamination in Poultry Rinsate. J Food Prot 2021. [PMID: 34015130 DOI: 10.4315/JFP-20-367] [Reference Citation Analysis]
400 Zhang H, Yan A, Liu X, Ma Y, Zhao F, Wang M, Loor JJ, Wang H. Melatonin ameliorates ochratoxin A induced liver inflammation, oxidative stress and mitophagy in mice involving in intestinal microbiota and restoring the intestinal barrier function. Journal of Hazardous Materials 2021;407:124489. [DOI: 10.1016/j.jhazmat.2020.124489] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
401 Vanhaecke T, Bretin O, Poirel M, Tap J. Drinking Water Source and Intake Are Associated with Distinct Gut Microbiota Signatures in US and UK Populations. J Nutr 2021:nxab312. [PMID: 34642755 DOI: 10.1093/jn/nxab312] [Reference Citation Analysis]
402 Xu P, Shi Y, Liu P, Yang Y, Zhou C, Li G, Luo J, Zhang C, Cao H, Hu G, Guo X. 16S rRNA gene sequencing reveals an altered composition of the gut microbiota in chickens infected with a nephropathogenic infectious bronchitis virus. Sci Rep 2020;10:3556. [PMID: 32103130 DOI: 10.1038/s41598-020-60564-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
403 Wang Z, Wang Y, Fuhrman JA, Sun F, Zhu S. Assessment of metagenomic assemblers based on hybrid reads of real and simulated metagenomic sequences. Brief Bioinform 2020;21:777-90. [PMID: 30860572 DOI: 10.1093/bib/bbz025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
404 Bichat A, Plassais J, Ambroise C, Mariadassou M. Incorporating Phylogenetic Information in Microbiome Differential Abundance Studies Has No Effect on Detection Power and FDR Control. Front Microbiol 2020;11:649. [PMID: 32351481 DOI: 10.3389/fmicb.2020.00649] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
405 Quince C, Walker AW, Simpson JT, Loman NJ, Segata N. Shotgun metagenomics, from sampling to analysis. Nat Biotechnol 2017;35:833-44. [PMID: 28898207 DOI: 10.1038/nbt.3935] [Cited by in Crossref: 522] [Cited by in F6Publishing: 399] [Article Influence: 104.4] [Reference Citation Analysis]
406 Zhu C, Wang X, Li J, Jiang R, Chen H, Chen T, Yang Y. Determine independent gut microbiota-diseases association by eliminating the effects of human lifestyle factors. BMC Microbiol 2022;22:4. [PMID: 34979898 DOI: 10.1186/s12866-021-02414-9] [Reference Citation Analysis]
407 Vitlic A, Sadiq S, Ahmed HI, Ale EC, Binetti AG, Collett A, Humpreys PN, Laws AP. Isolation and characterization of a high molecular mass β-glucan from Lactobacillus fermentum Lf2 and evaluation of its immunomodulatory activity. Carbohydrate Research 2019;476:44-52. [DOI: 10.1016/j.carres.2019.03.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
408 Xu C, Liu Q, Zhang Q, Jiang Z, Gu A. Urinary enterolactone associated with liver enzyme levels in US adults: National Health and Nutrition Examination Survey (NHANES). Br J Nutr 2015;114:91-7. [DOI: 10.1017/s000711451500149x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
409 Tikhonov M. Community-level cohesion without cooperation. Elife 2016;5:e15747. [PMID: 27310530 DOI: 10.7554/eLife.15747] [Cited by in Crossref: 52] [Cited by in F6Publishing: 21] [Article Influence: 8.7] [Reference Citation Analysis]
410 Wu H, Tremaroli V, Bäckhed F. Linking Microbiota to Human Diseases: A Systems Biology Perspective. Trends Endocrinol Metab 2015;26:758-70. [PMID: 26555600 DOI: 10.1016/j.tem.2015.09.011] [Cited by in Crossref: 95] [Cited by in F6Publishing: 76] [Article Influence: 13.6] [Reference Citation Analysis]
411 Wan S, Huang C, Wang A, Zhu X. Ursolic acid improves the bacterial community mapping of the intestinal tract in liver fibrosis mice. PeerJ 2020;8:e9050. [PMID: 32355580 DOI: 10.7717/peerj.9050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
412 Wirbel J, Zych K, Essex M, Karcher N, Kartal E, Salazar G, Bork P, Sunagawa S, Zeller G. Microbiome meta-analysis and cross-disease comparison enabled by the SIAMCAT machine learning toolbox. Genome Biol 2021;22:93. [PMID: 33785070 DOI: 10.1186/s13059-021-02306-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
413 Li D, Chen H, Zhao J, Zhang H, Chen W. Potential Functions of the Gastrointestinal Microbiome Inhabiting the Length of the Rat Digest Tract. Int J Mol Sci 2019;20:E1232. [PMID: 30870968 DOI: 10.3390/ijms20051232] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
414 Zheng Y, Fang Z, Xue Y, Zhang J, Zhu J, Gao R, Yao S, Ye Y, Wang S, Lin C, Chen S, Huang H, Hu L, Jiang GN, Qin H, Zhang P, Chen J, Ji H. Specific gut microbiome signature predicts the early-stage lung cancer. Gut Microbes 2020;11:1030-42. [PMID: 32240032 DOI: 10.1080/19490976.2020.1737487] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 10.5] [Reference Citation Analysis]
415 Li J, Rui J, Li Y, Tang N, Zhan S, Jiang J, Li X. Ambient temperature alters body size and gut microbiota of Xenopus tropicalis. Sci China Life Sci 2020;63:915-25. [PMID: 31686318 DOI: 10.1007/s11427-019-9540-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
416 Verhelst X, Dias AM, Colombel JF, Vermeire S, Van Vlierberghe H, Callewaert N, Pinho SS. Protein Glycosylation as a Diagnostic and Prognostic Marker of Chronic Inflammatory Gastrointestinal and Liver Diseases. Gastroenterology 2020;158:95-110. [PMID: 31626754 DOI: 10.1053/j.gastro.2019.08.060] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 9.3] [Reference Citation Analysis]
417 Lynch SV, Ng SC, Shanahan F, Tilg H. Translating the gut microbiome: ready for the clinic? Nat Rev Gastroenterol Hepatol 2019;16:656-61. [PMID: 31562390 DOI: 10.1038/s41575-019-0204-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
418 Riaz Rajoka MS, Shi J, Mehwish HM, Zhu J, Li Q, Shao D, Huang Q, Yang H. Interaction between diet composition and gut microbiota and its impact on gastrointestinal tract health. Food Science and Human Wellness 2017;6:121-30. [DOI: 10.1016/j.fshw.2017.07.003] [Cited by in Crossref: 58] [Cited by in F6Publishing: 23] [Article Influence: 11.6] [Reference Citation Analysis]
419 Xingqun C, Xin X, Xuedong Z. [Relationship between oral and gut microbes]. Hua Xi Kou Qiang Yi Xue Za Zhi 2017;35:322-7. [PMID: 28675020 DOI: 10.7518/hxkq.2017.03.017] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
420 Furune S, Yamamoto K, Honda T, Fujiyoshi T, Kakushima N, Furukawa K, Ohno E, Nakamura M, Miyahara R, Kawashima H, Ishigami M, Hirooka Y, Fujishiro M. Changes in the gut microbiome in relation to the degree of gastric mucosal atrophy before and after Helicobacter pylori eradication. Scand J Gastroenterol 2021;:1-8. [PMID: 34818132 DOI: 10.1080/00365521.2021.2005135] [Reference Citation Analysis]
421 Wang H, Kang D, Zhou XD, Li YQ. [Prevention of infectious diseases through microecology modulation techniques]. Hua Xi Kou Qiang Yi Xue Za Zhi 2018;36:564-7. [PMID: 30465353 DOI: 10.7518/hxkq.2018.05.018] [Reference Citation Analysis]
422 Saboo K, Petrakov NV, Shamsaddini A, Fagan A, Gavis EA, Sikaroodi M, McGeorge S, Gillevet PM, Iyer RK, Bajaj JS. Stool microbiota are superior to saliva in distinguishing cirrhosis and hepatic encephalopathy using machine learning. J Hepatol 2021:S0168-8278(21)02183-8. [PMID: 34793867 DOI: 10.1016/j.jhep.2021.11.011] [Reference Citation Analysis]
423 Commichaux S, Shah N, Ghurye J, Stoppel A, Goodheart JA, Luque GG, Cummings MP, Pop M. A critical assessment of gene catalogs for metagenomic analysis. Bioinformatics 2021:btab216. [PMID: 33792639 DOI: 10.1093/bioinformatics/btab216] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
424 Iida N, Mizukoshi E, Yamashita T, Terashima T, Arai K, Seishima J, Kaneko S. Overuse of antianaerobic drug is associated with poor postchemotherapy prognosis of patients with hepatocellular carcinoma. Int J Cancer. 2019;145:2701-2711. [PMID: 30980680 DOI: 10.1002/ijc.32339] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
425 Chopan M, Littenberg B. The Association of Hot Red Chili Pepper Consumption and Mortality: A Large Population-Based Cohort Study. PLoS One 2017;12:e0169876. [PMID: 28068423 DOI: 10.1371/journal.pone.0169876] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
426 Fuentes‐chust C, Parolo C, Rosati G, Rivas L, Perez‐toralla K, Simon S, Lecuona I, Junot C, Trebicka J, Merkoçi A. The Microbiome Meets Nanotechnology: Opportunities and Challenges in Developing New Diagnostic Devices. Adv Mater 2021;33:2006104. [DOI: 10.1002/adma.202006104] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
427 Ahmad MI, Zou X, Ijaz MU, Hussain M, Liu C, Xu X, Zhou G, Li C. Processed Meat Protein Promoted Inflammation and Hepatic Lipogenesis by Upregulating Nrf2/Keap1 Signaling Pathway in Glrx-Deficient Mice. J Agric Food Chem 2019;67:8794-809. [PMID: 31345023 DOI: 10.1021/acs.jafc.9b03136] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
428 Faner R, Sibila O, Agustí A, Bernasconi E, Chalmers JD, Huffnagle GB, Manichanh C, Molyneaux PL, Paredes R, Pérez Brocal V, Ponomarenko J, Sethi S, Dorca J, Monsó E. The microbiome in respiratory medicine: current challenges and future perspectives. Eur Respir J 2017;49:1602086. [PMID: 28404649 DOI: 10.1183/13993003.02086-2016] [Cited by in Crossref: 101] [Cited by in F6Publishing: 96] [Article Influence: 20.2] [Reference Citation Analysis]
429 Liu Y, Lin N, Dai C, Xu J, Zhang Y, Xu M, Wang F, Li Y, Chen D. Occurrence and distribution of per- and polyfluoroalkyl substances (PFASs) in human livers with liver cancer. Environ Res 2021;202:111775. [PMID: 34333008 DOI: 10.1016/j.envres.2021.111775] [Reference Citation Analysis]
430 Victor DW 3rd, Quigley EM. Microbial therapy in liver disease: probiotics probe the microbiome-gut-liver-brain axis. Gastroenterology 2014;147:1216-8. [PMID: 25457846 DOI: 10.1053/j.gastro.2014.10.023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
431 Xiao D, Ren W, Bin P, Chen S, Yin J, Gao W, Liu G, Nan Z, Hu X, He J. Chitosan lowers body weight through intestinal microbiota and reduces IL-17 expression via mTOR signalling. Journal of Functional Foods 2016;22:166-76. [DOI: 10.1016/j.jff.2016.01.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
432 Gerbes A, Zoulim F, Tilg H, Dufour JF, Bruix J, Paradis V, Salem R, Peck-Radosavljevic M, Galle PR, Greten TF. Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma. Gut. 2018;67:380-388. [PMID: 29150490 DOI: 10.1136/gutjnl-2017-315068] [Cited by in Crossref: 82] [Cited by in F6Publishing: 83] [Article Influence: 16.4] [Reference Citation Analysis]
433 Li R, Mao Z, Ye X, Zuo T. Human Gut Microbiome and Liver Diseases: From Correlation to Causation. Microorganisms 2021;9:1017. [PMID: 34066850 DOI: 10.3390/microorganisms9051017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
434 Zhu Z, Ren J, Michail S, Sun F. MicroPro: using metagenomic unmapped reads to provide insights into human microbiota and disease associations. Genome Biol 2019;20:154. [PMID: 31387630 DOI: 10.1186/s13059-019-1773-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
435 Li S, Qi Y, Chen L, Qu D, Li Z, Gao K, Chen J, Sun Y. Effects of Panax ginseng polysaccharides on the gut microbiota in mice with antibiotic-associated diarrhea. Int J Biol Macromol 2019;124:931-7. [PMID: 30503788 DOI: 10.1016/j.ijbiomac.2018.11.271] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 7.8] [Reference Citation Analysis]
436 Fabijanić M, Vlahoviček K. Big Data, Evolution, and Metagenomes: Predicting Disease from Gut Microbiota Codon Usage Profiles. In: Carugo O, Eisenhaber F, editors. Data Mining Techniques for the Life Sciences. New York: Springer; 2016. pp. 509-31. [DOI: 10.1007/978-1-4939-3572-7_26] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
437 Szabo G, Petrasek J. Gut-liver axis and sterile signals in the development of alcoholic liver disease. Alcohol Alcohol 2017;52:414-24. [PMID: 28482064 DOI: 10.1093/alcalc/agx025] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
438 Lelouvier B, Servant F, Païssé S, Brunet AC, Benyahya S, Serino M, Valle C, Ortiz MR, Puig J, Courtney M, Federici M, Fernández-Real JM, Burcelin R, Amar J. Changes in blood microbiota profiles associated with liver fibrosis in obese patients: A pilot analysis. Hepatology 2016;64:2015-27. [PMID: 27639192 DOI: 10.1002/hep.28829] [Cited by in Crossref: 125] [Cited by in F6Publishing: 115] [Article Influence: 25.0] [Reference Citation Analysis]
439 Hu J, Zhong X, Yan J, Zhou D, Qin D, Xiao X, Zheng Y, Liu Y. High-throughput sequencing analysis of intestinal flora changes in ESRD and CKD patients. BMC Nephrol 2020;21:12. [PMID: 31931722 DOI: 10.1186/s12882-019-1668-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
440 Santiago A, Sanchez E, Clark A, Pozuelo M, Calvo M, Yañez F, Sarrabayrouse G, Perea L, Vidal S, Gallardo A, Guarner C, Soriano G, Manichanh C. Sequential Changes in the Mesenteric Lymph Node Microbiome and Immune Response during Cirrhosis Induction in Rats. mSystems 2019;4:e00278-18. [PMID: 30801032 DOI: 10.1128/mSystems.00278-18] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
441 Liu Y, Li J, Jin Y, Zhao L, Zhao F, Feng J, Li A, Wei Y. Splenectomy Leads to Amelioration of Altered Gut Microbiota and Metabolome in Liver Cirrhosis Patients. Front Microbiol. 2018;9:963. [PMID: 29867867 DOI: 10.3389/fmicb.2018.00963] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
442 Oh TG, Kim SM, Caussy C, Fu T, Guo J, Bassirian S, Singh S, Madamba EV, Bettencourt R, Richards L, Yu RT, Atkins AR, Huan T, Brenner DA, Sirlin CB, Downes M, Evans RM, Loomba R. A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis. Cell Metab 2020;32:878-888.e6. [PMID: 32610095 DOI: 10.1016/j.cmet.2020.06.005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 16.0] [Reference Citation Analysis]
443 Wang W, Zheng S, Li L, Yang Y, Liu Y, Wang A, Sharshov K, Li Y. Comparative metagenomics of the gut microbiota in wild greylag geese (Anser anser) and ruddy shelducks (Tadorna ferruginea). Microbiologyopen 2019;8:e00725. [PMID: 30296008 DOI: 10.1002/mbo3.725] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
444 Shen TD, Daniel SG, Patel S, Kaplan E, Phung L, Lemelle-Thomas K, Chau L, Herman L, Trisolini C, Stonelake A, Toal E, Khungar V, Bittinger K, Reddy KR, Wu GD. The Mucosally-Adherent Rectal Microbiota Contains Features Unique to Alcohol-Related Cirrhosis. Gut Microbes 2021;13:1987781. [PMID: 34747331 DOI: 10.1080/19490976.2021.1987781] [Reference Citation Analysis]
445 Yu L, Wang L, Wu X, Yi H. RSPO4-CRISPR alleviates liver injury and restores gut microbiota in a rat model of liver fibrosis. Commun Biol 2021;4:230. [PMID: 33603089 DOI: 10.1038/s42003-021-01747-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
446 Gustot T, Stadlbauer V, Laleman W, Alessandria C, Thursz M. Transition to decompensation and acute-on-chronic liver failure: Role of predisposing factors and precipitating events. J Hepatol 2021;75 Suppl 1:S36-48. [PMID: 34039491 DOI: 10.1016/j.jhep.2020.12.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
447 Rocco A, Sgamato C, Compare D, Coccoli P, Nardone OM, Nardone G. Gut Microbes and Hepatic Encephalopathy: From the Old Concepts to New Perspectives. Front Cell Dev Biol 2021;9:748253. [PMID: 34900994 DOI: 10.3389/fcell.2021.748253] [Reference Citation Analysis]
448 Topçuoğlu BD, Lesniak NA, Ruffin MT 4th, Wiens J, Schloss PD. A Framework for Effective Application of Machine Learning to Microbiome-Based Classification Problems. mBio 2020;11:e00434-20. [PMID: 32518182 DOI: 10.1128/mBio.00434-20] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
449 Chen Y, Zhao Y, Cheng Q, Wu D, Liu H. The Role of Intestinal Microbiota in Acute Graft-versus-Host Disease. J Immunol Res 2015;2015:145859. [PMID: 26090477 DOI: 10.1155/2015/145859] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
450 Jiao J, Zhang J, He P, OuYang X, Yu Y, Wen B, Sun Y, Yuan Q, Xiong X. Identification of Tick-Borne Pathogens and Genotyping of Coxiella burnetii in Rhipicephalus microplus in Yunnan Province, China. Front Microbiol 2021;12:736484. [PMID: 34621258 DOI: 10.3389/fmicb.2021.736484] [Reference Citation Analysis]
451 Wang B, Yao M, Lv L, Ling Z, Li L. The Human Microbiota in Health and Disease. Engineering 2017;3:71-82. [DOI: 10.1016/j.eng.2017.01.008] [Cited by in Crossref: 266] [Article Influence: 53.2] [Reference Citation Analysis]
452 Rastelli M, Knauf C, Cani PD. Gut Microbes and Health: A Focus on the Mechanisms Linking Microbes, Obesity, and Related Disorders. Obesity (Silver Spring). 2018;26:792-800. [PMID: 29687645 DOI: 10.1002/oby.22175] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 18.0] [Reference Citation Analysis]
453 Zheng H, Chen M, Li Y, Wang Y, Wei L, Liao Z, Wang M, Ma F, Liao Q, Xie Z. Modulation of Gut Microbiome Composition and Function in Experimental Colitis Treated with Sulfasalazine. Front Microbiol 2017;8:1703. [PMID: 28936203 DOI: 10.3389/fmicb.2017.01703] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 10.6] [Reference Citation Analysis]
454 Liu W, Zhang J, Wu C, Cai S, Huang W, Chen J, Xi X, Liang Z, Hou Q, Zhou B, Qin N, Zhang H. Unique Features of Ethnic Mongolian Gut Microbiome revealed by metagenomic analysis. Sci Rep 2016;6:34826. [PMID: 27708392 DOI: 10.1038/srep34826] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 6.8] [Reference Citation Analysis]
455 Pan Y, Zhang X. Diet and gut microbiome in fatty liver and its associated liver cancer. J Gastroenterol Hepatol 2021. [PMID: 34664301 DOI: 10.1111/jgh.15713] [Reference Citation Analysis]
456 Fan HN, Zhu P, Zhang J, Zhu JS. Mucosal microbiome dysbiosis associated with duodenum bulb inflammation. Microb Pathog 2021;150:104711. [PMID: 33385493 DOI: 10.1016/j.micpath.2020.104711] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
457 Fujisawa K, Takami T, Matsumoto T, Yamamoto N, Sakaida I. Profiling of the circadian metabolome in thioacetamide-induced liver cirrhosis in mice. Hepatol Commun. 2017;1:704-718. [PMID: 29404487 DOI: 10.1002/hep4.1075] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
458 Liu Y, Zheng Z, Yu L, Wu S, Sun L, Wu S, Xu Q, Cai S, Qin N, Bao W. Examination of the temporal and spatial dynamics of the gut microbiome in newborn piglets reveals distinct microbial communities in six intestinal segments. Sci Rep 2019;9:3453. [PMID: 30837612 DOI: 10.1038/s41598-019-40235-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
459 Cornide-Petronio ME, Álvarez-Mercado AI, Jiménez-Castro MB, Peralta C. Current Knowledge about the Effect of Nutritional Status, Supplemented Nutrition Diet, and Gut Microbiota on Hepatic Ischemia-Reperfusion and Regeneration in Liver Surgery. Nutrients 2020;12:E284. [PMID: 31973190 DOI: 10.3390/nu12020284] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
460 Raittz RT, Reginatto De Pierri C, Maluk M, Bueno Batista M, Carmona M, Junghare M, Faoro H, Cruz LM, Battistoni F, Souza E, Pedrosa FO, Chen WM, Poole PS, Dixon RA, James EK. Comparative Genomics Provides Insights into the Taxonomy of Azoarcus and Reveals Separate Origins of Nif Genes in the Proposed Azoarcus and Aromatoleum Genera. Genes (Basel) 2021;12:71. [PMID: 33430351 DOI: 10.3390/genes12010071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
461 Sung CM, Lin YF, Chen KF, Ke HM, Huang HY, Gong YN, Tsai WS, You JF, Lu MJ, Cheng HT, Lin CY, Kuo CJ, Tsai IJ, Hsieh SY. Predicting Clinical Outcomes of Cirrhosis Patients With Hepatic Encephalopathy From the Fecal Microbiome. Cell Mol Gastroenterol Hepatol. 2019;8:301-318.e2. [PMID: 31004827 DOI: 10.1016/j.jcmgh.2019.04.008] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 10.7] [Reference Citation Analysis]
462 Yang Q, Wang Y, Wei X, Zhu J, Wang X, Xie X, Lu W. The Alterations of Vaginal Microbiome in HPV16 Infection as Identified by Shotgun Metagenomic Sequencing. Front Cell Infect Microbiol 2020;10:286. [PMID: 32656096 DOI: 10.3389/fcimb.2020.00286] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
463 Mills S, Stanton C, Lane JA, Smith GJ, Ross RP. Precision Nutrition and the Microbiome, Part I: Current State of the Science. Nutrients. 2019;11:923. [PMID: 31022973 DOI: 10.3390/nu11040923] [Cited by in Crossref: 77] [Cited by in F6Publishing: 63] [Article Influence: 25.7] [Reference Citation Analysis]
464 Liu X, Tong X, Zhu J, Tian L, Jie Z, Zou Y, Lin X, Liang H, Li W, Ju Y, Qin Y, Zou L, Lu H, Zhu S, Jin X, Xu X, Yang H, Wang J, Zong Y, Liu W, Hou Y, Jia H, Zhang T. Metagenome-genome-wide association studies reveal human genetic impact on the oral microbiome. Cell Discov 2021;7:117. [PMID: 34873157 DOI: 10.1038/s41421-021-00356-0] [Reference Citation Analysis]
465 Inoue T, Nakayama J, Moriya K, Kawaratani H, Momoda R, Ito K, Iio E, Nojiri S, Fujiwara K, Yoneda M, Yoshiji H, Tanaka Y. Gut Dysbiosis Associated With Hepatitis C Virus Infection.Clin Infect Dis. 2018;67:869-877. [PMID: 29718124 DOI: 10.1093/cid/ciy205] [Cited by in Crossref: 70] [Cited by in F6Publishing: 70] [Article Influence: 23.3] [Reference Citation Analysis]
466 Siddiqui MT, Cresci GAM. Microbiota reprogramming for treatment of alcohol-related liver disease. Transl Res 2020;226:26-38. [PMID: 32687975 DOI: 10.1016/j.trsl.2020.07.004] [Reference Citation Analysis]
467 Wang T, Guo XK, Xu H. Disentangling the Progression of Non-alcoholic Fatty Liver Disease in the Human Gut Microbiota. Front Microbiol 2021;12:728823. [PMID: 34721326 DOI: 10.3389/fmicb.2021.728823] [Reference Citation Analysis]
468 Tsuzuno T, Takahashi N, Yamada-Hara M, Yokoji-Takeuchi M, Sulijaya B, Aoki-Nonaka Y, Matsugishi A, Katakura K, Tabeta K, Yamazaki K. Ingestion of Porphyromonas gingivalis exacerbates colitis via intestinal epithelial barrier disruption in mice. J Periodontal Res 2021;56:275-88. [PMID: 33512709 DOI: 10.1111/jre.12816] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
469 Shalikiani NV, Bakulin IG, Dubinkina VB, Ishchenko DS, Alexeev DG, Tyakht AV, Pavlenko AV, Ilyina EN, Kostryukova ES, Taraskina AE, Skorodumova LO, Maev IV, Govorun VM. [Specific features of the enteric microbiota composition in patients with alcoholic liver cirrhosis]. Ter Arkh 2015;87:59-65. [PMID: 26978420 DOI: 10.17116/terarkh2015871259-65] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
470 Wang P, Dong Y, Jiao J, Zuo K, Han C, Zhao L, Ding S, Yang X, Chen M, Li J. Cigarette smoking status alters dysbiotic gut microbes in hypertensive patients. J Clin Hypertens (Greenwich) 2021;23:1431-46. [PMID: 34029428 DOI: 10.1111/jch.14298] [Reference Citation Analysis]
471 Yu S, Xiong Y, Xu J, Liang X, Fu Y, Liu D, Yu X, Wu D. Identification of Dysfunctional Gut Microbiota Through Rectal Swab in Patients with Different Severity of Acute Pancreatitis. Dig Dis Sci. 2020;65:3223-3237. [PMID: 32076933 DOI: 10.1007/s10620-020-06061-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
472 Roehlen N, Crouchet E, Baumert TF. Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells 2020;9:E875. [PMID: 32260126 DOI: 10.3390/cells9040875] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 24.5] [Reference Citation Analysis]
473 Acharya C, Bajaj JS. Chronic Liver Diseases and the Microbiome-Translating Our Knowledge of Gut Microbiota to Management of Chronic Liver Disease. Gastroenterology 2021;160:556-72. [PMID: 33253686 DOI: 10.1053/j.gastro.2020.10.056] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
474 Zhan S, Li N, Liu C, Mao R, Wu D, Li T, Chen M, Zhuang X, Zeng Z. Intestinal Fibrosis and Gut Microbiota: Clues From Other Organs. Front Microbiol 2021;12:694967. [PMID: 34335525 DOI: 10.3389/fmicb.2021.694967] [Reference Citation Analysis]
475 Zhao N, Wang S, Li H, Liu S, Li M, Luo J, Su W, He H. Influence of Novel Highly Pathogenic Avian Influenza A (H5N1) Virus Infection on Migrating Whooper Swans Fecal Microbiota. Front Cell Infect Microbiol 2018;8:46. [PMID: 29520341 DOI: 10.3389/fcimb.2018.00046] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
476 Qin C, Zhang H, Zhao L, Zeng M, Huang W, Fu G, Zhou W, Wang H, Yan H. Microbiota transplantation reveals beneficial impact of berberine on hepatotoxicity by improving gut homeostasis. Sci China Life Sci 2018;61:1537-44. [DOI: 10.1007/s11427-017-9202-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
477 Norvell JP. Spotlight on Impactful Research: Impact of Liver Transplantation on Gut Microbiota and Cognitive Function. Clin Liver Dis (Hoboken) 2019;13:72-3. [PMID: 30988940 DOI: 10.1002/cld.746] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
478 Koliarakis I, Messaritakis I, Nikolouzakis TK, Hamilos G, Souglakos J, Tsiaoussis J. Oral Bacteria and Intestinal Dysbiosis in Colorectal Cancer. Int J Mol Sci 2019;20:E4146. [PMID: 31450675 DOI: 10.3390/ijms20174146] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 13.0] [Reference Citation Analysis]
479 Lei YM, Nair L, Alegre ML. The interplay between the intestinal microbiota and the immune system. Clin Res Hepatol Gastroenterol 2015;39:9-19. [PMID: 25481240 DOI: 10.1016/j.clinre.2014.10.008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 4.8] [Reference Citation Analysis]
480 Yuan Y, Wu X, Zhang X, Hong Y, Yan H. Ameliorative effect of salidroside from Rhodiola Rosea L. on the gut microbiota subject to furan-induced liver injury in a mouse model. Food and Chemical Toxicology 2019;125:333-40. [DOI: 10.1016/j.fct.2019.01.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
481 Sauerbruch T, Schierwagen R, Trebicka J. Managing portal hypertension in patients with liver cirrhosis. F1000Res 2018;7:F1000 Faculty Rev-533. [PMID: 29780579 DOI: 10.12688/f1000research.13943.1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 3.8] [Reference Citation Analysis]
482 Minemura M, Shimizu Y. Gut microbiota and liver diseases. World J Gastroenterol 2015; 21(6): 1691-1702 [PMID: 25684933 DOI: 10.3748/wjg.v21.i6.1691] [Cited by in CrossRef: 84] [Cited by in F6Publishing: 71] [Article Influence: 12.0] [Reference Citation Analysis]
483 Kayser BD, Prifti E, Lhomme M, Belda E, Dao MC, Aron-Wisnewsky J, Kontush A, Zucker JD, Rizkalla SW, Dugail I, Clément K; MICRO-Obes Consortium. Elevated serum ceramides are linked with obesity-associated gut dysbiosis and impaired glucose metabolism. Metabolomics 2019;15:140. [PMID: 31605240 DOI: 10.1007/s11306-019-1596-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
484 Shu B, Liu L, Wei Y, Zhang D, Shi S. Differential selection pressure exerted by root rot disease on the microbial communities in the rhizosphere of avocado ( Persea americana Mill.). Ann Appl Biol 2019;175:376-87. [DOI: 10.1111/aab.12547] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
485 Albhaisi S, Shamsaddini A, Fagan A, McGeorge S, Sikaroodi M, Gavis E, Patel S, Davis BC, Acharya C, Sterling RK, Matherly S, Fuchs M, Gillevet PM, Bajaj JS. Gut Microbial Signature of Hepatocellular Cancer in Men With Cirrhosis. Liver Transpl 2021;27:629-40. [PMID: 33492761 DOI: 10.1002/lt.25994] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
486 Fan HN, Zhu P, Lu YM, Guo JH, Zhang J, Qu GQ, Zhu JS. Mild changes in the mucosal microbiome during terminal ileum inflammation. Microb Pathog 2020;142:104104. [PMID: 32120004 DOI: 10.1016/j.micpath.2020.104104] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
487 Albhaisi SAM, Bajaj JS, Sanyal AJ. Role of gut microbiota in liver disease. Am J Physiol Gastrointest Liver Physiol 2020;318:G84-98. [PMID: 31657225 DOI: 10.1152/ajpgi.00118.2019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
488 Zhang M, Yang L, Ren J, Ahlgren NA, Fuhrman JA, Sun F. Prediction of virus-host infectious association by supervised learning methods. BMC Bioinformatics 2017;18:60. [PMID: 28361670 DOI: 10.1186/s12859-017-1473-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
489 Ren W, Yin J, Xiao H, Chen S, Liu G, Tan B, Li N, Peng Y, Li T, Zeng B, Li W, Wei H, Yin Z, Wu G, Hardwidge PR, Yin Y. Intestinal Microbiota-Derived GABA Mediates Interleukin-17 Expression during Enterotoxigenic Escherichia coli Infection. Front Immunol 2016;7:685. [PMID: 28138329 DOI: 10.3389/fimmu.2016.00685] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 6.4] [Reference Citation Analysis]
490 Dan X, Mushi Z, Baili W, Han L, Enqi W, Huanhu Z, Shuchun L. Differential Analysis of Hypertension-Associated Intestinal Microbiota. Int J Med Sci 2019;16:872-81. [PMID: 31337961 DOI: 10.7150/ijms.29322] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 10.3] [Reference Citation Analysis]
491 Wang F, Kaplan JL, Gold BD, Bhasin MK, Ward NL, Kellermayer R, Kirschner BS, Heyman MB, Dowd SE, Cox SB. Detecting Microbial Dysbiosis Associated with Pediatric Crohn Disease Despite the High Variability of the Gut Microbiota. Cell Rep. 2016;14:945-955. [PMID: 26804920 DOI: 10.1016/j.celrep.2015.12.088] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 6.5] [Reference Citation Analysis]
492 Ponziani FR, Zocco MA, Cerrito L, Gasbarrini A, Pompili M. Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications. Expert Rev Gastroenterol Hepatol. 2018;12:641-656. [PMID: 29806487 DOI: 10.1080/17474124.2018.1481747] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 10.5] [Reference Citation Analysis]
493 Sayavedra L, Li T, Bueno Batista M, Seah BKB, Booth C, Zhai Q, Chen W, Narbad A. Desulfovibrio diazotrophicus sp. nov., a sulfate-reducing bacterium from the human gut capable of nitrogen fixation. Environ Microbiol 2021;23:3164-81. [PMID: 33876566 DOI: 10.1111/1462-2920.15538] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
494 Van Hul M, Le Roy T, Prifti E, Dao MC, Paquot A, Zucker JD, Delzenne NM, Muccioli G, Clément K, Cani PD. From correlation to causality: the case of Subdoligranulum. Gut Microbes 2020;12:1-13. [PMID: 33323004 DOI: 10.1080/19490976.2020.1849998] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
495 Trebicka J, Reiberger T, Laleman W. Gut-Liver Axis Links Portal Hypertension to Acute-on-Chronic Liver Failure. Visc Med. 2018;34:270-275. [PMID: 30345284 DOI: 10.1159/000490262] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
496 Zhang C, Zhao L. Strain-level dissection of the contribution of the gut microbiome to human metabolic disease. Genome Med 2016;8:41. [PMID: 27098841 DOI: 10.1186/s13073-016-0304-1] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 8.5] [Reference Citation Analysis]
497 Huang H, Ren Z, Gao X, Hu X, Zhou Y, Jiang J, Lu H, Yin S, Ji J, Zhou L, Zheng S. Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma. Genome Med. 2020;12:102. [PMID: 33225985 DOI: 10.1186/s13073-020-00796-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
498 Zhang L, Luo J, Li X, Guo S, Shi D. 16S rRNA Sequencing and Metagenomics Study of Gut Microbiota: Implications of BDB on Type 2 Diabetes Mellitus. Mar Drugs 2020;18:E469. [PMID: 32957565 DOI: 10.3390/md18090469] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
499 Lv J, Qi L, Yu C, Yang L, Guo Y, Chen Y, Bian Z, Sun D, Du J, Ge P. Consumption of spicy foods and total and cause specific mortality: population based cohort study. BMJ. 2015;351:h3942. [PMID: 26242395 DOI: 10.1136/bmj.h3942] [Cited by in Crossref: 86] [Cited by in F6Publishing: 78] [Article Influence: 12.3] [Reference Citation Analysis]
500 Tang R, Wei Y, Li Y, Chen W, Chen H, Wang Q, Yang F, Miao Q, Xiao X, Zhang H, Lian M, Jiang X, Zhang J, Cao Q, Fan Z, Wu M, Qiu D, Fang JY, Ansari A, Gershwin ME, Ma X. Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy. Gut 2018;67:534-41. [PMID: 28213609 DOI: 10.1136/gutjnl-2016-313332] [Cited by in Crossref: 148] [Cited by in F6Publishing: 144] [Article Influence: 29.6] [Reference Citation Analysis]
501 Yu J, Shi X, Ma J, Chen R, Dong S, Lu S, Wu J, Yan C, Wu J, Zheng S, Li L, Xu X, Cao H. C-Reactive Protein Is an Independent Predictor of 30-Day Bacterial Infection Post-Liver Transplantation. Biomolecules 2021;11:1195. [PMID: 34439862 DOI: 10.3390/biom11081195] [Reference Citation Analysis]
502 Yan X, He M, Zheng J, Zhu T, Zou Z, Tang B, Yu Y, Mai B. Tris (1,3-dichloro-2-propyl) phosphate exposure disrupts the gut microbiome and its associated metabolites in mice. Environ Int 2021;146:106256. [PMID: 33232877 DOI: 10.1016/j.envint.2020.106256] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
503 Zha H, Chen Y, Wu J, Chang K, Lu Y, Zhang H, Xie J, Wang Q, Tang R, Li L. Characteristics of three microbial colonization states in the duodenum of the cirrhotic patients. Future Microbiol 2020;15:855-68. [PMID: 32662659 DOI: 10.2217/fmb-2019-0270] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
504 Li J, Yang X, Zhou X, Cai J. The Role and Mechanism of Intestinal Flora in Blood Pressure Regulation and Hypertension Development. Antioxid Redox Signal 2021;34:811-30. [PMID: 32316741 DOI: 10.1089/ars.2020.8104] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
505 Ruuskanen MO, Åberg F, Männistö V, Havulinna AS, Méric G, Liu Y, Loomba R, Vázquez-Baeza Y, Tripathi A, Valsta LM, Inouye M, Jousilahti P, Salomaa V, Jain M, Knight R, Lahti L, Niiranen TJ. Links between gut microbiome composition and fatty liver disease in a large population sample. Gut Microbes 2021;13:1-22. [PMID: 33651661 DOI: 10.1080/19490976.2021.1888673] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
506 Raj AS, Shanahan ER, Tran CD, Bhat P, Fletcher LM, Vesey DA, Morrison M, Holtmann G, Macdonald GA. Dysbiosis of the Duodenal Mucosal Microbiota Is Associated With Increased Small Intestinal Permeability in Chronic Liver Disease. Clin Transl Gastroenterol 2019;10:e00068. [PMID: 31373933 DOI: 10.14309/ctg.0000000000000068] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
507 Ianiro G, Tilg H, Gasbarrini A. Antibiotics as deep modulators of gut microbiota: between good and evil. Gut. 2016;65:1906-1915. [PMID: 27531828 DOI: 10.1136/gutjnl-2016-312297] [Cited by in Crossref: 217] [Cited by in F6Publishing: 196] [Article Influence: 36.2] [Reference Citation Analysis]
508 Fukui H. Gut Microbiota and Host Reaction in Liver Diseases. Microorganisms. 2015;3:759-791. [PMID: 27682116 DOI: 10.3390/microorganisms3040759] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
509 Alves LF, Westmann CA, Lovate GL, de Siqueira GMV, Borelli TC, Guazzaroni ME. Metagenomic Approaches for Understanding New Concepts in Microbial Science. Int J Genomics 2018;2018:2312987. [PMID: 30211213 DOI: 10.1155/2018/2312987] [Cited by in Crossref: 41] [Cited by in F6Publishing: 27] [Article Influence: 10.3] [Reference Citation Analysis]
510 Zuo K, Li J, Wang P, Liu Y, Liu Z, Yin X, Liu X, Yang X. Duration of Persistent Atrial Fibrillation Is Associated with Alterations in Human Gut Microbiota and Metabolic Phenotypes. mSystems 2019;4:e00422-19. [PMID: 31822598 DOI: 10.1128/mSystems.00422-19] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
511 Song W, Sun LY, Zhu ZJ, Wei L, Qu W, Zeng ZG, Liu Y, Zhang HM, Guo W. Association of Gut Microbiota and Metabolites With Disease Progression in Children With Biliary Atresia. Front Immunol 2021;12:698900. [PMID: 34630385 DOI: 10.3389/fimmu.2021.698900] [Reference Citation Analysis]
512 Liu P, Wu L, Peng G, Han Y, Tang R, Ge J, Zhang L, Jia L, Yue S, Zhou K, Li L, Luo B, Wang B. Altered microbiomes distinguish Alzheimer's disease from amnestic mild cognitive impairment and health in a Chinese cohort. Brain Behav Immun 2019;80:633-43. [PMID: 31063846 DOI: 10.1016/j.bbi.2019.05.008] [Cited by in Crossref: 83] [Cited by in F6Publishing: 86] [Article Influence: 27.7] [Reference Citation Analysis]
513 Zhang J, Zhao J, Jin H, Lv R, Shi H, De G, Yang B, Sun Z, Zhang H. Probiotics maintain the intestinal microbiome homeostasis of the sailors during a long sea voyage. Gut Microbes 2020;11:930-43. [PMID: 32079472 DOI: 10.1080/19490976.2020.1722054] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
514 Hammerich L, Tacke F. Emerging roles of myeloid derived suppressor cells in hepatic inflammation and fibrosis. World J Gastrointest Pathophysiol 2015; 6(3): 43-50 [PMID: 26301117 DOI: 10.4291/wjgp.v6.i3.43] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
515 Engelmann C, Clària J, Szabo G, Bosch J, Bernardi M. Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction. J Hepatol 2021;75 Suppl 1:S49-66. [PMID: 34039492 DOI: 10.1016/j.jhep.2021.01.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
516 Li YT, Huang JR, Peng ML. Current Status and Prospects of Spontaneous Peritonitis in Patients with Cirrhosis. Biomed Res Int 2020;2020:3743962. [PMID: 32724800 DOI: 10.1155/2020/3743962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
517 Zhang Y, Wang C, Peng A, Zhang H, Wang H. Metagenomic Insight: Dietary Thiamine Supplementation Promoted the Growth of Carbohydrate-Associated Microorganisms and Enzymes in the Rumen of Saanen Goats Fed High-Concentrate Diets. Microorganisms 2021;9:632. [PMID: 33803603 DOI: 10.3390/microorganisms9030632] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
518 Moratalla A, Ampuero J, Bellot P, Gallego-Durán R, Zapater P, Roger M, Figueruela B, Martínez-Moreno B, González-Navajas JM, Such J, Romero-Gómez M, Francés R. Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy. Liver Int 2017;37:212-23. [PMID: 27388776 DOI: 10.1111/liv.13200] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
519 Zhang L, Li C, Zhai Y, Feng L, Bai K, Zhang Z, Huang Y, Li T, Li D, Li H, Cui P, Chen D, Wang H, Yang X. Analysis of the vaginal microbiome of giant pandas using metagenomics sequencing. Microbiologyopen 2020;9:e1131. [PMID: 33205903 DOI: 10.1002/mbo3.1131] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
520 Sanduzzi Zamparelli M, Rocco A, Compare D, Nardone G. The gut microbiota: A new potential driving force in liver cirrhosis and hepatocellular carcinoma. United European Gastroenterol J. 2017;5:944-953. [PMID: 29163959 DOI: 10.1177/2050640617705576] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
521 Liu S, Liu H, Chen L, Liang SS, Shi K, Meng W, Xue J, He Q, Jiang H. Effect of probiotics on the intestinal microbiota of hemodialysis patients: a randomized trial. Eur J Nutr 2020;59:3755-66. [PMID: 32112136 DOI: 10.1007/s00394-020-02207-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
522 Gluud LL, Vilstrup H, Morgan MY. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Database Syst Rev. 2016;4:CD003044. [PMID: 27089005 DOI: 10.1002/14651858.cd003044.pub3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
523 Gómez-hurtado I, Gimenez P, García I, Zapater P, Francés R, González-navajas JM, Manichanh C, Ramos JM, Bellot P, Guarner F, Such J. Norfloxacin is more effective than Rifaximin in avoiding bacterial translocation in an animal model of cirrhosis. Liver Int 2018;38:295-302. [DOI: 10.1111/liv.13551] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
524 Rühlemann M, Liwinski T, Heinsen FA, Bang C, Zenouzi R, Kummen M, Thingholm L, Tempel M, Lieb W, Karlsen T, Lohse A, Hov J, Denk G, Lammert F, Krawczyk M, Schramm C, Franke A. Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis. Aliment Pharmacol Ther 2019;50:580-9. [PMID: 31250469 DOI: 10.1111/apt.15375] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 9.3] [Reference Citation Analysis]
525 Yang J, Li D, Yang Z, Dai W, Feng X, Liu Y, Jiang Y, Li P, Li Y, Tang B, Zhou Q, Qiu C, Zhang C, Xu X, Feng S, Wang D, Wang H, Wang W, Zheng Y, Zhang L, Wang W, Zhou K, Li S, Yu P. Establishing high-accuracy biomarkers for colorectal cancer by comparing fecal microbiomes in patients with healthy families. Gut Microbes 2020;11:918-29. [PMID: 31971861 DOI: 10.1080/19490976.2020.1712986] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
526 Bubnov RV, Drahulian MV, Buchek PV, Gulko TP. High regenerative capacity of the liver and irreversible injury of male reproductive system in carbon tetrachloride-induced liver fibrosis rat model. EPMA J 2018;9:59-75. [PMID: 29515688 DOI: 10.1007/s13167-017-0115-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
527 Han L, Zhao L, Zhou Y, Yang C, Xiong T, Lu L, Deng Y, Luo W, Chen Y, Qiu Q, Shang X, Huang L, Mo Z, Huang S, Huang S, Liu Z, Yang W, Zhai L, Ning Z, Lin C, Huang T, Cheng C, Zhong LLD, Li S, Bian Z, Fang X. Altered metabolome and microbiome features provide clues in understanding irritable bowel syndrome and depression comorbidity. ISME J 2021. [PMID: 34750528 DOI: 10.1038/s41396-021-01123-5] [Reference Citation Analysis]
528 Ancona G, Alagna L, Lombardi A, Palomba E, Castelli V, Renisi G, Dondossola D, Iavarone M, Muscatello A, Gori A, Bandera A. The Interplay between Gut Microbiota and the Immune System in Liver Transplant Recipients and Its Role in Infections. Infect Immun 2021;89:e0037621. [PMID: 34460287 DOI: 10.1128/IAI.00376-21] [Reference Citation Analysis]
529 Weichselbaum L, Azouz A, Smolen KK, Das J, Splittgerber M, Lepida A, Moreno C, Schreiber J, Sersté T, Trepo E, Libert F, Gustot T, Goriely S. Epigenetic basis for monocyte dysfunction in patients with severe alcoholic hepatitis. Journal of Hepatology 2020;73:303-14. [DOI: 10.1016/j.jhep.2020.02.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
530 Zhu J, Tian L, Chen P, Han M, Song L, Tong X, Sun X, Yang F, Lin Z, Liu X, Liu C, Wang X, Lin Y, Cai K, Hou Y, Xu X, Yang H, Wang J, Kristiansen K, Xiao L, Zhang T, Jia H, Jie Z. Over 50,000 Metagenomically Assembled Draft Genomes for the Human Oral Microbiome Reveal New Taxa. Genomics Proteomics Bioinformatics 2021:S1672-0229(21)00176-5. [PMID: 34492339 DOI: 10.1016/j.gpb.2021.05.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
531 Li D, Wang P, Wang P, Hu X, Chen F. The gut microbiota: A treasure for human health. Biotechnology Advances 2016;34:1210-24. [DOI: 10.1016/j.biotechadv.2016.08.003] [Cited by in Crossref: 91] [Cited by in F6Publishing: 79] [Article Influence: 15.2] [Reference Citation Analysis]
532 Jin M, Kalainy S, Baskota N, Chiang D, Deehan EC, McDougall C, Tandon P, Martínez I, Cervera C, Walter J, Abraldes JG. Faecal microbiota from patients with cirrhosis has a low capacity to ferment non-digestible carbohydrates into short-chain fatty acids. Liver Int 2019;39:1437-47. [PMID: 30919578 DOI: 10.1111/liv.14106] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 9.3] [Reference Citation Analysis]
533 Jiao J, Lu Z, Yu Y, Ou Y, Fu M, Zhao Y, Wu N, Zhao M, Liu Y, Sun Y, Wen B, Zhou D, Yuan Q, Xiong X. Identification of tick-borne pathogens by metagenomic next-generation sequencing in Dermacentor nuttalli and Ixodes persulcatus in Inner Mongolia, China. Parasit Vectors 2021;14:287. [PMID: 34044867 DOI: 10.1186/s13071-021-04740-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
534 Bhatt BD, Lukose T, Siegel AB, Brown RS Jr, Verna EC. Increased risk of colorectal polyps in patients with non-alcoholic fatty liver disease undergoing liver transplant evaluation. J Gastrointest Oncol 2015;6:459-68. [PMID: 26487938 DOI: 10.3978/j.issn.2078-6891.2015.050] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
535 Ren X, Hao S, Yang C, Yuan L, Zhou X, Zhao H, Yao J. Alterations of intestinal microbiota in liver cirrhosis with muscle wasting. Nutrition 2021;83:111081. [PMID: 33348106 DOI: 10.1016/j.nut.2020.111081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
536 Tilg H, Zmora N, Adolph TE, Elinav E. The intestinal microbiota fuelling metabolic inflammation. Nat Rev Immunol 2020;20:40-54. [DOI: 10.1038/s41577-019-0198-4] [Cited by in Crossref: 179] [Cited by in F6Publishing: 171] [Article Influence: 59.7] [Reference Citation Analysis]
537 Kjærgaard K, Mikkelsen ACD, Wernberg CW, Grønkjær LL, Eriksen PL, Damholdt MF, Mookerjee RP, Vilstrup H, Lauridsen MM, Thomsen KL. Cognitive Dysfunction in Non-Alcoholic Fatty Liver Disease-Current Knowledge, Mechanisms and Perspectives. J Clin Med 2021;10:673. [PMID: 33572481 DOI: 10.3390/jcm10040673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
538 Wang C, Li Q, Li J. Gut microbiota and its implications in small bowel transplantation. Front Med 2018;12:239-48. [PMID: 29524068 DOI: 10.1007/s11684-018-0617-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
539 Jia X, Lu S, Zeng Z, Liu Q, Dong Z, Chen Y, Zhu Z, Hong Z, Zhang T, Du G, Xiang J, Wu D, Bai W, Yang B, Li Y, Huang J, Li H, Safadi R, Lu Y. Characterization of Gut Microbiota, Bile Acid Metabolism, and Cytokines in Intrahepatic Cholangiocarcinoma. Hepatology 2020;71:893-906. [PMID: 31298745 DOI: 10.1002/hep.30852] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
540 Tett A, Huang KD, Asnicar F, Fehlner-Peach H, Pasolli E, Karcher N, Armanini F, Manghi P, Bonham K, Zolfo M, De Filippis F, Magnabosco C, Bonneau R, Lusingu J, Amuasi J, Reinhard K, Rattei T, Boulund F, Engstrand L, Zink A, Collado MC, Littman DR, Eibach D, Ercolini D, Rota-Stabelli O, Huttenhower C, Maixner F, Segata N. The Prevotella copri Complex Comprises Four Distinct Clades Underrepresented in Westernized Populations. Cell Host Microbe 2019;26:666-679.e7. [PMID: 31607556 DOI: 10.1016/j.chom.2019.08.018] [Cited by in Crossref: 100] [Cited by in F6Publishing: 86] [Article Influence: 33.3] [Reference Citation Analysis]
541 Lou JM, Ren ZG, Li A, Rao BC, Yu ZJ. Fecal microbiota transplantation has therapeutic effects on chronic hepatits B patients via altering composition of gut microbiota. Hepatobiliary Pancreat Dis Int 2020;19:486-7. [PMID: 31974041 DOI: 10.1016/j.hbpd.2019.12.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
542 Pan M, Wan C, Xie Q, Huang R, Tao X, Shah NP, Wei H. Changes in gastric microbiota induced by Helicobacter pylori infection and preventive effects of Lactobacillus plantarum ZDY 2013 against such infection. J Dairy Sci. 2016;99:970-981. [PMID: 26709179 DOI: 10.3168/jds.2015-10510] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
543 Baima G, Massano A, Squillace E, Caviglia GP, Buduneli N, Ribaldone DG, Aimetti M. Shared microbiological and immunological patterns in periodontitis and IBD: A scoping review. Oral Dis 2021. [PMID: 33690955 DOI: 10.1111/odi.13843] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
544 Liu PC, Yan YK, Ma YJ, Wang XW, Geng J, Wang MC, Wei FX, Zhang YW, Xu XD, Zhang YC. Probiotics Reduce Postoperative Infections in Patients Undergoing Colorectal Surgery: A Systematic Review and Meta-Analysis. Gastroenterol Res Pract 2017;2017:6029075. [PMID: 28484489 DOI: 10.1155/2017/6029075] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
545 Gao B, Bian X, Mahbub R, Lu K. Sex-Specific Effects of Organophosphate Diazinon on the Gut Microbiome and Its Metabolic Functions. Environ Health Perspect 2017;125:198-206. [PMID: 27203275 DOI: 10.1289/EHP202] [Cited by in Crossref: 67] [Cited by in F6Publishing: 31] [Article Influence: 11.2] [Reference Citation Analysis]
546 Lange CM, Moreau R. Immunodysfunction in Acute-on-Chronic Liver Failure. Visc Med 2018;34:276-82. [PMID: 30345285 DOI: 10.1159/000488690] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
547 Wang F, Song M, Lu X, Zhu X, Deng J. Gut microbes in gastrointestinal cancers. Semin Cancer Biol 2021:S1044-579X(21)00098-5. [PMID: 33812983 DOI: 10.1016/j.semcancer.2021.03.037] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
548 Li Q, Chen H, Zhang M, Wu T, Liu R, Zhang Z. Potential Correlation between Dietary Fiber-Suppressed Microbial Conversion of Choline to Trimethylamine and Formation of Methylglyoxal. J Agric Food Chem 2019;67:13247-57. [DOI: 10.1021/acs.jafc.9b04860] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
549 Rahman MA, Rangwala H. IDMIL: an alignment-free Interpretable Deep Multiple Instance Learning (MIL) for predicting disease from whole-metagenomic data. Bioinformatics 2020;36:i39-47. [PMID: 32657370 DOI: 10.1093/bioinformatics/btaa477] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
550 Zhou PC, Sun LQ, Shao L, Yi LZ, Li N, Fan XG. Establishment of a pattern recognition metabolomics model for the diagnosis of hepatocellular carcinoma. World J Gastroenterol 2020; 26(31): 4607-4623 [PMID: 32884220 DOI: 10.3748/wjg.v26.i31.4607] [Cited by in CrossRef: 3] [Article Influence: 1.5] [Reference Citation Analysis]
551 Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G, Wu S, Liu W, Cui Q, Geng B, Zhang W, Weldon R, Auguste K, Yang L, Liu X, Chen L, Yang X, Zhu B, Cai J. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 2017;5:14. [PMID: 28143587 DOI: 10.1186/s40168-016-0222-x] [Cited by in Crossref: 491] [Cited by in F6Publishing: 461] [Article Influence: 98.2] [Reference Citation Analysis]
552 Estrela AB, Türck P, Stutz E, Abraham WR. Release of Periplasmic Nucleotidase Induced by Human Antimicrobial Peptide in E. coli Causes Accumulation of the Immunomodulator Adenosine. PLoS One 2015;10:e0138033. [PMID: 26371472 DOI: 10.1371/journal.pone.0138033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
553 Bajaj JS, Acharya C, Fagan A, White MB, Gavis E, Heuman DM, Hylemon PB, Fuchs M, Puri P, Schubert ML, Sanyal AJ, Sterling RK, Stravitz TR, Siddiqui MS, Luketic V, Lee H, Sikaroodi M, Gillevet PM. Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in Cirrhosis. Am J Gastroenterol. 2018;113:1177-1186. [PMID: 29872220 DOI: 10.1038/s41395-018-0085-9] [Cited by in Crossref: 58] [Cited by in F6Publishing: 45] [Article Influence: 14.5] [Reference Citation Analysis]
554 Xia GH, You C, Gao XX, Zeng XL, Zhu JJ, Xu KY, Tan CH, Xu RT, Wu QH, Zhou HW, He Y, Yin J. Stroke Dysbiosis Index (SDI) in Gut Microbiome Are Associated With Brain Injury and Prognosis of Stroke. Front Neurol 2019;10:397. [PMID: 31068891 DOI: 10.3389/fneur.2019.00397] [Cited by in Crossref: 27] [Cited by in F6Publishing: 36] [Article Influence: 9.0] [Reference Citation Analysis]
555 Scotti E, Boué S, Sasso GL, Zanetti F, Belcastro V, Poussin C, Sierro N, Battey J, Gimalac A, Ivanov NV, Hoeng J. Exploring the microbiome in health and disease: Implications for toxicology. Toxicology Research and Application 2017;1:239784731774188. [DOI: 10.1177/2397847317741884] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
556 Pisano G, Fracanzani AL, Caccamo L, Donato MF, Fargion S. Cardiovascular risk after orthotopic liver transplantation, a review of the literature and preliminary results of a prospective study. World J Gastroenterol 2016; 22(40): 8869-8882 [PMID: 27833378 DOI: 10.3748/wjg.v22.i40.8869] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
557 Sharma D, Paterson AD, Xu W. TaxoNN: ensemble of neural networks on stratified microbiome data for disease prediction. Bioinformatics 2020;36:4544-50. [PMID: 32449747 DOI: 10.1093/bioinformatics/btaa542] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
558 Horvath A, Rainer F, Bashir M, Leber B, Schmerboeck B, Klymiuk I, Groselj-Strele A, Durdevic M, Freedberg DE, Abrams JA, Fickert P, Stiegler P, Stadlbauer V. Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis. Sci Rep. 2019;9:12000. [PMID: 31427714 DOI: 10.1038/s41598-019-48352-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
559 Bajaj JS, Fagan A, Sikaroodi M, Kakiyama G, Takei H, Degefu Y, Pandak WM, Hylemon PB, Fuchs M, John B, Heuman DM, Gavis E, Nittono H, Patil R, Gillevet PM. Alterations in Skin Microbiomes of Patients With Cirrhosis. Clin Gastroenterol Hepatol 2019;17:2581-2591.e15. [PMID: 30905718 DOI: 10.1016/j.cgh.2019.03.028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
560 Yan Q, Gu Y, Li X, Yang W, Jia L, Chen C, Han X, Huang Y, Zhao L, Li P, Fang Z, Zhou J, Guan X, Ding Y, Wang S, Khan M, Xin Y, Li S, Ma Y. Alterations of the Gut Microbiome in Hypertension. Front Cell Infect Microbiol 2017;7:381. [PMID: 28884091 DOI: 10.3389/fcimb.2017.00381] [Cited by in Crossref: 137] [Cited by in F6Publishing: 127] [Article Influence: 27.4] [Reference Citation Analysis]
561 Wang R, Tang R, Li B, Ma X, Schnabl B, Tilg H. Gut microbiome, liver immunology, and liver diseases.Cell Mol Immunol. 2021;18:4-17. [PMID: 33318628 DOI: 10.1038/s41423-020-00592-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
562 Jing G, Liu L, Wang Z, Zhang Y, Qian L, Gao C, Zhang M, Li M, Zhang Z, Liu X, Xu J, Su X. Microbiome Search Engine 2: a Platform for Taxonomic and Functional Search of Global Microbiomes on the Whole-Microbiome Level. mSystems 2021;6:e00943-20. [PMID: 33468706 DOI: 10.1128/mSystems.00943-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
563 Van der Merwe S, Chokshi S, Bernsmeier C, Albillos A. The multifactorial mechanisms of bacterial infection in decompensated cirrhosis. J Hepatol 2021;75 Suppl 1:S82-S100. [PMID: 34039494 DOI: 10.1016/j.jhep.2020.11.029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
564 Rose CF, Amodio P, Bajaj JS, Dhiman RK, Montagnese S, Taylor-Robinson SD, Vilstrup H, Jalan R. Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy. J Hepatol. 2020;73:1526-1547. [PMID: 33097308 DOI: 10.1016/j.jhep.2020.07.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 10.5] [Reference Citation Analysis]
565 Juanola O, Ferrusquía-Acosta J, García-Villalba R, Zapater P, Magaz M, Marín A, Olivas P, Baiges A, Bellot P, Turon F, Hernández-Gea V, González-Navajas JM, Tomás-Barberán FA, García-Pagán JC, Francés R. Circulating levels of butyrate are inversely related to portal hypertension, endotoxemia, and systemic inflammation in patients with cirrhosis. FASEB J 2019;33:11595-605. [PMID: 31345057 DOI: 10.1096/fj.201901327R] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 7.7] [Reference Citation Analysis]
566 He X, Gao J, Peng L, Hu T, Wan Y, Zhou M, Zhen P, Cao H. Bacterial O-GlcNAcase genes abundance decreases in ulcerative colitis patients and its administration ameliorates colitis in mice. Gut. 2020;. [PMID: 33310751 DOI: 10.1136/gutjnl-2020-322468] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
567 Tariq R, Wahab A, Singal AK. Editorial: direct anti-viral agents, hepatitis C virus eradication, and gut-liver axis-another mechanistic piece to the puzzle. Aliment Pharmacol Ther 2018;48:1321-2. [PMID: 30488623 DOI: 10.1111/apt.15047] [Reference Citation Analysis]
568 Loomba R, Ling L, Dinh DM, DePaoli AM, Lieu HD, Harrison SA, Sanyal AJ. The Commensal Microbe Veillonella as a Marker for Response to an FGF19 Analog in NASH. Hepatology 2021;73:126-43. [PMID: 32794259 DOI: 10.1002/hep.31523] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
569 Baghai Arassi M, Zeller G, Karcher N, Zimmermann M, Toenshoff B. The gut microbiome in solid organ transplantation. Pediatr Transplant 2020;24:e13866. [PMID: 32997434 DOI: 10.1111/petr.13866] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
570 Martínez JE, Vargas A, Pérez-Sánchez T, Encío IJ, Cabello-Olmo M, Barajas M. Human Microbiota Network: Unveiling Potential Crosstalk between the Different Microbiota Ecosystems and Their Role in Health and Disease. Nutrients 2021;13:2905. [PMID: 34578783 DOI: 10.3390/nu13092905] [Reference Citation Analysis]
571 Armour CR, Nayfach S, Pollard KS, Sharpton TJ. A Metagenomic Meta-analysis Reveals Functional Signatures of Health and Disease in the Human Gut Microbiome. mSystems 2019;4:e00332-18. [PMID: 31098399 DOI: 10.1128/mSystems.00332-18] [Cited by in Crossref: 52] [Cited by in F6Publishing: 35] [Article Influence: 17.3] [Reference Citation Analysis]
572 Luo Y, Fang J, Yuan K, Jin S, Guo Y. Ameliorative effect of purified anthocyanin from Lycium ruthenicum on atherosclerosis in rats through synergistic modulation of the gut microbiota and NF-κB/SREBP-2 pathways. Journal of Functional Foods 2019;59:223-33. [DOI: 10.1016/j.jff.2019.05.038] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
573 Zheng H, Chen M, Lu S, Zhao L, Ji J, Gao H. Metabolic characterization of hepatitis B virus-related liver cirrhosis using NMR-based serum metabolomics. Metabolomics 2017;13. [DOI: 10.1007/s11306-017-1260-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
574 Singh A, Garg R, Lan N, Siddiqui MT, Gupta M, Alkhouri N. Association between anti-acid therapies and advanced fibrosis in type 2 diabetics with biopsy-proven non-alcoholic fatty liver disease. Indian J Gastroenterol 2020;39:591-8. [DOI: 10.1007/s12664-020-01087-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
575 Hu X, Wang T, Liang S, Li W, Wu X, Jin F. Antibiotic-induced imbalances in gut microbiota aggravates cholesterol accumulation and liver injuries in rats fed a high-cholesterol diet. Appl Microbiol Biotechnol 2015;99:9111-22. [PMID: 26129950 DOI: 10.1007/s00253-015-6753-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
576 Rosca AE, Iesanu MI, Zahiu CDM, Voiculescu SE, Paslaru AC, Zagrean AM. Capsaicin and Gut Microbiota in Health and Disease. Molecules 2020;25:E5681. [PMID: 33276488 DOI: 10.3390/molecules25235681] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
577 Zhu Z, Cao M, Wang W, Zhang L, Ma T, Liu G, Zhang Y, Shang Z, Chen X, Shi Y, Zhang J. Exploring the Prevalence and Distribution Patterns of Antibiotic Resistance Genes in Bovine Gut Microbiota Using a Metagenomic Approach. Microb Drug Resist 2021;27:980-90. [PMID: 33395552 DOI: 10.1089/mdr.2020.0271] [Reference Citation Analysis]
578 Shao Y, Huo D, Peng Q, Pan Y, Jiang S, Liu B, Zhang J. Lactobacillus plantarum HNU082-derived improvements in the intestinal microbiome prevent the development of hyperlipidaemia. Food Funct 2017;8:4508-16. [PMID: 29094115 DOI: 10.1039/c7fo00902j] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 5.8] [Reference Citation Analysis]
579 Kurina I, Popenko A, Klimenko N, Koshechkin S, Chuprikova L, Filipenko M, Tyakht A, Alexeev D. Development of qPCR platform with probes for quantifying prevalent and biomedically relevant human gut microbial taxa. Mol Cell Probes 2020;52:101570. [PMID: 32304824 DOI: 10.1016/j.mcp.2020.101570] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
580 Ding X, Lan W, Yan A, Li Y, Katayama Y, Gu JD. Microbiome characteristics and the key biochemical reactions identified on stone world cultural heritage under different climate conditions. J Environ Manage 2021;302:114041. [PMID: 34741944 DOI: 10.1016/j.jenvman.2021.114041] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
581 Peng Z, Liao Y, Chen L, Liu S, Shan Z, Nüssler AK, Yao P, Yan H, Liu L, Yang W. Heme oxygenase-1 attenuates low-dose of deoxynivalenol-induced liver inflammation potentially associating with microbiota. Toxicology and Applied Pharmacology 2019;374:20-31. [DOI: 10.1016/j.taap.2019.04.020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
582 Lozano VL, Defarge N, Rocque LM, Mesnage R, Hennequin D, Cassier R, de Vendômois JS, Panoff JM, Séralini GE, Amiel C. Sex-dependent impact of Roundup on the rat gut microbiome. Toxicol Rep 2018;5:96-107. [PMID: 29854581 DOI: 10.1016/j.toxrep.2017.12.005] [Cited by in Crossref: 55] [Cited by in F6Publishing: 41] [Article Influence: 11.0] [Reference Citation Analysis]
583 Elison E, Vigsnaes LK, Rindom Krogsgaard L, Rasmussen J, Sørensen N, McConnell B, Hennet T, Sommer MO, Bytzer P. Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota. Br J Nutr 2016;116:1356-68. [PMID: 27719686 DOI: 10.1017/S0007114516003354] [Cited by in Crossref: 76] [Cited by in F6Publishing: 36] [Article Influence: 12.7] [Reference Citation Analysis]
584 Wu S, Yano S, Hisanaga A, He X, He J, Sakao K, Hou DX. Polyphenols from Lonicera caerulea L. berry attenuate experimental nonalcoholic steatohepatitis by inhibiting proinflammatory cytokines productions and lipid peroxidation. Mol Nutr Food Res 2017;61. [PMID: 27935258 DOI: 10.1002/mnfr.201600858] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
585 Kuang YS, Lu JH, Li SH, Li JH, Yuan MY, He JR, Chen NN, Xiao WQ, Shen SY, Qiu L, Wu YF, Hu CY, Wu YY, Li WD, Chen QZ, Deng HW, Papasian CJ, Xia HM, Qiu X. Connections between the human gut microbiome and gestational diabetes mellitus. Gigascience 2017;6:1-12. [PMID: 28873967 DOI: 10.1093/gigascience/gix058] [Cited by in Crossref: 82] [Cited by in F6Publishing: 72] [Article Influence: 20.5] [Reference Citation Analysis]
586 Bajaj JS. Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis. Aliment Pharmacol Ther. 2016;43 Suppl 1:11-26. [PMID: 26618922 DOI: 10.1111/apt.13435] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 8.8] [Reference Citation Analysis]
587 Gupta H, Suk KT, Kim DJ. Gut Microbiota at the Intersection of Alcohol, Brain, and the Liver. J Clin Med 2021;10:541. [PMID: 33540624 DOI: 10.3390/jcm10030541] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
588 Jiang Y, Chowdhury S, Xu BH, Meybodi MA, Damiris K, Devalaraju S, Pyrsopoulos N. Nonalcoholic fatty liver disease is associated with worse intestinal complications in patients hospitalized for Clostridioides difficile infection. World J Hepatol 2021; 13(11): 1777-1790 [PMID: 34904045 DOI: 10.4254/wjh.v13.i11.1777] [Reference Citation Analysis]
589 Nghiem-rao TH. Potential Hepatotoxicities of Intravenous Fat Emulsions in Infants and Children. Nutr Clin Pract 2016;31:619-28. [DOI: 10.1177/0884533616663487] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
590 Belcheva A, Irrazabal T, Martin A. Gut microbial metabolism and colon cancer: Can manipulations of the microbiota be useful in the management of gastrointestinal health? BioEssays 2015;37:403-12. [DOI: 10.1002/bies.201400204] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.1] [Reference Citation Analysis]
591 Ainsworth D, Sternberg MJE, Raczy C, Butcher SA. k-SLAM: accurate and ultra-fast taxonomic classification and gene identification for large metagenomic data sets. Nucleic Acids Res 2017;45:1649-56. [PMID: 27965413 DOI: 10.1093/nar/gkw1248] [Cited by in Crossref: 10] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
592 Yan D, Huang YD, Chen YB, Lv T, Zhu CX, Huang JR, Li LJ. Prediction of Clostridium difficile infection based on gut microbial traits in patients with Clostridium difficile colonization. Hepatobiliary Pancreat Dis Int 2021;20:298-300. [PMID: 33810987 DOI: 10.1016/j.hbpd.2021.03.004] [Reference Citation Analysis]
593 Christian LM, Galley JD, Hade EM, Schoppe-Sullivan S, Kamp Dush C, Bailey MT. Gut microbiome composition is associated with temperament during early childhood. Brain Behav Immun 2015;45:118-27. [PMID: 25449582 DOI: 10.1016/j.bbi.2014.10.018] [Cited by in Crossref: 86] [Cited by in F6Publishing: 72] [Article Influence: 10.8] [Reference Citation Analysis]
594 Wang B, Li L. Who determines the outcomes of HBV exposure? Trends Microbiol 2015;23:328-9. [PMID: 25864882 DOI: 10.1016/j.tim.2015.04.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
595 Ren W, Wang P, Yan J, Liu G, Zeng B, Hussain T, Peng C, Yin J, Li T, Wei H, Zhu G, Reiter RJ, Tan B, Yin Y. Melatonin alleviates weanling stress in mice: Involvement of intestinal microbiota. J Pineal Res 2018;64. [PMID: 28875556 DOI: 10.1111/jpi.12448] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 13.2] [Reference Citation Analysis]
596 Kordy K, Li F, Lee DJ, Kinchen JM, Jew MH, La Rocque ME, Zabih S, Saavedra M, Woodward C, Cunningham NJ, Tobin NH, Aldrovandi GM. Metabolomic Predictors of Non-alcoholic Steatohepatitis and Advanced Fibrosis in Children. Front Microbiol 2021;12:713234. [PMID: 34475864 DOI: 10.3389/fmicb.2021.713234] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
597 Jiang S, Xiao G, Koh AY, Chen Y, Yao B, Li Q, Zhan X. HARMONIES: A Hybrid Approach for Microbiome Networks Inference via Exploiting Sparsity. Front Genet 2020;11:445. [PMID: 32582274 DOI: 10.3389/fgene.2020.00445] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
598 Tripathi A, Debelius J, Brenner DA, Karin M, Loomba R, Schnabl B, Knight R. Publisher Correction: The gut-liver axis and the intersection with the microbiome. Nat Rev Gastroenterol Hepatol 2018;15:785. [PMID: 29785003 DOI: 10.1038/s41575-018-0031-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
599 Han P, Gu JQ, Li LS, Wang XY, Wang HT, Wang Y, Chang C, Sun JL. The Association Between Intestinal Bacteria and Allergic Diseases-Cause or Consequence? Front Cell Infect Microbiol 2021;11:650893. [PMID: 33937097 DOI: 10.3389/fcimb.2021.650893] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
600 Paratore M, Santopaolo F, Cammarota G, Pompili M, Gasbarrini A, Ponziani FR. Fecal Microbiota Transplantation in Patients with HBV Infection or Other Chronic Liver Diseases: Update on Current Knowledge and Future Perspectives. J Clin Med 2021;10:2605. [PMID: 34204748 DOI: 10.3390/jcm10122605] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
601 Brahe LK, Le Chatelier E, Prifti E, Pons N, Kennedy S, Hansen T, Pedersen O, Astrup A, Ehrlich SD, Larsen LH. Specific gut microbiota features and metabolic markers in postmenopausal women with obesity. Nutr Diabetes. 2015;5:e159. [PMID: 26075636 DOI: 10.1038/nutd.2015.9] [Cited by in Crossref: 111] [Cited by in F6Publishing: 101] [Article Influence: 15.9] [Reference Citation Analysis]
602 Giordano DM, Pinto C, Maroni L, Benedetti A, Marzioni M. Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies. Int J Mol Sci 2018;19:E3003. [PMID: 30275402 DOI: 10.3390/ijms19103003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
603 Zhang Z, Hu T, Lu G, Zhu L. Lessons from bamboo-eating pandas and their gut microbiome: Gut microbiome flow and applications. Evol Appl 2020;13:615-9. [PMID: 32211055 DOI: 10.1111/eva.12915] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
604 Rizzatti G, Ianiro G, Gasbarrini A. Antibiotic and Modulation of Microbiota: A New Paradigm? Journal of Clinical Gastroenterology 2018;52:S74-7. [DOI: 10.1097/mcg.0000000000001069] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
605 Wang Z, Koonen D, Hofker M, Fu J. Gut microbiome and lipid metabolism: from associations to mechanisms. Current Opinion in Lipidology 2016;27:216-24. [DOI: 10.1097/mol.0000000000000308] [Cited by in Crossref: 42] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
606 Nimgaonkar I, Ploss A. A porcine model for chronic hepatitis E. Hepatology 2018;67:787-90. [PMID: 28961321 DOI: 10.1002/hep.29566] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
607 Rillig MC, Antonovics J, Caruso T, Lehmann A, Powell JR, Veresoglou SD, Verbruggen E. Interchange of entire communities: microbial community coalescence. Trends in Ecology & Evolution 2015;30:470-6. [DOI: 10.1016/j.tree.2015.06.004] [Cited by in Crossref: 115] [Cited by in F6Publishing: 76] [Article Influence: 16.4] [Reference Citation Analysis]
608 Kato K, Nagao M, Miyamoto K, Oka K, Takahashi M, Yamamoto M, Matsumura Y, Kaido T, Uemoto S, Ichiyama S. Longitudinal Analysis of the Intestinal Microbiota in Liver Transplantation. Transplant Direct. 2017;3:e144. [PMID: 28405600 DOI: 10.1097/txd.0000000000000661] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
609 Fu ZD, Cui JY. Remote Sensing between Liver and Intestine: Importance of Microbial Metabolites. Curr Pharmacol Rep 2017;3:101-13. [PMID: 28983453 DOI: 10.1007/s40495-017-0087-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
610 Zhao Y, Wang CC, Chen X. Microbes and complex diseases: from experimental results to computational models. Brief Bioinform 2021;22:bbaa158. [PMID: 32766753 DOI: 10.1093/bib/bbaa158] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
611 Esposito S, Polinori I, Rigante D. The Gut Microbiota-Host Partnership as a Potential Driver of Kawasaki Syndrome. Front Pediatr 2019;7:124. [PMID: 31024869 DOI: 10.3389/fped.2019.00124] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
612 Sun Z, Huang C, Shi Y, Wang R, Fan J, Yu Y, Zhang Z, Zhu K, Li M, Ni Q, Chen Z, Zheng M, Yang Z. Distinct Bile Acid Profiles in Patients With Chronic Hepatitis B Virus Infection Reveal Metabolic Interplay Between Host, Virus and Gut Microbiome. Front Med (Lausanne) 2021;8:708495. [PMID: 34671614 DOI: 10.3389/fmed.2021.708495] [Reference Citation Analysis]
613 Hao Y, Pei Z, Brown SM. Bioinformatics in Microbiome Analysis. The Human Microbiome. Elsevier; 2017. pp. 1-18. [DOI: 10.1016/bs.mim.2017.08.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
614 Zhu H, Liu Y, Li S, Jin Y, Zhao L, Zhao F, Feng J, Yan W, Wei Y. Altered gut microbiota after traumatic splenectomy is associated with endotoxemia. Emerg Microbes Infect 2018;7:197. [PMID: 30498207 DOI: 10.1038/s41426-018-0202-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
615 Gluud LL, Vilstrup H, Morgan MY. Nonabsorbable disaccharides for hepatic encephalopathy: A systematic review and meta-analysis. Hepatology 2016;64:908-22. [PMID: 27081787 DOI: 10.1002/hep.28598] [Cited by in Crossref: 42] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
616 Bajaj JS. Microbiome and complications of liver disease. Clin Liver Dis (Hoboken) 2015;5:96-9. [PMID: 31040960 DOI: 10.1002/cld.460] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
617 Shi D, Lv L, Fang D, Wu W, Hu C, Xu L, Chen Y, Guo J, Hu X, Li A, Guo F, Ye J, Li Y, Andayani D, Li L. Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 prevents CCl4-induced liver cirrhosis by protecting the intestinal barrier in rats. Sci Rep 2017;7:6927. [PMID: 28761060 DOI: 10.1038/s41598-017-07091-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 6.2] [Reference Citation Analysis]
618 Moya A, Ferrer M. Functional Redundancy-Induced Stability of Gut Microbiota Subjected to Disturbance. Trends Microbiol 2016;24:402-13. [PMID: 26996765 DOI: 10.1016/j.tim.2016.02.002] [Cited by in Crossref: 219] [Cited by in F6Publishing: 195] [Article Influence: 36.5] [Reference Citation Analysis]
619 Macnaughtan J, Jalan R. Clinical and pathophysiological consequences of alterations in the microbiome in cirrhosis. Am J Gastroenterol. 2015;110:1399-1410; quiz 1411. [PMID: 26416191 DOI: 10.1038/ajg.2015] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
620 Xie H, Guo R, Zhong H, Feng Q, Lan Z, Qin B, Ward KJ, Jackson MA, Xia Y, Chen X, Chen B, Xia H, Xu C, Li F, Xu X, Al-Aama JY, Yang H, Wang J, Kristiansen K, Wang J, Steves CJ, Bell JT, Li J, Spector TD, Jia H. Shotgun Metagenomics of 250 Adult Twins Reveals Genetic and Environmental Impacts on the Gut Microbiome. Cell Syst 2016;3:572-584.e3. [PMID: 27818083 DOI: 10.1016/j.cels.2016.10.004] [Cited by in Crossref: 140] [Cited by in F6Publishing: 112] [Article Influence: 23.3] [Reference Citation Analysis]
621 Li BL, Cheng L, Zhou XD, Peng X. [Research progress on the relationship between oral microbes and digestive system diseases]. Hua Xi Kou Qiang Yi Xue Za Zhi 2018;36:331-5. [PMID: 29984938 DOI: 10.7518/hxkq.2018.03.019] [Reference Citation Analysis]
622 Ghorbani M, Rajandas H, Parimannan S, Stephen Joseph GB, Tew MM, Ramly SS, Muhamad Rasat MA, Lee SY. Understanding the role of gut microbiota in the pathogenesis of schizophrenia. Psychiatr Genet 2021;31:39-49. [PMID: 33252574 DOI: 10.1097/YPG.0000000000000270] [Reference Citation Analysis]
623 Qi D, Nie XL, Zhang JJ. The effect of probiotics supplementation on blood pressure: a systemic review and meta-analysis. Lipids Health Dis 2020;19:79. [PMID: 32334580 DOI: 10.1186/s12944-020-01259-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
624 van Best N, Jansen PL, Rensen SS. The gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretation. Hepatol Int. 2015;9:406-415. [PMID: 26067771 DOI: 10.1007/s12072-015-9640-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
625 El-Mowafy M, Elgaml A, El-Mesery M, Sultan S, Ahmed TAE, Gomaa AI, Aly M, Mottawea W. Changes of Gut-Microbiota-Liver Axis in Hepatitis C Virus Infection. Biology (Basel) 2021;10:55. [PMID: 33451143 DOI: 10.3390/biology10010055] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
626 Chopyk DM, Grakoui A. Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders. Gastroenterology 2020;159:849-63. [PMID: 32569766 DOI: 10.1053/j.gastro.2020.04.077] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 11.0] [Reference Citation Analysis]
627 Jiang S, Lu S, Chen X, Li F, Zhu C, Zheng Y, Wang X, Xu S. Dysbiosis of urine microbiota in obstructive urinary retention patients revealed by next-generation sequencing. Ann Clin Microbiol Antimicrob 2021;20:2. [PMID: 33407528 DOI: 10.1186/s12941-020-00408-5] [Reference Citation Analysis]
628 Hoyles L, Snelling T, Umlai UK, Nicholson JK, Carding SR, Glen RC, McArthur S. Microbiome-host systems interactions: protective effects of propionate upon the blood-brain barrier. Microbiome 2018;6:55. [PMID: 29562936 DOI: 10.1186/s40168-018-0439-y] [Cited by in Crossref: 112] [Cited by in F6Publishing: 112] [Article Influence: 28.0] [Reference Citation Analysis]
629 Fang D, Shi D, Lv L, Gu S, Wu W, Chen Y, Guo J, Li A, Hu X, Guo F, Ye J, Li Y, Li L. Bifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota. Sci Rep 2017;7:8770. [PMID: 28821814 DOI: 10.1038/s41598-017-09395-8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 6.2] [Reference Citation Analysis]
630 Liu R, Kang JD, Sartor RB, Sikaroodi M, Fagan A, Gavis EA, Zhou H, Hylemon PB, Herzog JW, Li X, Lippman RH, Gonzalez-Maeso J, Wade JB, Ghosh S, Gurley E, Gillevet PM, Bajaj JS. Neuroinflammation in Murine Cirrhosis Is Dependent on the Gut Microbiome and Is Attenuated by Fecal Transplant. Hepatology 2020;71:611-26. [PMID: 31220352 DOI: 10.1002/hep.30827] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 10.3] [Reference Citation Analysis]
631 Martin-Gallausiaux C, Marinelli L, Blottière HM, Larraufie P, Lapaque N. SCFA: mechanisms and functional importance in the gut. Proc Nutr Soc 2021;80:37-49. [PMID: 32238208 DOI: 10.1017/S0029665120006916] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 8.5] [Reference Citation Analysis]
632 Kaako A, Al-Amer M, Abdeen Y. Bezlotoxumab use as adjunctive therapy with the third fecal microbiota transplant in refractory recurrent Clostridium difficile colitis; a case report and concise literature review. Anaerobe 2019;55:112-6. [PMID: 30521856 DOI: 10.1016/j.anaerobe.2018.11.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
633 Milosevic I, Vujovic A, Barac A, Djelic M, Korac M, Radovanovic Spurnic A, Gmizic I, Stevanovic O, Djordjevic V, Lekic N, Russo E, Amedei A. Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature. Int J Mol Sci. 2019;20:395. [PMID: 30658519 DOI: 10.3390/ijms20020395] [Cited by in Crossref: 82] [Cited by in F6Publishing: 79] [Article Influence: 27.3] [Reference Citation Analysis]
634 Chen Z, Ruan J, Li D, Wang M, Han Z, Qiu W, Wu G. The Role of Intestinal Bacteria and Gut-Brain Axis in Hepatic Encephalopathy. Front Cell Infect Microbiol 2020;10:595759. [PMID: 33553004 DOI: 10.3389/fcimb.2020.595759] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
635 Cani PD, Plovier H, Van Hul M, Geurts L, Delzenne NM, Druart C, Everard A. Endocannabinoids — at the crossroads between the gut microbiota and host metabolism. Nat Rev Endocrinol 2016;12:133-43. [DOI: 10.1038/nrendo.2015.211] [Cited by in Crossref: 161] [Cited by in F6Publishing: 154] [Article Influence: 23.0] [Reference Citation Analysis]
636 Lu HF, Ren ZG, Li A, Zhang H, Xu SY, Jiang JW, Zhou L, Ling Q, Wang BH, Cui GY, Chen XH, Zheng SS, Li LJ. Fecal Microbiome Data Distinguish Liver Recipients With Normal and Abnormal Liver Function From Healthy Controls. Front Microbiol 2019;10:1518. [PMID: 31333622 DOI: 10.3389/fmicb.2019.01518] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
637 Caussy C, Loomba R. Gut microbiome, microbial metabolites and the development of NAFLD. Nat Rev Gastroenterol Hepatol 2018;15:719-20. [PMID: 30158571 DOI: 10.1038/s41575-018-0058-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
638 Levy M, Thaiss CA, Elinav E. Metagenomic cross-talk: the regulatory interplay between immunogenomics and the microbiome. Genome Med 2015;7:120. [PMID: 26589591 DOI: 10.1186/s13073-015-0249-9] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.7] [Reference Citation Analysis]
639 Acharya C, Sahingur SE, Bajaj JS. Microbiota, cirrhosis, and the emerging oral-gut-liver axis. JCI Insight. 2017;2:e94416. [PMID: 28978799 DOI: 10.1172/jci.insight.94416] [Cited by in Crossref: 72] [Cited by in F6Publishing: 63] [Article Influence: 14.4] [Reference Citation Analysis]
640 Zhou W, Zhang, Li Z, Jiang H, Li J, Ren R, Gao X, Li J, Wang X, Wang W, Yang Y. The fecal microbiota of patients with pancreatic ductal adenocarcinoma and autoimmune pancreatitis characterized by metagenomic sequencing. J Transl Med 2021;19:215. [PMID: 34006295 DOI: 10.1186/s12967-021-02882-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
641 Fukui H, Wiest R. Changes of Intestinal Functions in Liver Cirrhosis. Inflamm Intest Dis. 2016;1:24-40. [PMID: 29922655 DOI: 10.1159/000444436] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
642 Ohtani N, Kawada N. Role of the Gut-Liver Axis in Liver Inflammation, Fibrosis, and Cancer: A Special Focus on the Gut Microbiota Relationship. Hepatol Commun. 2019;3:456-470. [PMID: 30976737 DOI: 10.1002/hep4.1331] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 11.0] [Reference Citation Analysis]
643 Shen H, Ye F, Xie L, Yang J, Li Z, Xu P, Meng F, Li L, Chen Y, Bo X. Metagenomic sequencing of bile from gallstone patients to identify different microbial community patterns and novel biliary bacteria. Sci Rep. 2015;5:17450. [PMID: 26625708 DOI: 10.1038/srep17450] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
644 Micó-Carnero M, Rojano-Alfonso C, Álvarez-Mercado AI, Gracia-Sancho J, Casillas-Ramírez A, Peralta C. Effects of Gut Metabolites and Microbiota in Healthy and Marginal Livers Submitted to Surgery. Int J Mol Sci 2020;22:E44. [PMID: 33375200 DOI: 10.3390/ijms22010044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
645 Liu J, Lkhagva E, Chung HJ, Kim HJ, Hong ST. The Pharmabiotic Approach to Treat Hyperammonemia. Nutrients 2018;10:E140. [PMID: 29382084 DOI: 10.3390/nu10020140] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
646 Mariadassou M, Pichon S, Ebert D, Grover JP. Microbial ecosystems are dominated by specialist taxa. Ecol Lett 2015;18:974-82. [DOI: 10.1111/ele.12478] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 7.0] [Reference Citation Analysis]
647 Zhu Z, Sun Y, Zhu F, Liu Z, Pan R, Teng L, Guo S. Seasonal Variation and Sexual Dimorphism of the Microbiota in Wild Blue Sheep (Pseudois nayaur). Front Microbiol 2020;11:1260. [PMID: 32670222 DOI: 10.3389/fmicb.2020.01260] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
648 Zhao J, Li G, Lu W, Huang S, Zhang Z. Dominant and Subordinate Relationship Formed by Repeated Social Encounters Alters Gut Microbiota in Greater Long-Tailed Hamsters. Microb Ecol 2020;79:998-1010. [PMID: 31807860 DOI: 10.1007/s00248-019-01462-z] [Reference Citation Analysis]
649 Wang W, Wei X, Wu L, Shang X, Cheng F, Li B, Zhou X, Zhang J. The occurrence of antibiotic resistance genes in the microbiota of yak, beef and dairy cattle characterized by a metagenomic approach. J Antibiot (Tokyo) 2021;74:508-18. [PMID: 34103703 DOI: 10.1038/s41429-021-00425-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
650 Nagao Y, Tsuji M. Effects of Hepatitis C Virus Elimination by Direct-Acting Antiviral Agents on the Occurrence of Oral Lichen Planus and Periodontal Pathogen Load: A Preliminary Report. Int J Dent 2021;2021:8925879. [PMID: 34804168 DOI: 10.1155/2021/8925879] [Reference Citation Analysis]
651 Levin BJ, Huang YY, Peck SC, Wei Y, Martínez-Del Campo A, Marks JA, Franzosa EA, Huttenhower C, Balskus EP. A prominent glycyl radical enzyme in human gut microbiomes metabolizes trans-4-hydroxy-l-proline. Science 2017;355:eaai8386. [PMID: 28183913 DOI: 10.1126/science.aai8386] [Cited by in Crossref: 73] [Cited by in F6Publishing: 61] [Article Influence: 14.6] [Reference Citation Analysis]
652 Cui S, Gu J, Liu X, Li D, Mao B, Zhang H, Zhao J, Chen W. Lactulose significantly increased the relative abundance of Bifidobacterium and Blautia in mice feces as revealed by 16S rRNA amplicon sequencing. J Sci Food Agric 2021;101:5721-9. [PMID: 33650140 DOI: 10.1002/jsfa.11181] [Reference Citation Analysis]
653 Guo Z, Zhang J, Wang Z, Ang KY, Huang S, Hou Q, Su X, Qiao J, Zheng Y, Wang L, Koh E, Danliang H, Xu J, Lee YK, Zhang H. Intestinal Microbiota Distinguish Gout Patients from Healthy Humans. Sci Rep 2016;6:20602. [PMID: 26852926 DOI: 10.1038/srep20602] [Cited by in Crossref: 92] [Cited by in F6Publishing: 99] [Article Influence: 15.3] [Reference Citation Analysis]
654 Oduaran OH, Tamburini FB, Sahibdeen V, Brewster R, Gómez-Olivé FX, Kahn K, Norris SA, Tollman SM, Twine R, Wade AN, Wagner RG, Lombard Z, Bhatt AS, Hazelhurst S. Gut microbiome profiling of a rural and urban South African cohort reveals biomarkers of a population in lifestyle transition. BMC Microbiol 2020;20:330. [PMID: 33129264 DOI: 10.1186/s12866-020-02017-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
655 Suzuki K, Endo R, Takikawa Y, Moriyasu F, Aoyagi Y, Moriwaki H, Terai S, Sakaida I, Sakai Y, Nishiguchi S, Ishikawa T, Takagi H, Naganuma A, Genda T, Ichida T, Takaguchi K, Miyazawa K, Okita K. Efficacy and safety of rifaximin in Japanese patients with hepatic encephalopathy: A phase II/III, multicenter, randomized, evaluator-blinded, active-controlled trial and a phase III, multicenter, open trial. Hepatol Res. 2018;48:411-423. [PMID: 29235218 DOI: 10.1111/hepr.13045] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
656 Chuaypen N, Jinato T, Avihingsanon A, Chirapongsathorn S, Cheevadhanarak S, Nookaew I, Tanaka Y, Tangkijvanich P. Improvement of Gut Diversity and Composition after Direct-Acting Antivirals in HCV-Infected Patients with or without HIV Coinfection. J Infect Dis 2021:jiab094. [PMID: 33598686 DOI: 10.1093/infdis/jiab094] [Reference Citation Analysis]
657 Li Q, Zhang M, Wu T, Liu R. Potential correlation between carbohydrate-active enzyme family 48 expressed by gut microbiota and the expression of intestinal epithelial AMP-activated protein kinase β. J Food Biochem 2020;44:e13123. [PMID: 31837163 DOI: 10.1111/jfbc.13123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
658 Rosenblum Lichtenstein JH, Hsu YH, Gavin IM, Donaghey TC, Molina RM, Thompson KJ, Chi CL, Gillis BS, Brain JD. Environmental mold and mycotoxin exposures elicit specific cytokine and chemokine responses. PLoS One 2015;10:e0126926. [PMID: 26010737 DOI: 10.1371/journal.pone.0126926] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
659 Yuan X, Chang C, Chen X, Li K. Emerging trends and focus of human gastrointestinal microbiome research from 2010-2021: a visualized study. J Transl Med 2021;19:327. [PMID: 34332587 DOI: 10.1186/s12967-021-03009-8] [Reference Citation Analysis]
660 Zhai S, Zhu Y, Feng P, Li M, Wang W, Yang L, Yang Y. Ochratoxin A: its impact on poultry gut health and microbiota, an overview. Poult Sci 2021;100:101037. [PMID: 33752074 DOI: 10.1016/j.psj.2021.101037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
661 Horvath A, Durdevic M, Leber B, di Vora K, Rainer F, Krones E, Douschan P, Spindelboeck W, Durchschein F, Zollner G, Stauber RE, Fickert P, Stiegler P, Stadlbauer V. Changes in the Intestinal Microbiome during a Multispecies Probiotic Intervention in Compensated Cirrhosis. Nutrients 2020;12:E1874. [PMID: 32585997 DOI: 10.3390/nu12061874] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
662 Li S, Qi Y, Ren D, Qu D, Sun Y. The Structure Features and Improving Effects of Polysaccharide from Astragalus membranaceus on Antibiotic-Associated Diarrhea. Antibiotics (Basel) 2019;9:E8. [PMID: 31877915 DOI: 10.3390/antibiotics9010008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
663 Qiao Y, Wu M, Feng Y, Zhou Z, Chen L, Chen F. Alterations of oral microbiota distinguish children with autism spectrum disorders from healthy controls. Sci Rep 2018;8:1597. [PMID: 29371629 DOI: 10.1038/s41598-018-19982-y] [Cited by in Crossref: 60] [Cited by in F6Publishing: 46] [Article Influence: 15.0] [Reference Citation Analysis]
664 Singer RE, Moss K, Kim SJ, Beck JD, Offenbacher S. Oxidative Stress and IgG Antibody Modify Periodontitis-CRP Association. J Dent Res 2015;94:1698-705. [PMID: 26318589 DOI: 10.1177/0022034515602693] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
665 Wang W, Xu S, Ren Z, Jiang J, Zheng S. Gut microbiota and allogeneic transplantation. J Transl Med 2015;13. [DOI: 10.1186/s12967-015-0640-8] [Reference Citation Analysis]
666 Panebianco C, Potenza A, Andriulli A, Pazienza V. Exploring the microbiota to better understand gastrointestinal cancers physiology. Clin Chem Lab Med 2018;56:1400-12. [PMID: 29630505 DOI: 10.1515/cclm-2017-1163] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
667 Lei Z, Zhang K, Li C, Jiao T, Wu J, Wei Y, Tian K, Li C, Tang D, Davis DI, Casper DP, Jiang H, Wang X, Wang J. Ruminal metagenomic analyses of goat data reveals potential functional microbiota by supplementation with essential oil-cobalt complexes. BMC Microbiol 2019;19:30. [PMID: 30717674 DOI: 10.1186/s12866-019-1400-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
668 El-Jurdi N, Ghannoum MA. The Mycobiome: Impact on Health and Disease States. Microbiol Spectr 2017;5. [PMID: 28597821 DOI: 10.1128/microbiolspec.FUNK-0045-2016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
669 Lobb B, Tremblay BJ, Moreno-Hagelsieb G, Doxey AC. PathFams: statistical detection of pathogen-associated protein domains. BMC Genomics 2021;22:663. [PMID: 34521345 DOI: 10.1186/s12864-021-07982-8] [Reference Citation Analysis]
670 Plichta DR, Graham DB, Subramanian S, Xavier RJ. Therapeutic Opportunities in Inflammatory Bowel Disease: Mechanistic Dissection of Host-Microbiome Relationships. Cell. 2019;178:1041-1056. [PMID: 31442399 DOI: 10.1016/j.cell.2019.07.045] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 30.5] [Reference Citation Analysis]
671 Zhao Y, Mao YF, Tang YS, Ni MZ, Liu QH, Wang Y, Feng Q, Peng JH, Hu YY. Altered oral microbiota in chronic hepatitis B patients with different tongue coatings. World J Gastroenterol 2018; 24(30): 3448-3461 [PMID: 30122883 DOI: 10.3748/wjg.v24.i30.3448] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
672 Shoaie S, Ghaffari P, Kovatcheva-Datchary P, Mardinoglu A, Sen P, Pujos-Guillot E, de Wouters T, Juste C, Rizkalla S, Chilloux J, Hoyles L, Nicholson JK, Dore J, Dumas ME, Clement K, Bäckhed F, Nielsen J; MICRO-Obes Consortium. Quantifying Diet-Induced Metabolic Changes of the Human Gut Microbiome. Cell Metab 2015;22:320-31. [PMID: 26244934 DOI: 10.1016/j.cmet.2015.07.001] [Cited by in Crossref: 248] [Cited by in F6Publishing: 213] [Article Influence: 41.3] [Reference Citation Analysis]
673 Zhao Y, Chen J, Hao Y, Wang B, Wang Y, Liu Q, Zhao J, Li Y, Wang P, Wang X, Zhang P, Zhang L. Predicting the recurrence of chronic rhinosinusitis with nasal polyps using nasal microbiota. Allergy 2021. [PMID: 34735742 DOI: 10.1111/all.15168] [Reference Citation Analysis]
674 Zhao Y, Xue F, Hua D, Wang Y, Pan X, Nan X, Sun F, Jiang L, Xiong B. Metagenomic Insights into Effects of Thiamine Supplementation on Carbohydrate-Active Enzymes' Profile in Dairy Cows Fed High-Concentrate Diets. Animals (Basel) 2020;10:E304. [PMID: 32074983 DOI: 10.3390/ani10020304] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
675 Sato K, Yokoji M, Yamada M, Nakajima T, Yamazaki K. An orally administered oral pathobiont and commensal have comparable and innocuous systemic effects in germ-free mice. J Periodontal Res 2018;53:950-60. [PMID: 30047130 DOI: 10.1111/jre.12593] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
676 Durack J, Boushey HA, Lynch SV. Airway Microbiota and the Implications of Dysbiosis in Asthma. Curr Allergy Asthma Rep 2016;16:52. [PMID: 27393699 DOI: 10.1007/s11882-016-0631-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
677 Bajaj JS, Betrapally NS, Hylemon PB, Thacker LR, Daita K, Kang DJ, White MB, Unser AB, Fagan A, Gavis EA, Sikaroodi M, Dalmet S, Heuman DM, Gillevet PM. Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus. Sci Rep. 2015;5:18559. [PMID: 26692421 DOI: 10.1038/srep18559] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 7.3] [Reference Citation Analysis]
678 Behary J, Amorim N, Jiang XT, Raposo A, Gong L, McGovern E, Ibrahim R, Chu F, Stephens C, Jebeili H, Fragomeli V, Koay YC, Jackson M, O'Sullivan J, Weltman M, McCaughan G, El-Omar E, Zekry A. Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma. Nat Commun 2021;12:187. [PMID: 33420074 DOI: 10.1038/s41467-020-20422-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 13.0] [Reference Citation Analysis]
679 Kriss M, Verna EC, Rosen HR, Lozupone CA. Functional Microbiomics in Liver Transplantation: Identifying Novel Targets for Improving Allograft Outcomes. Transplantation 2019;103:668-78. [PMID: 30507741 DOI: 10.1097/TP.0000000000002568] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
680 Yang L, Li Y, Wang S, Bian X, Jiang X, Wu J, Wang K, Wang Q, Xia J, Jiang S, Zhuge A, Yuan Y, Li S, Li L. Western Diet Aggravated Carbon Tetrachloride-Induced Chronic Liver Injury by Disturbing Gut Microbiota and Bile Acid Metabolism. Mol Nutr Food Res 2021;65:e2000811. [PMID: 33458949 DOI: 10.1002/mnfr.202000811] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
681 Özdirik B, Müller T, Wree A, Tacke F, Sigal M. The Role of Microbiota in Primary Sclerosing Cholangitis and Related Biliary Malignancies. Int J Mol Sci 2021;22:6975. [PMID: 34203536 DOI: 10.3390/ijms22136975] [Reference Citation Analysis]
682 Riella LV, Bagley J, Iacomini J, Alegre ML. Impact of environmental factors on alloimmunity and transplant fate. J Clin Invest 2017;127:2482-91. [PMID: 28481225 DOI: 10.1172/JCI90596] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
683 Vidot H, Cvejic E, Finegan LJ, Shores EA, Bowen DG, Strasser SI, McCaughan GW, Carey S, Allman-Farinelli M, Shackel NA. Supplementation with Synbiotics and/or Branched Chain Amino Acids in Hepatic Encephalopathy: A Pilot Randomised Placebo-Controlled Clinical Study. Nutrients 2019;11:E1810. [PMID: 31390762 DOI: 10.3390/nu11081810] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
684 López-Moreno A, Acuña I, Torres-Sánchez A, Ruiz-Moreno Á, Cerk K, Rivas A, Suárez A, Monteoliva-Sánchez M, Aguilera M. Next Generation Probiotics for Neutralizing Obesogenic Effects: Taxa Culturing Searching Strategies. Nutrients 2021;13:1617. [PMID: 34065873 DOI: 10.3390/nu13051617] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
685 Niu YW, Qu CQ, Wang GH, Yan GY. RWHMDA: Random Walk on Hypergraph for Microbe-Disease Association Prediction. Front Microbiol 2019;10:1578. [PMID: 31354672 DOI: 10.3389/fmicb.2019.01578] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
686 Lee S, Lee H, Kim S, Lee J, Ha J, Choi Y, Oh H, Kim Y, Lee Y, Choi KH, Yoon Y. Intestinal Clostridioides difficile Can Cause Liver Injury through the Occurrence of Inflammation and Damage to Hepatocytes. Biomed Res Int 2020;2020:7929610. [PMID: 33005688 DOI: 10.1155/2020/7929610] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
687 Fagan KJ, Rogers GB, Melino M, Arthur DM, Costello ME, Morrison M, Powell EE, Irvine KM. Ascites bacterial burden and immune cell profile are associated with poor clinical outcomes in the absence of overt infection. PLoS One. 2015;10:e0120642. [PMID: 25781164 DOI: 10.1371/journal.pone.0120642] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
688 Dobrijevic D, Abraham AL, Jamet A, Maguin E, van de Guchte M. Functional Comparison of Bacteria from the Human Gut and Closely Related Non-Gut Bacteria Reveals the Importance of Conjugation and a Paucity of Motility and Chemotaxis Functions in the Gut Environment. PLoS One 2016;11:e0159030. [PMID: 27416027 DOI: 10.1371/journal.pone.0159030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
689 Wadhawan A, Reynolds MA, Makkar H, Scott AJ, Potocki E, Hoisington AJ, Brenner LA, Dagdag A, Lowry CA, Dwivedi Y, Postolache TT. Periodontal Pathogens and Neuropsychiatric Health. Curr Top Med Chem 2020;20:1353-97. [PMID: 31924157 DOI: 10.2174/1568026620666200110161105] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
690 Gao R, Zhu Y, Kong C, Xia K, Li H, Zhu Y, Zhang X, Liu Y, Zhong H, Yang R, Chen C, Qin N, Qin H. Alterations, Interactions, and Diagnostic Potential of Gut Bacteria and Viruses in Colorectal Cancer. Front Cell Infect Microbiol 2021;11:657867. [PMID: 34307189 DOI: 10.3389/fcimb.2021.657867] [Reference Citation Analysis]
691 Jiang S, Ma C, Peng Q, Huo D, Li W, Zhang J. Microbial Profile and Genetic Polymorphism of Predominant Species in Some Traditional Fermented Seafoods of the Hainan Area in China. Front Microbiol 2019;10:564. [PMID: 30984126 DOI: 10.3389/fmicb.2019.00564] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
692 Lin R, Zhang Y, Chen L, Qi Y, He J, Hu M, Zhang Y, Fan L, Yang T, Wang L, Si M, Chen S. The effects of cigarettes and alcohol on intestinal microbiota in healthy men. J Microbiol 2020;58:926-37. [DOI: 10.1007/s12275-020-0006-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
693 Zhou X, Li J, Guo J, Geng B, Ji W, Zhao Q, Li J, Liu X, Liu J, Guo Z, Cai W, Ma Y, Ren D, Miao J, Chen S, Zhang Z, Chen J, Zhong J, Liu W, Zou M, Li Y, Cai J. Gut-dependent microbial translocation induces inflammation and cardiovascular events after ST-elevation myocardial infarction. Microbiome 2018;6:66. [PMID: 29615110 DOI: 10.1186/s40168-018-0441-4] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 15.0] [Reference Citation Analysis]
694 Su Z, Lu L, Chen F, Chen J, Chen X. Gut Microbiota and Sunitinib-Induced Diarrhea in Metastatic Renal Cell Carcinoma: A Pilot Study. Cancer Manag Res 2021;13:8663-72. [PMID: 34849023 DOI: 10.2147/CMAR.S328451] [Reference Citation Analysis]
695 Kronsten VT, Shawcross DL. Hepatic encephalopathy and depression in chronic liver disease: is the common link systemic inflammation? Anal Biochem 2021;:114437. [PMID: 34715068 DOI: 10.1016/j.ab.2021.114437] [Reference Citation Analysis]
696 Sultan S, El-Mowafy M, Elgaml A, El-Mesery M, El Shabrawi A, Elegezy M, Hammami R, Mottawea W. Alterations of the Treatment-Naive Gut Microbiome in Newly Diagnosed Hepatitis C Virus Infection.ACS Infect Dis. 2021;7:1059-1068. [PMID: 33119247 DOI: 10.1021/acsinfecdis.0c00432] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
697 Gitto S, Villa E. Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome after Liver Transplant. Int J Mol Sci. 2016;17:490. [PMID: 27049380 DOI: 10.3390/ijms17040490] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
698 Thoendel MJ, Jeraldo PR, Greenwood-Quaintance KE, Yao JZ, Chia N, Hanssen AD, Abdel MP, Patel R. Identification of Prosthetic Joint Infection Pathogens Using a Shotgun Metagenomics Approach. Clin Infect Dis 2018;67:1333-8. [PMID: 29648630 DOI: 10.1093/cid/ciy303] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 22.3] [Reference Citation Analysis]
699 Beraza N. Fibrosis and the intestinal microbiome; a focus on chronic liver disease. Curr Opin Pharmacol 2019;49:76-81. [PMID: 31670055 DOI: 10.1016/j.coph.2019.09.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
700 Marfil-Sánchez A, Zhang L, Alonso-Pernas P, Mirhakkak M, Mueller M, Seelbinder B, Ni Y, Santhanam R, Busch A, Beemelmanns C, Ermolaeva M, Bauer M, Panagiotou G. An integrative understanding of the large metabolic shifts induced by antibiotics in critical illness. Gut Microbes 2021;13:1993598. [PMID: 34793277 DOI: 10.1080/19490976.2021.1993598] [Reference Citation Analysis]
701 Patel VC, Williams R. Antimicrobial resistance in chronic liver disease. Hepatol Int. 2020;14:24-34. [PMID: 31797303 DOI: 10.1007/s12072-019-10004-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]